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Since the production of the first sheep by somatic cell nuclear transfer a great deal 
of effort has been made to improve efficiency and to understand nuclear reprogramming 
mechanisms. Unfortunately efficiency remains low, and nuclear reprogramming 
mechanisms remain uncharacterized. The objectives of this research were to identify 
factors associated with somatic cell nuclear transfer efficiency and to analyze the 
transcriptome of blastocyst-stage clone and control embryos and cotyledonary tissue in 
an effort to elucidate mechanisms responsible for the low developmental efficiency and 
high post-implantation losses. 
The experiments reported here identify factors including oocyte source and timing 
of activation following nuclear transfer that yield improved efficiencies. It was 
determined the use of cow oocytes for somatic cell nuclear transfer results in improved in 
vitro development and increased pregnancy rates. These data further indicate prolonged 
exposure of the donor nucleus to pre-activated oocyte cytoplasm results in increased 
nuclear fragmentation and reduced developmental efficiency in vitro. 
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Several aberrantly expressed genes were identified in nuclear transfer 
blastocysts and cotyledons that could impact cloning efficiency. Major histocompatibility 
complex I and down-regulator of transcription 1 were overexpressed in nuclear transfer 
blastocysts, and retinol binding protein 1 was overexpressed in nuclear transfer 
cotyledons. The functions of these genes in immune response, transcriptional regulation, 
and retinol binding and transport make them attractive candidates for further nuclear 
transfer research. 
Expression levels of six developmentally important genes were analyzed in 
various stages of preimplantation nuclear transfer embryos by real-time polymerase chain 
reaction to determine the timing of nuclear reprogramming following nuclear transfer. 
Five of the six genes were aberrantly expressed multiple developmental stages, however 
by the blastocyst stage only one gene was aberrantly expressed. These data indicate 
reprogramming is delayed in nuclear transfer embryos resulting in over- or under-
expression of developmentally important genes during early embryogenesis. 
These experiments report factors associated with improved nuclear transfer 
efficiency; provide insight into potential mechanisms for low developmental rates, 
abnormal placentation, and fetal loss of clones; and characterize the timing of nuclear 
reprogramming following somatic cell nuclear transfer.    
         (216 pages)  
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CHAPTER 1 
REVIEW OF LITERATURE 
Cloning by nuclear transfer (NT) involves the removal of DNA from an oocyte, 
yielding a cytoplast, followed by the transfer of foreign DNA (nucleus) into the cytoplast, 
thus producing an oocyte with the full complement of DNA and the potential to produce 
a living organism. Somatic cell nuclear transfer (SCNT) involves nuclear transfer with a 
differentiated cell. While relatively simple in principle, SCNT requires a dramatic 
remodeling and reprogramming of DNA following transfer of the differentiated cell or 
nucleus into a host cytoplast in order for the DNA to be converted from its differentiated 
state to a totipotent, embryonic state. Consequently, while research in the field of SCNT 
continues at a rapid pace, understanding the mechanisms involved in the reprogramming 
process as well as methods for improved efficiencies of SCNT development remain 
somewhat elusive.  
A Brief History of Cloning 
   The NT procedure was first devised by the German Nobel Laureate Hans 
Spemann in 1938 when he proposed an experiment involving the insertion of a nucleus 
into an enucleated oocyte. The idea was not pursued, however, because he did not have 
the equipment required to perform such an experiment (Spemann 1938). Briggs and King 
were the first to successfully utilize NT in the production of live offspring from metazoan 
cells. They reported the successful production of Northern Leopard Frog, Rana pipiens, 
tadpoles via NT in May of 1952 (Briggs and King 1952). Continued research by this 
same group later concluded that developmental potential of NT embryos declined as cells 
from increasingly more developed embryos were utilized for NT (King and Briggs 1956). 
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In 1966 frog larval nuclei were used to successfully produce fertile Xenopus frogs 
(Gurdon and Uehlinger 1966). The first attempts with SCNT in frogs provided evidence 
that somatic cells from a variety of sources including skin (Gurdon et al. 1975), 
lymphocytes (Wabl et al. 1975), erythrocytes (DiBerardino and Hoffner 1983), 
leukocytes, and erythroblasts (Di Berardino and Orr 1992)  were able to de-differentiate 
and yield morphologically normal tadpoles, however none of these tadpoles survived to 
adulthood. These results showed the potential of differentiated cells to derive numerous 
different cell types in a complex organism; however, the question remained whether adult 
cells could be reprogrammed back to totipotency.  
 Success with NT in mammals was not reported until the 1980’s. Initially 
experiments involving the transfer of pronuclei from one mouse embryo to another 
proved successful in producing live births, however they were unable to produce viable 
embryos beyond the blastocyst stage using blastomeres from cleavage-staged embryos as 
nuclear donors (McGrath and Solter 1984). Finally in 1986 Willadsen reported the 
production of completely viable sheep embryos derived from the transfer of 8- and 16-
cell blastomeres to enucleated oocytes that result in the birth of live lambs (Willadsen 
1986). In 1987, Prather et al. used essentially the same procedure to produce live cattle 
(Prather et al. 1987). Over the next few years, a number of other species successfully 
cloned from cells of preimplantation embryos followed including mice, rats, rabbits, pigs, 
goats, and monkeys (Di Berardino 2001). In an effort to stretch the envelope of NT and 
produce a larger number of genetically identical offspring, generational cloning or serial 
NT was implemented (Stice and Keefer 1993; Westhusin et al. 1991; Willadsen 1989). 
This technology involved producing embryonic clones then harvesting blastomeres from 
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those first generation clones and producing a second generation of clones by the same 
process. This could be repeated for several generations potentially resulting in several 
thousand cloned embryos derived from a single embryo. With continuing advances in 
nuclear transfer technology, the question remained: could offspring be produced by NT 
from differentiated cells? A number of embryonic stem cell-like lines were produced 
from mice (Piedrahita et al. 1990), cattle (Stice et al. 1996), sheep (Notarianni et al. 
1991), and pigs (Notarianni et al. 1990), but attempts at producing cloned animals from 
stem cell-like lines proved ineffective (Stice et al. 1996; Tsunoda and Kato 1993). 
 Based on early work with somatic cells and cultured stem cell-like cells it was 
believed that it was not possible to produce viable offspring from adult cells; however, in 
1994 Sims and First came a step closer reporting the successful production of cloned 
calves using inner cell mass (ICM) cells cultured in vitro for up to 28 days (Sims and 
First 1994). In 1996 Campbell et al. announced the production of five cloned sheep 
derived from in vitro cultured, putative differentiated ICM cells (Campbell et al. 1996b). 
The success with cultured cells was closely followed by the announcement of the birth of 
Dolly, the first cloned animal derived from an adult cell (Wilmut et al. 1997). The 
announcement of Dolly was significant in that it demonstrated a differentiated mammary 
cell derived from an adult animal was able to be reprogrammed to an embryonic state and 
give rise to a complete and healthy animal.  Since the first successful SCNT experiments 
in sheep, the technology has been applied in the production of a number of other species 
including mice (Wakayama et al. 1998), cattle (Wells et al. 1999), goats (Baguisi et al. 
1999), pigs (Polejaeva et al. 2000), mouflon sheep (Loi et al. 2001), rabbits (Chesne et al. 
2002), mules (Woods et al. 2003), cats (Shin et al. 2002b), rats (Zhou et al. 2003), a deer 
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(unpublished), horses (Galli et al. 2003b), a dog (Lee et al. 2005), and ferrets (Li et al. 
2006b), and the list continues to grow. 
Status of Somatic Cell Nuclear  
Transfer Technology 
While an incredible amount of research has focused on SCNT, and progress 
continues, the molecular events underlying the successful conversion of a differentiated 
somatic cell to a totipotent embryonic cell with the capacity to derive a healthy and 
normal animal remain poorly understood. Further, the efficiency with which this process 
occurs successfully remains very low. While it is difficult to ascertain the overall 
efficiencies due to differences in protocols, embryo transfer criteria, and data presentation 
the overall efficiency of SCNT across species based on the number of embryos produced 
is believed to be less than 5% (Campbell et al. 2005). In cattle approximately 10-15% of 
SCNT embryos transferred develop to term (Oback and Wells 2007). 
In addition to the problems associated with poor efficiency following SCNT 
including lower rates of development to the blastocyst stage in vitro (Chapter 2; Arat et 
al. 2003; Bhuiyan et al. 2004) lower rates of pregnancy establishment (Hill et al. 2000; 
Powell et al. 2004), and higher rates of pregnancy loss (Heyman et al. 2002) a number of  
other differences between SCNT and control embryos and fetuses have been reported. 
These include abnormal chromosome constitutions and higher incidence of aneuploidy in 
SCNT embryos (Bureau et al. 2003; Shi et al. 2004), abnormal gene expression patterns 
in SCNT embryos (Daniels et al. 2000; Han et al. 2003; Li et al. 2006a; Santos et al. 
2003) and fetuses (Hill et al. 2002; Schrader et al. 2003), delayed and incomplete 
demethylation followed by aberrant re-methylation of DNA in SCNT embryos and 
  5 
fetuses (Kang et al. 2001; Kang et al. 2002; Kang et al. 2003; Mann et al. 2003; Shi and 
Haaf 2002; Young and Beaujean 2004) and altered patterns of  histone acetylation in 
SCNT embryos and fetuses (Enright et al. 2003; Enright et al. 2005; Santos et al. 2003), 
and abnormal placentation often characterized by enlarged placentomes, edematious 
membranes, and hypovascularization of placentomes (Constant et al. 2006; Heyman et al. 
2002; Hoffert et al. 2005; Oishi et al. 2006). Given the complexity of the SCNT process, 
it is not surprising that a variety of different factors can affect efficiency.  
Factors Affecting SCNT Efficiency 
The inefficiencies associated with SCNT likely stem largely from deficiencies in 
the reprogramming process following NT. Following the transfer of a differentiated cell 
or nucleus into an enucleated oocyte, the DNA must be reprogrammed from a cell-type-
specific gene expression pattern to a totipotent embryonic-cell state. Modifications to the 
epigenetic state of the DNA are required in order for this to occur. 
Numerous factors can have an impact on the efficiency of nuclear reprogramming 
following nuclear transfer. These factors include the state and source of the donor cell, 
cytoplast source and quality, timing and methods of manipulation and activation, and 
embryo culture conditions. Evaluation of the literature associated with SCNT suggests 
that most if not all deficiencies associated with the low efficiency in cloning stem from 
failures or deficiencies in epigenetic reprogramming. 
State and Source of the Donor Cell 
A variety of donor cell types have been utilized to successfully produce cattle by 
SCNT including mammary (Kishi et al. 2000), adult and fetal skin (Hill et al. 2000), lung, 
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muscle (Powell et al. 2004), and granulosa (Wells et al. 1999) cells. Some reports 
indicate certain somatic cell types or culture conditions result in more efficient 
development following SCNT (Batchelder et al. 2005; Collas et al. 1992; Kasinathan et 
al. 2001; Lei et al. 2003; Powell et al. 2004), however there is no consensus as to the best 
somatic cell type or culture conditions for SCNT (Campbell et al. 2005). It has been 
proposed that cloning efficiency may be inversely correlated with the degree of donor 
cell differentiation (Jaenisch et al. 2002; Oback and Wells 2002). This is supported by the 
fact that embryonic cells and early fetal cells are generally more efficient in NT than 
adult somatic cells (Oback and Wells 2007). Contrary to expectation, NT with stem cells 
does not generally result in improved efficiency (Amano et al. 2001; Ono et al. 2001) and 
in fact can result in reduced efficiency compared with differentiated cells (Sung et al. 
2006). The reasons for the reduced efficiency of SCNT using adult stem cells are 
unknown. Additional research is required in order to more fully characterize the factors 
associated with donor cell epigenetic status that result in improved SCNT efficiency.       
Attempts have been made to improve the efficiency of NT by manipulation of the 
donor cell prior to NT. One approach is treatment of donor cells to change DNA 
methylation or histone acetylation levels to more closely approximate levels found in in 
vitro fertilized (IVF) embryos. The DNA methyl-transferase inhibitor 5-aza-2'-
deoxycytidine has been utilized to reduce DNA methylation levels in the transferred 
nucleus, and Trichostatin A, a histone deacetylase inhibitor has been used to increase 
histone acetylation (Enright et al. 2003; Enright et al. 2005; Shi et al. 2003). These 
approaches have demonstrated reduced DNA methylation and increased histone 
acetylation in preimplantation NT embryos, but to date, no report addressing the viability 
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of transferred embryos exists. Synchronization of donor cells using roscovitine, a cyclin 
dependent kinase 2-inhibitor has been reported to improve SCNT efficiency (Gibbons et 
al. 2002; Miyoshi et al. 2006).  
While it is clear donor cell type, culture conditions, and donor cell treatment can 
affect the efficiency of SCNT embryo development, it remains unclear what cell types, 
culture conditions and treatments result in the most efficient development following 
SCNT and by what mechanism such factors impact development.    
Cytoplast Source and Quality 
The recipient cytoplast likely has a more profound impact on the success of NT 
than the donor cell simply because it makes a more significant contribution to the 
reprogramming process. This is supported by the observation that SCNT  utilizing 
fertilized oocytes or oocytes activated prior to NT does not support in vitro development 
(Tani et al. 2001). In the early bovine embryo rRNA is not transcribed until the 4-cell 
stage (Viuff et al. 1998), and high transcriptional activity is not observed until the 8- to 
16-cell stage (Bilodeau-Goeseels and Panich 2002; Memili et al. 1998), so events of early 
embryogenesis are almost completely dependent on maternal transcripts and oocyte 
proteins. Differences in the developmental capacity of fetal, calf, and adult oocytes in 
IVF experiments have been noted by several groups (Pujol et al. 2004; Rizos et al. 2005) 
demonstrating important differences in developmental capacity depending on the source 
of oocytes. 
Little research has been done to evaluate the mechanisms by which differences in 
oocytes result in altered SCNT outcomes; however, it has been well established that calf 
oocytes differ from cow oocytes, and embryos derived from calf oocytes following IVF 
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are less developmentally competent than IVF embryos resulting from cow oocytes 
(Damiani et al. 1996; de Paz et al. 2001; Gandolfi et al. 1998; Khatir et al. 1998; 
Levesque and Sirard 1994; Majerus et al. 2000; Revel et al. 1995; Salamone et al. 2001).  
Studies of pre-pubertal calf oocytes have indicated they differ from cow oocytes 
in several important ways. It has been reported that IVF embryos derived from calf 
oocytes develop slower in vitro, arrest more frequently at the 9-cell stage, and exhibit a 
longer lag phase before maternal to zygotic transition (Majerus et al. 2000). Calf oocytes 
also undergo nuclear maturation at a slower rate than cow oocytes (Khatir et al. 1998). 
Gandolfi et al. (1998) reported that calf oocytes are smaller in diameter, metabolize 
glutamine and pyruvate at a lower rate during the first three h of IVM, and exhibit a 
decline in protein synthesis earlier as compared with cow oocytes (Gandolfi et al. 1998). 
Other groups have also reported different patterns of protein synthesis between cow and 
calf oocytes (Gandolfi et al. 1998; Levesque and Sirard 1994; Salamone et al. 2001). Calf 
oocytes contain more microvilli on their cell surface and more endocytic vesicles than 
cow oocytes, while cow oocytes contain a larger superior mitochondrial population than 
calf oocytes (de Paz et al. 2001). Numerous reports have indicated that fewer calf oocytes 
develop to blastocyst as compared with cow oocytes in IVF, parthenogenetic, and NT 
experiments (Damiani et al. 1996; Levesque and Sirard 1994; Majerus et al. 2000; Revel 
et al. 1995; Salamone et al. 2001). Additional work by Revel et al. (1995) indicated that a 
much lower pregnancy rate results from the transfer of blastocysts derived from calf 
oocytes (1 of 23 recipients; 4%) compared to cow-oocyte-derived blastocysts (10 of 26 
recipients; 38%). In this experiment, the single pregnancy established from calf embryos 
resulted in a full-term live calf (Revel et al. 1995). This indicates that although the overall 
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developmental competence of calf oocytes is much lower, some oocytes derived from 
pre-pubertal animals do have the capacity to direct development to term.     
 While many studies have evaluated the differences in developmental competence 
between cow and pre-pubertal calf oocytes fertilized in vitro, less attention has been 
given to potential differences between cow and heifer oocytes. There are several reports 
of differences between cow and heifer oocytes in terms of numbers of oocytes per ovary 
and in vitro developmental efficiency. Researchers have reported fewer oocytes collected 
from cows than from heifers following slaughter (Moreno et al. 1992) and also in 
conjunction with ovum pick up (Rizos et al. 2005). Researchers also compared the 
number and quality of oocytes from slaughtered crossbred beef heifers under 30 months 
and cows over 4 years old (Rizos et al. 2005). There were no differences observed in the 
number of oocytes collected per ovary; however, following IVF significantly more cow 
oocytes developed to the blastocyst stage on day 8 as compared to heifer oocytes (46.5% 
and 33.4%, respectively). In their experiment, heifer oocytes were further divided into 
groups based on the age of the donor (12-18 months, 19-24 months, and 25-30 months). 
There was no difference in development to the blastocyst stage between the three age 
groups (35.0%, 35.2%, and 36.5%, respectively). The superiority of cow oocytes over 
heifer oocytes in terms of development to blastocyst following IVF (27.5% and 16.4%, 
respectively) was also reported (Zhang et al. 1991). One group evaluated the 
developmental potential of oocytes collected from cows of different ages and found no 
significant difference in blastocyst yield between oocytes from 1-3 year old cows 
compared with oocytes from cows older than 3 years (Mermillod et al. 1992). A study 
involving the collection of oocytes from a slaughtered, Bovine Spongiform 
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Encephalopathy (BSE)-infected herd also compared development to the blastocyst 
stage using oocytes collected from heifers and cows. Cow oocytes developed into grade-
one blastocysts at a slightly higher efficiency than heifer oocytes (14.6% and 10.2% 
respectively) however the difference was not significant (Galli et al. 2003a).  
In addition to the scarcity of research evaluating the developmental competence 
of heifer oocytes, very little research has been done to evaluate the effect of oocyte 
source on bovine SCNT.  Two studies have evaluated the developmental competence of 
calf oocytes used in SCNT. Both reported lower rates of development to the 2-cell and to 
blastocyst stages compared with development using cow oocytes. In one study, cleavage 
of NT embryos was 75% with cow oocytes and 69% with calf oocytes, and blastocyst 
development was 21% and 9% respectively (Mermillod et al. 1998). A second study 
reported cleavage rates of 67% and 22% and blastocyst rates of 20% and 5% using cow 
and calf oocytes, respectively (Salamone et al. 2001).  
 In the environment of the recipient cytoplast following NT, the donor nucleus 
undergoes dramatic changes that result in the restoration of totipotency to a differentiated 
nucleus in a process referred to as nuclear reprogramming.  
The same machinery that is involved in chromatin modifications following 
fertilization is likely recruited for reprogramming of the donor nucleus following NT. 
Nuclear reprogramming of the donor cell following SCNT involves nuclear envelope 
breakdown (NEBD) and premature chromosome condensation (PCC; Barnes et al. 1993; 
Campbell et al. 1996a; Czolowska et al. 1984), followed by erasure of epigenetic 
modifications to DNA including changes in histone acetylation (Nakao 2001) and DNA 
methylation (Kang et al. 2003; Shi et al. 2003). Since maternal transcripts are responsible 
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for the events of early embryonic development (Telford et al. 1990), and given the 
events that occur naturally following fertilization, nuclear reprogramming is likely 
mediated by factors in the oocyte cytoplasm emphasizing the importance of selecting 
optimal oocytes for SCNT. While the effect of oocyte source and status on SCNT 
efficiency have not been extensively studied it is clear that these factors can have a 
profound impact on success. Indeed, the duration of in vitro maturation (Zakhartchenko 
et al. 2001), the exposure time of the donor nucleus to oocyte cytoplasm (Wells et al. 
1998), and differences in mitosis/meiosis/maturation-promoting factor (MPF) and 
mitogen activated protein (MAP) kinase levels within the oocyte (Lee and Campbell 
2006) have all been demonstrated to impact SCNT efficiency. MAP kinase within the 
oocyte has been shown to be involved in a number of different epigenetic reprogramming 
processes including histone deacetylase phosphorylation (Galasinski et al. 2002), histone 
H3 phosphorylation (Clayton and Mahadevan 2003) and changes in histone acetylation-
dependent DNA methylation (Gregory et al. 2001). With the extensive involvement of 
the oocyte cytoplasm on nuclear reprogramming it is clear that the oocyte can have a 
profound impact on SCNT efficiency. 
Oocyte maturation is another important factor in successful SCNT. As expected, 
in vivo matured oocytes have been shown to perform better for SCNT than in vitro 
matured oocytes (Wells et al. 1997), however collection of in vivo matured oocytes from 
livestock species is labor intensive, not cost effective, and therefore impractical for 
application in most SCNT programs. Continued research on the effect of oocyte source as 
well as maturation conditions on SCNT efficiency is required, along with further research 
to elucidate mechanisms associated with specific aspects of reprogramming.  
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Methods of Manipulation and Activation 
A great deal of research has evaluated numerous manipulation and activation 
protocols in an effort to develop methods resulting in improved SCNT efficiencies. 
SCNT typically involves the removal of DNA from a mature oocyte (enucleation) 
followed by the injection of a donor cell or nucleus either in the perivitelline space (donor 
cell), the space between the oocyte plasma membrane and the zona pellucida, or directly 
into the oocyte cytoplasm (nucleus). Injection of the cell into the perivitelline space 
requires a subsequent fusion step in order to fuse the donor cell and oocyte membranes 
and introduce the donor nucleus into the oocyte cytoplasm. Usually following, but 
sometimes preceding NT, activation of the embryo is required in order to signal the 
oocyte to initiate cell division. In the case of natural fertilization, the interaction between 
the sperm and the oocyte triggers this activation event, but with SCNT a synthetic 
activation is required. A variety of methods have been employed for manipulation and 
activation of SCNT embryos with varying degrees of success.  
The most common method for enucleation employs the use of a small polished 
glass holding pipette to keep the oocyte stationary and an enucleation pipette that is used 
to pierce the zona pellucida and plasma membranes and aspirate both the DNA within the 
cytoplasm of the oocyte and the associated first polar body (Li et al. 2004). Other 
methods include chemically-induced enucleation using etoposide  (Elsheikh et al. 1998), 
etoposide in conjunction with cycloheximide (Fulka and Moor 1993), and ethanol with 
demecolcine (Ibanez et al. 2003). While these methods greatly facilitate the enucleation 
process, development of NT embryos following chemically-induced enucleation remains 
lower than development of mechanically enucleated oocytes (Gasparrini et al. 2003). 
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Zona-free cloning methods have also been employed successfully in bovine and 
porcine SCNT (Oback et al. 2003; Peura 2003; Vajta et al. 2001). This method does not 
require micromanipulation and has the potential to be automated, but the culture 
requirements for zona-free embryos are more problematic than for manually manipulated 
embryos and for this reason has not found wide acceptance in the field (Vajta et al. 2005). 
Researchers have evaluated the effect of manipulation and activation of oocytes in 
various stages of meiosis on SCNT efficiency. Two predominant methods have been 
successfully utilized for NT. The first is a protocol in which the donor nucleus is 
transferred into a pre-activated, enucleated cytoplast. The other protocol involves the 
transfer of a donor nucleus into a metaphase II (MII)-arrested cytoplast followed by 
subsequent activation. The latter protocol results in much more efficient development to 
blastocyst in bovine NT and is therefore most frequently used (Shin et al. 2002a). The 
extremely low in vitro efficiency using pre-activated cytoplasts has precluded the transfer 
and pregnancy evaluation of pre-activated SCNT embryos so no data exist reporting post-
transfer developmental potential.   
In addition to the effects of manipulation methods and timing of the NT on SCNT 
efficiency, timing and method of activation has been shown to impact efficiency. Several 
groups have shown that the duration of exposure of the donor nucleus to oocyte 
cytoplasm affects in vitro development. Exposure of transferred nuclei to cytoplasm for 
less than 30 min prior to activation yielded significantly lower blastocyst development 
than 2 h exposure (Liu et al. 2001). However, excessive exposure of the donor DNA to 
oocyte cytoplasm results in lower rates of in vitro development in cloned embryos (Akagi 
et al. 2001). Most recently, Choi et al. demonstrated that in vitro development of bovine 
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NT embryos to blastocyst decreased as time in hold was increased from one to five h 
(Choi et al. 2004). However, little data exist indicating the viability to term of SCNT 
embryos based on timing of activation following exposure of the transferred nuclei to 
recipient cytoplasm until publication of results contained in this dissertation. The 
mechanisms underlying the differences observed in development rates based on the 
duration of cytoplasmic exposure prior to activation remain obscure. 
Following normal fertilization, activation by the sperm elicits regular, repetitive 
intracellular calcium transients. Activation results in resumption of meiosis, cortical 
granule release, decondensation of the sperm nucleus, and formation of male and female 
pronuclei. As the donor cell does not have the capacity to activate the oocyte, artificial 
means of activation are required. Early on it was discovered that mature oocytes could 
undergo parthenogenetic activation in the absence of the male gamete using a number of 
physical and chemical methods (Kaufman and Gardner 1974).  A number of 
parthenogenetic activation protocols have been applied successfully to SCNT. A short, 
high voltage electrical pulse can be used to create transient pores in cellular membranes 
allowing the influx of calcium from extra-cellular pools (Zimmermann and Vienken 
1982). Treatment with Ca2+ ionophores such as ionomycin result in the influx of Ca2+  as 
well as the release of Ca2+  from intracellular  stores (Steinhardt et al. 1974). Exposure of 
the embryo to 7% ethanol has been used in mice to induce Ca2+ release and activation 
(Ilyin and Parker 1992). Inhibition of protein synthesis using agents such as 
cycloheximide or puromycin induces activation in mouse (Siracusa et al. 1978) and 
human oocytes (Balakier and Casper 1993), however more efficient activation occurs 
with a combination of calcium stimulus in conjunction with protein synthesis inhibition 
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(Presicce and Yang 1994; Tanaka and Kanagawa 1997). While a number of methods 
have been demonstrated for activation of bovine SCNT embryos, none of the present 
alternatives closely mimic physiological activation following fertilization, and none stand 
out as being significantly better than the rest (Atabay et al. 2003; Bhak et al. 2006; Hill et 
al. 1999a; Yamazaki et al. 2005).  Substantial research evaluating the post-transfer 
developmental potential of SCNT embryos generated by different activation protocols is 
lacking. There is certainly a need for continued and substantially more research effort 
evaluating the long term developmental impacts of various oocyte activation protocols in 
SCNT outcomes. 
Embryo Culture 
Another critical and relatively deficient component in the SCNT process is 
embryo culture. Following NT and activation, bovine embryos are generally cultured in 
vitro for 6-7 day prior to transfer. To date no in vitro embryo culture system rivals in vivo 
culture in terms of development efficiency and embryo quality when considering the 
outcome of any assisted reproduction approach. Bovine SCNT embryos have been 
successfully cultured in a number of different media. Typical media used for bovine 
SCNT include CR1aa (Rosenkrans and First 1994), Synthetic Oviductal Fluid (SOF) 
(Brandao et al. 2004), and G1/G2 medium (Krisher et al. 1999). Attempts to improve in 
vitro development efficiency of bovine IVF and SCNT embryos have resulted in a wide 
variety of culture media and culture environments. The use of a monolayer of co-culture 
cells was shown in the mid-1980s to improve the developmental rates of both in vivo- and 
in vitro-produced bovine embryos cultured for various periods of time (Kuzan and 
Wright 1982). Fukui determined in 1991 that embryos not cultured with co-culture cells 
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grew better in environments with less than 20% oxygen (Fukui et al. 1991). While 
great strides have been made to improve bovine embryo culture conditions, culture 
conditions remain sub-optimal for both IVF embryos and SCNT embryos. Currently, 
under the best conditions, rates of development of bovine IVF and SCNT embryos to 
blastocyst remain about 40%. Even more troubling is the more frequent occurrence of 
complications during pregnancy associated with in vitro-cultured embryos as compared 
with in vivo-produced (IVP) embryos. While increased occurrence of complications 
during pregnancy is likely associated with in vitro culture, the problems occur more 
frequently in SCNT pregnancies than in IVF pregnancies. Increased incidences of large 
offspring syndrome (LOS), characterized by abnormally large fetuses, extended gestation 
length, and difficult parturition, and hydrallantois, a condition associated with excessive 
accumulation of allantoic fluid, have been associated with both IVF and SCNT 
pregnancies (Young et al. 1998), however the severity and frequency of both LOS and 
hydrallantois is significantly greater following SCNT (Constant et al. 2006; Hill et al. 
1999b; Lawrence et al. 2005). The problems common to IVF and SCNT pregnancies are 
most likely a consequence of the in vitro culture conditions and specifically the presence 
of serum or bovine serum albumin (BSA) in the culture medium (Lazzari et al. 2002).  
These observations have provided increased impetus to develop completely 
defined media and further improved culture conditions in which to culture embryos (Lim 
et al. 2007). The elimination of the need for co-culture cells, serum, and BSA, which 
introduce variability as well as many uncharacterized factors into the culture, has been a 
focus of much research. Sequential media such as G1/G2 in which different media are 
used at different stages in the culture process are also being developed in an effort to 
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further mimic physiological conditions. Despite the progress made thus far, sub-
optimal embryo culture conditions remain a contributing problem to the inefficiencies 
associated with SCNT.  
Epigenetics 
Epigenetics refers to stable and heritable changes in gene expression beyond the 
scope of conventional genetics. In other words, gene expression in a cell is not controlled 
exclusively by the DNA sequence, but also by these stable “epigenetic” influences to 
specific genes (Jaenisch and Bird 2003). In addition to their importance in differentiation 
of tissue types during development, epigenetic alterations can also arise randomly or as a 
result of environmental influence (Issa 2000). The genome adapts to developmental or 
environmental cues either by post-synthetic modification to DNA or by modification of 
proteins associated with DNA. It is believed that epigenetic modifications have arisen 
and evolved as a genome defense against viruses and other parasitic sequences (Matzke 
et al. 1999). Cellular differentiation occurs as a consequence of epigenetic modifications 
imposed upon the genome. These epigenetic modifications direct the expression patterns 
of cell-type-specific genes; therefore SCNT necessitates the reprogramming of the donor 
cell carrying cell-type specific epigenetic modifications in order for every cell type to be 
derived from a once-differentiated donor cell. It is widely believed that incomplete or 
improper epigenetic reprogramming following SCNT results in the low efficiency as well 
as the phenotypic problems observed in clones. 
Epigenetic Mechanisms  
A variety of epigenetic modifications to DNA and its associated proteins have 
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been characterized. These modifications can serve either to silence expression or to 
enhance transcription of specific genes. Predominant epigenetic modifications include 
DNA methylation, and modifications to histones including methylation, acetylation, 
ribosylation, phosphorylation, and ubiquitination. 
DNA methylation. In 1975, Holliday and Pugh suggested DNA methylation might 
be a mechanism whereby a stable pattern of gene expression is maintained through 
mitosis (Holliday and Pugh 1975). More recently, it has been shown that methylation of 
DNA usually, though not always, has a silencing effect on chromatin (Wolffe and Matzke 
1999). Methylation is a post-synthetic modification that generally occurs at the 5’-
position of cytosines of the CpG dinucleotide.  
While the protein(s) involved in active demethylation during early development 
have not yet been characterized, several proteins have been implicated in cytosine 
methylation (Jaenisch and Bird 2003). These DNA methyltransferases (Dnmt) function to 
methylate cytosines by catalyzing the transfer of CH3 from S-adenosylmethionine to 
carbon 5 of cytosine (Strathdee and Brown 2002). The methyltransferase family includes 
Dnmt 1, Dnmt 1o, Dnmt 2, Dnmt 3a, Dnmt 3b, and Dnmt 3L.  
Some understanding of the functions of these proteins has been gained through 
the study of mice with mutations of the various Dnmt genes. Dnmt 1 (Li et al. 1992) and 
the oocyte-specific isoform Dnmt 1o (Howell et al. 2001) exhibit a high binding affinity 
for hemi-methylated DNA and are responsible for the maintenance of methylation on the 
newly synthesized strand of DNA. A mutation in Dnmt 2 (Okano et al. 1998) yields no 
phenotypic change, perhaps owing to a redundancy in the developmentally critical system 
of DNA methylation. In Drosophila Dnmt 2 has been shown to have non-CpG 
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methylation activity (Lyko et al. 2000). Dnmt 3a and Dnmt 3b (Okano et al. 1999) are 
present at high levels in the early mouse embryo and are responsible for global de novo 
methylation  subsequent to active and passive demethylation in the paternal and maternal 
genomes, respectively following fertilization. Dnmt 3L functions in concert with Dnmt 
3a and Dnmt 3b in establishing proper maternal imprinting (Bourc'his et al. 2001). 
It is still somewhat unclear how the seemingly minor modification of DNA 
methylation can have such a profound impact gene expression. There are several 
proposed models for its influence: methylation may prevent the binding of protein 
regulators to their targets, involvement of regulatory proteins that bind only to methylated 
DNA, or methylation of DNA changes its structural properties (Urnov and Wolffe 2001). 
There is data to suggest that all three models may play roles, but regulatory 
proteins that bind only methylated DNA have been studied most extensively. A group of 
four proteins known as methylated-DNA binding domain proteins  (MBD1-MBD4) have 
been shown to preferentially bind to the CpG dinucleotide in which the cytosine is 
methylated (Hendrich et al. 2001). MBD1, MBD2, and MBD3 function as transcription 
repressors (Bird and Wolffe 1999), while MBD4 is a protein involved in mismatch repair 
(Hendrich et al. 1999). Gene targeting in mice of different Mbd genes results in effects 
ranging in severity from defective maternal behavior to lethality depending on the MBD 
targeted (Hendrich et al. 2001).  
Histone modifications. In addition to DNA methylation as an epigenetic 
modification, histone modifications also function as epigenetic marks to the genome. 
Covalent modifications to histones such as methylation, acetylation, phosphorylation, 
ADP ribosylation, and ubiquitination have a direct impact on chromatin structure, which 
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in turn acts as a modulator of gene expression (Goll and Bestor 2002). Histones are the 
primary proteins responsible for the packaging of genomic DNA. The basic repeating 
unit of chromatin is the nucleosome. The nucleosome consists of 146 bp of DNA 
wrapped around a core composed of eight histones- two copies each of H2A, H2B, H3, 
and H4 (Kornberg and Lorch 1999).  
 Post-translational modifications to histones are mediated by histone-modifying 
and chromatin-modifying enzymes. Examples of these enzymes are histone 
acetyltransferases (HATs), deacetylases (HDACs), and histone methyltransferases 
(HMTs). The complex array of histone modifications observed experimentally gave rise 
to the histone code hypothesis- the idea that histone modifications may be interdependent 
and together they impact chromatin structure in such a way as to affect gene activation or 
inactivation (Strahl and Allis 2000). Each of the four core histones can be modified at a 
variety of sites. The number of different modifications and the multiple sites at which the 
modifications can occur yields an incredibly large number of possible combinations, 
which has made characterization of the histone code quite difficult. 
Genomic imprinting. Epigenetic modifications are also responsible for genomic 
imprinting, a mechanism whereby one of the two copies of a gene within a genome is 
silenced and only one remains active. At least 45 imprinted genes have been identified in 
the mouse, and of these genes, about 80% are clustered with other imprinted genes. 
Initially, imprints are established during spermatogenesis and oogenesis. After 
fertilization, while most genes are demethylated and re-methylated, imprinted genes 
maintain their native methylated or demethylated state throughout the reprogramming 
process. During early embryonic development, the imprints are erased in the germ cells 
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then re-established later in development (Reik et al. 2001). 
As with other epigenetic modifications, genomic imprinting probably arose in 
response to parasitic DNA. It is possible that gene sequences located near these regions 
of foreign DNA were silenced as an extension of the normal epigenetic silencing of 
neighboring sequences. Imprints established in this way that conferred a selective 
advantage were propagated, and others were eliminated (Barlow 1993). 
X-chromosome inactivation. An interesting epigenetic mechanism has evolved in 
mammals to compensate for differences in X-linked gene dosage between males (XY) 
and females (XX). In placental mammals and marsupials, one of the X chromosomes is 
inactivated by modification of chromosome architecture. The modifications that 
inactivate the chromosome include DNA methylation and histone deacetylation. 
Interestingly, the decision of which X-chromosome to inactivate in the embryo proper is 
random, whereas in extra-embryonic tissues, the paternal X is always chosen for 
inactivation (Park and Kuroda 2001). 
Epigenetic Reprogramming 
Following Fertilization 
A dramatic demonstration of the dynamic involvement of epigenetics in 
development is demonstrated by the reprogramming events that occur during germ cell 
and early embryonic development in mammals. During germ cell development the 
genomes of both the sperm and the egg are globally demethylated then re-methylated- 
prior to meiosis in the male (Davis et al. 2000) and during the oocyte growth phase of 
meiotic arrest in the female, so that prior to fertilization, sperm and egg genomes are 
much more highly methylated than somatic cells (Obata et al. 1998). At fertilization, 
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sperm chromatin is actively demethylated, possibly by direct removal of the methyl 
group from the cytosine (Bhattacharya et al. 1999) or by exchange of the 5-
methylcytosine with unmethylated cytosine via base excision (Weiss et al. 1996). The 
mechanisms responsible for active demethylation of the paternal genome following 
fertilization remain uncharacterized (McLay and Clarke 2003) although enzymatic 
catalysis is most likely involved (Morgan et al. 2005). The maternal genome is also 
demethylated during early development, but in a passive, replication-dependent manner, 
such that the original DNA retains its methylation, but newly replicated strands are not 
methylated. This global demethylation is subsequently followed by de novo methylation 
of the genome starting at the 8- to 16-cell stage in bovine embryos and the blastocyst 
stage in mice resulting in differentiation of cell lineages during development (Reik et al. 
2001). 
The successes achieved following SCNT suggest the same oocyte components 
that are involved in the reprogramming events observed following fertilization can also 
be utilized to de-differentiate a somatic cell and return it to a totipotent embryonic state. 
The epigenetic modifications to the chromatin of a fibroblast distinguish it from an 
embryonic cell or any other cell type. Following SCNT, the epigenetic state of the donor 
cell is reprogrammed such that its epigenetic state closely resembles that of an embryonic 
cell. 
Epigenetic Reprogramming  
Following SCNT 
Epigenetic reprogramming is essential in order for SCNT be successful. During 
nuclear reprogramming epigenetic marks are erased from the donor nucleus genome, 
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resulting in an erasure of tissue-specific gene expression patterns effectively resetting 
the cell to a totipotent state (Santos and Dean 2004). Studies evaluating the epigenetic 
status of embryos following SCNT have demonstrated deficiencies in epigenetic 
reprogramming frequently occur. These deficiencies are made manifest in several ways 
including changes in histone modifications, DNA methylation patterns, and gene 
expression. 
Several studies have evaluated differences in epigenetic modifications following 
SCNT. Hypermethylation of lysine 9 on histone H3 (H3-K9) as well as DNA 
hypermethylation was reported in the majority of bovine preimplantation SCNT embryos 
in one study (Santos et al. 2003). A number of studies evaluating the reprogramming 
dynamics of epigenetic modifications in vitro following NT have also been reported. 
Evaluation of DNA methylation patterns in developing NT embryos indicates 
demethylation and remethylation events are not always faithfully recapitulated in the 
mouse (Chung et al. 2003; Mann et al. 2003; Shi and Haaf 2002) and the cow (Bordignon 
et al. 2001; Dean et al. 2001; Kang et al. 2002). It is also clear that histone acetylation is 
sometimes aberrant in bovine SCNT embryos (Enright et al. 2003). This incomplete 
epigenetic reprogramming is the predominant explanation for the frequent aberrant gene 
expression in NT embryos and the subsequent failures in development (Santos et al. 
2003). 
Immunofluorescent staining of bovine NT embryos with an antibody directed 
against 5-methyl-cytosine by Dean et al. (2001) demonstrated the occurrence of active 
demethylation of the donor chromatin shortly after fusion similar to the active 
demethylation of sperm chromatin observed following fertilization (Dean et al. 2001). 
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However, de novo methylation occurred starting in 4-cell NT embryos as compared to 
normal bovine embryos, which exhibit de novo methylation at the 8- to 16-cell stage 
(Dean et al. 2001; Reik and Dean 2001). The enzymes responsible for DNA 
demethylation may follow a pattern of activity similar to maturation promoting factor 
(MPF) with high activity prior to activation and a diminishing of activity following 
activation. Further research will be required to determine those dynamics, but based on 
one study there appears to be a critical window of time in which active demethylation can 
occur following fusion (Dean et al. 2001). The idea of this critical window between 
fusion and activation is supported by the work of Bourc'his et al. (2001) in which active 
demethylation was not observed when activation was performed at the time of fusion 
(Bourc'his et al. 2001).  
Other studies have focused on epigenetic reprogramming of specific genes 
following SCNT. Evaluation of methylation patterns of imprinted genes following SCNT 
indicates methylation errors at imprinted loci are common (Humpherys et al. 2002; Mann 
et al. 2003; Mann et al. 2004). In addition, errors in X-inactivation (Eggan et al. 2000; 
Jiang et al. 2007; Xue et al. 2002) and failures to activate important pluripotency genes 
have been observed in SCNT embryos (Boiani et al. 2002; Bortvin et al. 2003). Critical 
errors in the fundamental epigenetic state of chromatin during early development 
following SCNT are likely the foundation for the numerous other deficiencies observed 
in clones (Fulka and Fulka 2007).  
Nuclear Organization and Gene  
Expression Following SCNT 
In addition to the requirement for correct epigenetic reprogramming, it is also 
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necessary that a diploid chromosome constitution be maintained to ensure proper 
development. In order for proper ploidy to be maintained in a NT embryo, donor cell 
chromosomes must be condensed prior to activation, and following activation, a single 
pronucleus should appear as the chromatin decondenses in preparation for DNA 
replication. 
MPF is an enzyme that is highly active in the MII oocyte and is a key factor in 
nuclear remodeling prior to activation or fertilization. MPF is a protein kinase composed 
of two proteins, cyclin and p34cdc2 (Gautier et al. 1990). The active kinase is responsible 
for the resumption of mitosis or meiosis. Prior to activation or fertilization in the MII-
arrested oocyte, MPF activity is high then following activation its activity declines 
rapidly (Campbell et al. 1993a).  Several significant morphological changes occur in the 
donor nucleus following NT into cytoplasts with high MPF activity. These changes 
include NEBD and PCC (Campbell et al. 1996a; Czolowska et al. 1984). Following these 
two events, the nuclear envelope is reformed, and DNA synthesis commences (Campbell 
et al. 1993b).  
 NEBD is essential for cytoplasmic spindle microtubules to gain access to 
chromosomes prior to resumption of meiosis or mitosis. MPF, at least in part, facilitates 
the breakdown of the nuclear membrane by phosphorylation of nuclear lamins resulting 
in their depolymerization (Peter et al. 1990). Phosphorylation of nuclear pore complex 
subunits further destabilizes the nuclear envelope (Macaulay et al. 1995). More recently it 
has been proposed that mechanical tearing of the lamina by microtubules might work in 
conjunction with phosphorylation events to break down the nuclear envelope (Beaudouin 
et al. 2002).  
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As the name implies, PCC involves the condensation of chromatin, which 
occurs prematurely in the donor nucleus. It has been demonstrated that when an s-phase 
nucleus undergoes PCC, the chromatin appears pulverized (Schwartz et al. 1971). 
Additionally, an increased incidence of chromosomal abnormalities in s-phase nuclei that 
underwent PCC has been reported (Collas et al. 1992). Several studies have reported 
problems with nuclear organization and ploidy following SCNT (Alberio et al. 2001; Li 
et al. 2005; Wakayama et al. 2003). 
In addition to problems associated with nuclear organization following SCNT, a 
number of groups have reported aberrant expression of genes in SCNT embryos and 
fetuses, an additional manifestation of incomplete or improper epigenetic 
reprogramming. One study used microarray analysis to compare global gene expression 
profiles of bovine somatic donor cells, SCNT blastocysts, IVF blastocysts, and IVP 
blastocysts. Based on these studies it was determined that a significant amount of 
reprogramming has occurred by the blastocyst stage as SCNT expression profiles 
resembled profiles for control embryos generated by IVF and artificial insemination (AI)  
much more closely that their progenitor donor cells (Smith et al. 2005). The study 
reported 50 genes differentially expressed between SCNT and IVP blastocysts, an 
indication that, while a substantial amount of reprogramming has occurred properly in the 
conversion of a somatic cell epigenetic pattern to that of an embryo; there are still 
deficiencies in the reprogramming process. Another study evaluated the transcriptome of 
mouse SCNT and IVP embryos during the first two cell cycles. During the second cell 
cycle over 1000 genes were differentially expressed in SCNT embryos indicating the 
reprogramming process occurs over several cell cycles, and the divergence in gene 
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expression patterns narrows greatly by the blastocyst stage (Vassena et al. 2007a). 
Numerous other studies report aberrant gene expression in SCNT embryos (Beyhan et al. 
2007; Li et al. 2006a; Vassena et al. 2007b), placentas (Oishi et al. 2006; Patel et al. 
2004), conceptuses (Moore et al. 2007; Schrader et al. 2003), and neonates (Jiang et al. 
2007; Li et al. 2007).   
Summary 
A great deal of research and effort has been focused on SCNT over the past 
decade, and while progress continues, SCNT is still very inefficient in terms of rates of 
development in vitro and to a greater extent survival to term. A growing body of data 
supports the idea that a common thread between nearly all deficiencies associated with 
SCNT is inappropriate epigenetic reprogramming of the somatic cell nucleus as manifest 
by genes being expressed when they should not be, not expressed when they should be, 
or most commonly expressed at altered levels. The efficiency and fidelity with which 
epigenetic reprogramming occurs is undoubtedly affected by all of the factors discussed 
in this review including factors associated with the donor cell and cytoplast, manipulation 
and activation procedures, and embryo culture conditions. An increased understanding of 
how each of these factors impacts epigenetic reprogramming and further improvements 
in each of these areas will continue to result in increased SCNT efficiency.   
Research Goals and Possible Applications of Project 
 The focus of my research includes two primary objectives associated with bovine 
SCNT; first to characterize factors associated with the process of SCNT that impact 
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efficiency, specifically oocyte source and activation timing, and second to characterize 
gene expression differences between SCNT and control embryos and placental tissues.  
In the first objective I determined that the use of oocytes derived from cows in 
SCNT results in greatly improved rates of development to term compared with heifer 
oocytes. I also found that prolonged exposure of the somatic nucleus to oocyte cytoplasm 
prior to activation results in nuclear fragmentation and reduced embryonic viability.  
The subsequent gene expression studies revealed a variety of genes 
inappropriately expressed in SCNT embryos and placentomes. Global gene expression 
analysis of SCNT and AI blastocysts as well as fibroblast donor cells substantiated 
previous findings as well as revealed a novel subset of aberrantly-expressed genes in 
SCNT embryos. Microarray analysis of the fetal component of the placenta associated 
with maternal/fetal nutrient exchange, the cotyledon, revealed a smaller subset of 
differentially expresses genes. Of note, major histocompatibility complex I and down-
regulator of transcription 1 were overexpressed in SCNT embryos and retinol binding 
protein 1 was overexpressed in SCNT cotyledons. 
Comparisons of embryonic and fibroblast transcriptomes provided a large list of 
differentially expressed genes from which six developmentally important genes were 
selected for more detailed analysis. For this analysis Quantitative Reverse Transcriptase 
PCR (Q-RT-PCR) was utilized to evaluate the expression levels of genes in various 
stages of SCNT and IVF. For five of the six genes analyzed, aberrant expression was 
detected in multiple developmental stages, however by the blastocyst stage only one gene 
was aberrantly expressed in nuclear transfer embryos. This data indicate reprogramming 
is delayed in nuclear transfer embryos resulting in over- or under-expression of 
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developmentally important genes during early embryogenesis however the majority of 
aberrant expression is rectified by the blastocyst stage. These experiments provided a 
detailed analysis of reprogramming dynamics following SCNT for a group of 
developmentally important genes. 
Somatic cell nuclear transfer offers promise for many different applications 
including rescue of endangered species, production of animals with genetically superior 
traits, biopharmaceutical production, xenotransplantation applications, and stem cell 
production. As SCNT efficiency increases the utility of the process will lend to further 
advances in these applications. In addition, an understanding of the factors that affect 
SCNT efficiency will offer insights into the complex and poorly understood field of 
epigenetic reprogramming. The complex processes by which epigenetic modifications are 
initiated and propagated and the mechanisms by which these modifications effect gene 
expression are beginning to be characterized. There remains, however, much to be 
learned in this area including understanding how specific environmental cues function to 
bring about epigenetic changes and how specific genes are targeted for silencing or 
activation by epigenetic controls. Continued research in the field of epigenetics will 
undoubtedly open doors to increased understanding in many related fields. 
References 
Akagi S, Yokota M, Neguebi T, Taniyama A, Fuebimoto D, Izaile Y. 2001. The timing 
of fusion and chemical activation in nuclear transfer affects development potential 
of bovine embryos. Theriogenology 55(1):252. 
  30 
Alberio R, Brero A, Motlik J, Cremer T, Wolf E, Zakhartchenko V. 2001. Remodeling 
of donor nuclei, DNA-synthesis, and ploidy of bovine cumulus cell nuclear 
transfer embryos: effect of activation protocol. Mol Reprod Dev 59(4):371-379. 
Amano T, Tani T, Kato Y, Tsunoda Y. 2001. Mouse cloned from embryonic stem (ES) 
cells synchronized in metaphase with nocodazole. J Exp Zool 289(2):139-145. 
Arat S, Rzucidlo SJ, Stice SL. 2003. Gene expression and in vitro development of inter-
species nuclear transfer embryos. Mol Reprod Dev 66(4):334-342. 
Atabay EC, Katagiri S, Nagano M, Takahashi Y. 2003. Effect of activation treatments of 
recipient oocytes on subsequent development of bovine nuclear transfer embryos. 
Jpn J Vet Res 50(4):185-194. 
Baguisi A, Behboodi E, Melican DT, Pollock JS, Destrempes MM, Cammuso C, 
Williams JL, Nims SD, Porter CA, Midura P, Palacios MJ, Ayres SL, Denniston 
RS, Hayes ML, Ziomek CA, Meade HM, Godke RA, Gavin WG, Overstrom EW, 
Echelard Y. 1999. Production of goats by somatic cell nuclear transfer. Nat 
Biotechnol 17(5):456-461. 
Balakier H, Casper RF. 1993. Experimentally induced parthenogenetic activation of 
human oocytes. Hum Reprod 8(5):740-743. 
Barlow DP. 1993. Methylation and imprinting: from host defense to gene regulation? 
Science 260(5106):309-310. 
Barnes FL, Collas P, Powell R, King WA, Westhusin M, Shepherd D. 1993. Influence of 
recipient oocyte cell cycle stage on DNA synthesis, nuclear envelope breakdown, 
chromosome constitution, and development in nuclear transplant bovine embryos. 
Mol Reprod Dev 36(1):33-41. 
  31 
Batchelder CA, Hoffert KA, Bertolini M, Moyer AL, Mason JB, Petkov SG, Famula 
TR, Anderson GB. 2005. Effect of the nuclear-donor cell lineage, type, and cell 
donor on development of somatic cell nuclear transfer embryos in cattle. Cloning 
Stem Cells 7(4):238-254. 
Beaudouin J, Gerlich D, Daigle N, Eils R, Ellenberg J. 2002. Nuclear envelope 
breakdown proceeds by microtubule-induced tearing of the lamina. Cell 
108(1):83-96. 
Beyhan Z, Ross PJ, Iager AE, Kocabas AM, Cunniff K, Rosa GJ, Cibelli JB. 2007. 
Transcriptional reprogramming of somatic cell nuclei during preimplantation 
development of cloned bovine embryos. Dev Biol 305(2):637-649. 
Bhak JS, Lee SL, Ock SA, Mohana Kumar B, Choe SY, Rho GJ. 2006. Developmental 
rate and ploidy of embryos produced by nuclear transfer with different activation 
treatments in cattle. Anim Reprod Sci 92(1-2):37-49. 
Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M. 1999. A mammalian protein with 
specific demethylase activity for mCpG DNA. Nature 397(6720):579-583. 
Bhuiyan MM, Cho J, Jang G, Park E, Kang S, Lee B, Hwang W. 2004. Effect of 
transfection and passage number of ear fibroblasts on in vitro development of 
bovine transgenic nuclear transfer embryos. J Vet Med Sci 66(3):257-261. 
Bilodeau-Goeseels S, Panich P. 2002. Effects of oocyte quality on development and 
transcriptional activity in early bovine embryos. Anim Reprod Sci 71(3-4):143-
155. 
Bird AP, Wolffe AP. 1999. Methylation-induced repression--belts, braces, and 
chromatin. Cell 99(5):451-454. 
  32 
Boiani M, Eckardt S, Scholer HR, McLaughlin KJ. 2002. Oct4 distribution and level in 
mouse clones: consequences for pluripotency. Genes Dev 16(10):1209-1219. 
Bordignon V, Clarke HJ, Smith LC. 2001. Factors controlling the loss of immunoreactive 
somatic histone H1 from blastomere nuclei in oocyte cytoplasm: a potential 
marker of nuclear reprogramming. Dev Biol 233(1):192-203. 
Bortvin A, Eggan K, Skaletsky H, Akutsu H, Berry DL, Yanagimachi R, Page DC, 
Jaenisch R. 2003. Incomplete reactivation of Oct4-related genes in mouse 
embryos cloned from somatic nuclei. Development 130(8):1673-1680. 
Bourc'his D, Le Bourhis D, Patin D, Niveleau A, Comizzoli P, Renard JP, Viegas-
Pequignot E. 2001. Delayed and incomplete reprogramming of chromosome 
methylation patterns in bovine cloned embryos. Curr Biol 11(19):1542-1546. 
Brandao DO, Maddox-Hyttel P, Lovendahl P, Rumpf R, Stringfellow D, Callesen H. 
2004. Post hatching development: a novel system for extended in vitro culture of 
bovine embryos. Biol Reprod 71(6):2048-2055. 
Briggs R, King TJ. 1952. Transplantation of living nuclei from blastula cells into 
enucleated frogs' eggs. Proc Natl Acad Sci USA 38(5):455-463. 
Bureau WS, Bordignon V, Leveillee C, Smith LC, King WA. 2003. Assessment of 
chromosomal abnormalities in bovine nuclear transfer embryos and in their donor 
cells. Cloning Stem Cells 5(2):123-132. 
Campbell KH, Alberio R, Choi I, Fisher P, Kelly RD, Lee JH, Maalouf W. 2005. 
Cloning: eight years after Dolly. Reprod Domest Anim 40(4):256-268. 
Campbell KH, Loi P, Otaegui PJ, Wilmut I. 1996a. Cell cycle co-ordination in embryo 
cloning by nuclear transfer. Rev Reprod 1(1):40-46. 
  33 
Campbell KH, McWhir J, Ritchie WA, Wilmut I. 1996b. Sheep cloned by nuclear 
transfer from a cultured cell line. Nature 380(6569):64-66. 
Campbell KH, Ritchie WA, Wilmut I. 1993a. Disappearance of maturation promoting 
factor activity and the formation of pronuclei in electrically activated in vitro 
matured bovine oocytes. Theriogenology 39(1):199. 
Campbell KH, Ritchie WA, Wilmut I. 1993b. Nuclear-cytoplasmic interactions during 
the first cell cycle of nuclear transfer reconstructed bovine embryos: implications 
for deoxyribonucleic acid replication and development. Biol Reprod 49(5):933-
942. 
Chesne P, Adenot PG, Viglietta C, Baratte M, Boulanger L, Renard JP. 2002. Cloned 
rabbits produced by nuclear transfer from adult somatic cells. Nat Biotechnol 
20(4):366-369. 
Choi JY, Kim CI, Park CK, Yang BK, Cheong HT. 2004. Effect of activation time on the 
nuclear remodeling and in vitro development of nuclear transfer embryos derived 
from bovine somatic cells. Mol Reprod Dev 69(3):289-295. 
Chung YG, Ratnam S, Chaillet JR, Latham KE. 2003. Abnormal regulation of DNA 
methyltransferase expression in cloned mouse embryos. Biol Reprod 69(1):146-
153. 
Clayton AL, Mahadevan LC. 2003. MAP kinase-mediated phosphoacetylation of histone 
H3 and inducible gene regulation. FEBS Lett 546(1):51-58. 
Collas P, Pinto-Correia C, Ponce de Leon FA, Robl JM. 1992. Effect of donor cell cycle 
stage on chromatin and spindle morphology in nuclear transplant rabbit embryos. 
Biol Reprod 46(3):501-511. 
  34 
Constant F, Guillomot M, Heyman Y, Vignon X, Laigre P, Servely JL, Renard JP, 
Chavatte-Palmer P. 2006. Large offspring or large placenta syndrome? 
Morphometric analysis of late gestation bovine placentomes from somatic nuclear 
transfer pregnancies complicated by hydrallantois. Biol Reprod 75(1):122-130. 
Czolowska R, Modlinski JA, Tarkowski AK. 1984. Behaviour of thymocyte nuclei in 
non-activated and activated mouse oocytes. J Cell Sci 69:19-34. 
Damiani P, Fissore RA, Cibelli JB, Long CR, Balise JJ, Robl JM, Duby RT. 1996. 
Evaluation of developmental competence, nuclear and ooplasmic maturation of 
calf oocytes. Mol Reprod Dev 45(4):521-534. 
Daniels R, Hall V, Trounson AO. 2000. Analysis of gene transcription in bovine nuclear 
transfer embryos reconstructed with granulosa cell nuclei. Biol Reprod 
63(4):1034-1040. 
Davis TL, Yang GJ, McCarrey JR, Bartolomei MS. 2000. The H19 methylation imprint 
is erased and re-established differentially on the parental alleles during male germ 
cell development. Hum Mol Genet 9(19):2885-2894. 
de Paz P, Sanchez AJ, De la Fuente J, Chamorro CA, Alvarez M, Anel E, Anel L. 2001. 
Ultrastructural and cytochemical comparison between calf and cow oocytes. 
Theriogenology 55(5):1107-1116. 
Dean W, Santos F, Stojkovic M, Zakhartchenko V, Walter J, Wolf E, Reik W. 2001. 
Conservation of methylation reprogramming in mammalian development: 
aberrant reprogramming in cloned embryos. Proc Natl Acad Sci USA 
98(24):13734-13738. 
Di Berardino MA. 2001. Animal cloning--the route to new genomics in agriculture and 
medicine. Differentiation 68(2-3):67-83. 
  35 
Di Berardino MA, Orr NH. 1992. Genomic potential of erythroid and leukocytic cells 
of Rana pipiens analyzed by nuclear transfer into diplotene and maturing oocytes. 
Differentiation 50(1):1-13. 
DiBerardino MA, Hoffner NJ. 1983. Gene reactivation in erythrocytes: nuclear 
transplantation in oocytes and eggs of Rana. Science 219(4586):862-864. 
Eggan K, Akutsu H, Hochedlinger K, Rideout W, 3rd, Yanagimachi R, Jaenisch R. 2000. 
X-Chromosome inactivation in cloned mouse embryos. Science 290(5496):1578-
1581. 
Elsheikh AS, Takahashi Y, Katagiri S, Kanagawa H. 1998. Functional enucleation of 
mouse metaphase II oocytes with etoposide. Jpn J Vet Res 45(4):217-220. 
Enright BP, Jeong BS, Yang X, Tian XC. 2003. Epigenetic characteristics of bovine 
donor cells for nuclear transfer: levels of histone acetylation. Biol Reprod 
69(5):1525-1530. 
Enright BP, Sung LY, Chang CC, Yang X, Tian XC. 2005. Methylation and acetylation 
characteristics of cloned bovine embryos from donor cells treated with 5-aza-2'-
deoxycytidine. Biol Reprod 72(4):944-948. 
Fukui Y, McGowan LT, James RW, Pugh PA, Tervit HR. 1991. Factors affecting the in-
vitro development to blastocysts of bovine oocytes matured and fertilized in vitro. 
J Reprod Fertil 92(1):125-131. 
Fulka J, Jr., Fulka H. 2007. Somatic cell nuclear transfer (SCNT) in mammals: the 
cytoplast and its reprogramming activities. Adv Exp Med Biol 591:93-102. 
Fulka J, Jr., Moor RM. 1993. Noninvasive chemical enucleation of mouse oocytes. Mol 
Reprod Dev 34(4):427-430. 
  36 
Galasinski SC, Resing KA, Goodrich JA, Ahn NG. 2002. Phosphatase inhibition leads 
to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor 
interactions. J Biol Chem 277(22):19618-19626. 
Galli C, Duchi R, Crotti G, Turini P, Ponderato N, Colleoni S, Lagutina I, Lazzari G. 
2003a. Bovine embryo technologies. Theriogenology 59(2):599-616. 
Galli C, Lagutina I, Crotti G, Colleoni S, Turini P, Ponderato N, Duchi R, Lazzari G. 
2003b. Pregnancy: a cloned horse born to its dam twin. Nature 424(6949):635. 
Gandolfi F, Milanesi E, Pocar P, Luciano AM, Brevini TA, Acocella F, Lauria A, 
Armstrong DT. 1998. Comparative analysis of calf and cow oocytes during in 
vitro maturation. Mol Reprod Dev 49(2):168-175. 
Gasparrini B, Gao S, Ainslie A, Fletcher J, McGarry M, Ritchie WA, Springbett AJ, 
Overstrom EW, Wilmut I, De Sousa PA. 2003. Cloned mice derived from 
embryonic stem cell karyoplasts and activated cytoplasts prepared by induced 
enucleation. Biol Reprod 68(4):1259-1266. 
Gautier J, Minshull J, Lohka M, Glotzer M, Hunt T, Maller JL. 1990. Cyclin is a 
component of maturation-promoting factor from Xenopus. Cell 60(3):487-494. 
Gibbons J, Arat S, Rzucidlo J, Miyoshi K, Waltenburg R, Respess D, Venable A, Stice S. 
2002. Enhanced survivability of cloned calves derived from roscovitine-treated 
adult somatic cells. Biol Reprod 66(4):895-900. 
Goll MG, Bestor TH. 2002. Histone modification and replacement in chromatin 
activation. Genes Dev 16(14):1739-1742. 
Gregory RI, Randall TE, Johnson CA, Khosla S, Hatada I, O'Neill LP, Turner BM, Feil 
R. 2001. DNA methylation is linked to deacetylation of histone H3, but not H4, 
on the imprinted genes Snrpn and U2af1-rs1. Mol Cell Biol 21(16):5426-5436. 
  37 
Gurdon JB, Laskey RA, Reeves OR. 1975. The developmental capacity of nuclei 
transplanted from keratinized skin cells of adult frogs. J Embryol Exp Morphol 
34(1):93-112. 
Gurdon JB, Uehlinger V. 1966. "Fertile" intestine nuclei. Nature 210(42):1240-1241. 
Han DW, Song SJ, Uhum SJ, Do JT, Kim NH, Chung KS, Lee HT. 2003. Expression of 
IGF2 and IGF receptor mRNA in bovine nuclear transferred embryos. Zygote 
11(3):245-252. 
Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A. 2001. Closely related proteins 
MBD2 and MBD3 play distinctive but interacting roles in mouse development. 
Genes Dev 15(6):710-723. 
Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A. 1999. The thymine glycosylase 
MBD4 can bind to the product of deamination at methylated CpG sites. Nature 
401(6750):301-304. 
Heyman Y, Chavatte-Palmer P, LeBourhis D, Camous S, Vignon X, Renard JP. 2002. 
Frequency and occurrence of late-gestation losses from cattle cloned embryos. 
Biol Reprod 66(1):6-13. 
Hill J, Winger Q, Jones K, Keller D, King WA, Westhusin M. 1999a. The effect of donor 
cell serum starvation and oocyte activation compounds on the development of 
somatic cell cloned embryos. Cloning 1(4):201-208. 
Hill JR, Roussel AJ, Cibelli JB, Edwards JF, Hooper NL, Miller MW, Thompson JA, 
Looney CR, Westhusin ME, Robl JM, Stice SL. 1999b. Clinical and pathologic 
features of cloned transgenic calves and fetuses (13 case studies). Theriogenology 
51(8):1451-1465. 
  38 
Hill JR, Schlafer DH, Fisher PJ, Davies CJ. 2002. Abnormal expression of trophoblast 
major histocompatibility complex class I antigens in cloned bovine pregnancies is 
associated with a pronounced endometrial lymphocytic response. Biol Reprod 
67(1):55-63. 
Hill JR, Winger QA, Long CR, Looney CR, Thompson JA, Westhusin ME. 2000. 
Development rates of male bovine nuclear transfer embryos derived from adult 
and fetal cells. Biol Reprod 62(5):1135-1140. 
Hoffert KA, Batchelder CA, Bertolini M, Moyer AL, Famula TR, Anderson DL, 
Anderson GB. 2005. Measures of maternal-fetal interaction in day-30 bovine 
pregnancies derived from nuclear transfer. Cloning Stem Cells 7(4):289-305. 
Holliday R, Pugh JE. 1975. DNA modification mechanisms and gene activity during 
development. Science 187(4173):226-232. 
Howell CY, Bestor TH, Ding F, Latham KE, Mertineit C, Trasler JM, Chaillet JR. 2001. 
Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene. 
Cell 104(6):829-838. 
Humpherys D, Eggan K, Akutsu H, Friedman A, Hochedlinger K, Yanagimachi R, 
Lander ES, Golub TR, Jaenisch R. 2002. Abnormal gene expression in cloned 
mice derived from embryonic stem cell and cumulus cell nuclei. Proc Natl Acad 
Sci USA 99(20):12889-12894. 
Ibanez E, Albertini DF, Overstrom EW. 2003. Demecolcine-induced oocyte enucleation 
for somatic cell cloning: coordination between cell-cycle egress, kinetics of 
cortical cytoskeletal interactions, and second polar body extrusion. Biol Reprod 
68(4):1249-1258. 
  39 
Ilyin V, Parker I. 1992. Effects of alcohols on responses evoked by inositol 
trisphosphate in Xenopus oocytes. J Physiol 448:339-354. 
Issa JP. 2000. The epigenetics of colorectal cancer. Ann N Y Acad Sci 910:140-153; 
discussion 153-145. 
Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: how the genome 
integrates intrinsic and environmental signals. Nat Genet 33 Suppl:245-254. 
Jaenisch R, Eggan K, Humpherys D, Rideout W, Hochedlinger K. 2002. Nuclear cloning, 
stem cells, and genomic reprogramming. Cloning Stem Cells 4(4):389-396. 
Jiang L, Lai L, Samuel M, Prather RS, Yang X, Tian XC. 2007. Expression of X-linked 
genes in deceased neonates and surviving cloned female piglets. Mol Reprod Dev. 
Kang YK, Koo DB, Park JS, Choi YH, Kim HN, Chang WK, Lee KK, Han YM. 2001. 
Typical demethylation events in cloned pig embryos. Clues on species-specific 
differences in epigenetic reprogramming of a cloned donor genome. J Biol Chem 
276(43):39980-39984. 
Kang YK, Park JS, Koo DB, Choi YH, Kim SU, Lee KK, Han YM. 2002. Limited 
demethylation leaves mosaic-type methylation states in cloned bovine pre-
implantation embryos. Embo J 21(5):1092-1100. 
Kang YK, Yeo S, Kim SH, Koo DB, Park JS, Wee G, Han JS, Oh KB, Lee KK, Han 
YM. 2003. Precise recapitulation of methylation change in early cloned embryos. 
Mol Reprod Dev 66(1):32-37. 
Kasinathan P, Knott JG, Moreira PN, Burnside AS, Jerry DJ, Robl JM. 2001. Effect of 
fibroblast donor cell age and cell cycle on development of bovine nuclear transfer 
embryos in vitro. Biol Reprod 64(5):1487-1493. 
  40 
Kaufman MH, Gardner RL. 1974. Diploid and haploid mouse parthenogenetic 
development following in vitro activation and embryo transfer. J Embryol Exp 
Morphol 31(3):635-642. 
Khatir H, Lonergan P, Mermillod P. 1998. Kinetics of nuclear maturation and protein 
profiles of oocytes from prepubertal and adult cattle during in vitro maturation. 
Theriogenology 50(6):917-929. 
King TJ, Briggs R. 1956. Serial transplantation of embryonic nuclei. Cold Spring Harb 
Symp Quant Biol 21:271-290. 
Kishi M, Itagaki Y, Takakura R, Imamura M, Sudo T, Yoshinari M, Tanimoto M, Yasue 
H, Kashima N. 2000. Nuclear transfer in cattle using colostrum-derived mammary 
gland epithelial cells and ear-derived fibroblast cells. Theriogenology 54(5):675-
684. 
Kornberg RD, Lorch Y. 1999. Twenty-five years of the nucleosome, fundamental particle 
of the eukaryote chromosome. Cell 98(3):285-294. 
Krisher RL, Lane M, Bavister BD. 1999. Developmental competence and metabolism of 
bovine embryos cultured in semi-defined and defined culture media. Biol Reprod 
60(6):1345-1352. 
Kuzan FB, Wright RW, Jr. 1982. Observations on the development of bovine morulae on 
various cellular and noncellular substrata. J Anim Sci 54(4):811-816. 
Lawrence JL, Schrick FN, Hopkins FM, Welborn MG, McCracken MD, Sonstegard T, 
Wilson TJ, Edwards JL. 2005. Fetal losses and pathologic findings of clones 
derived from serum-starved versus serum-fed bovine ovarian granulosa cells. 
Reprod Biol 5(2):171-184. 
  41 
Lazzari G, Wrenzycki C, Herrmann D, Duchi R, Kruip T, Niemann H, Galli C. 2002. 
Cellular and molecular deviations in bovine in vitro-produced embryos are related 
to the large offspring syndrome. Biol Reprod 67(3):767-775. 
Lee BC, Kim MK, Jang G, Oh HJ, Yuda F, Kim HJ, Shamim MH, Kim JJ, Kang SK, 
Schatten G, Hwang WS. 2005. Dogs cloned from adult somatic cells. Nature 
436(7051):641. 
Lee JH, Campbell KH. 2006. Effects of enucleation and caffeine on maturation-
promoting factor (MPF) and mitogen-activated protein kinase (MAPK) activities 
in ovine oocytes used as recipient cytoplasts for nuclear transfer. Biol Reprod 
74(4):691-698. 
Lei L, Liu ZH, Wang H, Kou ZH, Wu YQ, Xu Y, Cheng Y, Zhu ZY, Xia GL, Chen DY. 
2003. The effects of different donor cells and passages on development of 
reconstructed embryos. Yi Chuan Xue Bao 30(3):215-220. 
Levesque JT, Sirard MA. 1994. Proteins in oocytes from calves and adult cows before 
maturation: relationship with their development capacity. Reprod Nutr Dev 
34(2):133-139. 
Li E, Bestor TH, Jaenisch R. 1992. Targeted mutation of the DNA methyltransferase 
gene results in embryonic lethality. Cell 69(6):915-926. 
Li GP, Liu Y, Bunch TD, White KL, Aston KI. 2005. Asymmetric division of spindle 
microtubules and microfilaments during bovine meiosis from metaphase I to 
metaphase III. Mol Reprod Dev 71(2):220-226. 
Li GP, White KL, Bunch TD. 2004. Review of enucleation methods and procedures used 
in animal cloning: state of the art. Cloning Stem Cells 6(1):5-13. 
  42 
Li S, Li Y, Yu S, Du W, Zhang L, Dai Y, Liu Y, Li N. 2007. Expression of insulin-like 
growth factors systems in cloned cattle dead within hours after birth. Mol Reprod 
Dev 74(4):397-402. 
Li X, Amarnath D, Kato Y, Tsunoda Y. 2006a. Analysis of development-related gene 
expression in cloned bovine blastocysts with different developmental potential. 
Cloning Stem Cells 8(1):41-50. 
Li Z, Sun X, Chen J, Liu X, Wisely SM, Zhou Q, Renard JP, Leno GH, Engelhardt JF. 
2006b. Cloned ferrets produced by somatic cell nuclear transfer. Dev Biol 
293(2):439-448. 
Lim KT, Jang G, Ko KH, Lee WW, Park HJ, Kim JJ, Lee SH, Hwang WS, Lee BC, 
Kang SK. 2007. Improved in vitro bovine embryo development and increased 
efficiency in producing viable calves using defined media. Theriogenology 
67(2):293-302. 
Liu L, Shin T, Pryor JH, Kraemer D, Westhusin M. 2001. Regenerated bovine fetal 
fibroblasts support high blastocyst development following nuclear transfer. 
Cloning 3(2):51-58. 
Loi P, Ptak G, Barboni B, Fulka J, Jr., Cappai P, Clinton M. 2001. Genetic rescue of an 
endangered mammal by cross-species nuclear transfer using post-mortem somatic 
cells. Nat Biotechnol 19(10):962-964. 
Lyko F, Ramsahoye BH, Jaenisch R. 2000. DNA methylation in Drosophila 
melanogaster. Nature 408(6812):538-540. 
Macaulay C, Meier E, Forbes DJ. 1995. Differential mitotic phosphorylation of proteins 
of the nuclear pore complex. J Biol Chem 270(1):254-262. 
  43 
Majerus V, Lequarre AS, Ferguson EM, Kaidi S, Massip A, Dessy F, Donnay I. 2000. 
Characterization of embryos derived from calf oocytes: kinetics of cleavage, cell 
allocation to inner cell mass, and trophectoderm and lipid metabolism. Mol 
Reprod Dev 57(4):346-352. 
Mann MR, Chung YG, Nolen LD, Verona RI, Latham KE, Bartolomei MS. 2003. 
Disruption of imprinted gene methylation and expression in cloned 
preimplantation stage mouse embryos. Biol Reprod 69(3):902-914. 
Mann MR, Lee SS, Doherty AS, Verona RI, Nolen LD, Schultz RM, Bartolomei MS. 
2004. Selective loss of imprinting in the placenta following preimplantation 
development in culture. Development 131(15):3727-3735. 
Matzke MA, Mette MF, Aufsatz W, Jakowitsch J, Matzke AJ. 1999. Host defenses to 
parasitic sequences and the evolution of epigenetic control mechanisms. Genetica 
107(1-3):271-287. 
McGrath J, Solter D. 1984. Inability of mouse blastomere nuclei transferred to enucleated 
zygotes to support development in vitro. Science 226(4680):1317-1319. 
McLay DW, Clarke HJ. 2003. Remodelling the paternal chromatin at fertilization in 
mammals. Reproduction 125(5):625-633. 
Memili E, Dominko T, First NL. 1998. Onset of transcription in bovine oocytes and 
preimplantation embryos. Mol Reprod Dev 51(1):36-41. 
Mermillod P, Le Bourhis D, Lonergan P, Khatir H, Heyman Y. 1998. Assessment of 
cytoplasmic competence of prepubertal calf oocytes by use of nuclear transfer. 
Theriogenology 49:187. 
  44 
Mermillod P, Wils C, Massip A, Dessy F. 1992. Collection of oocytes and production 
of blastocysts in vitro from individual, slaughtered cows. J Reprod Fertil 
96(2):717-723. 
Miyoshi K, Arat S, Stice SL. 2006. Production of cloned calves using roscovitine-treated 
adult somatic cells as donors. Methods Mol Biol 348:125-134. 
Moore K, Kramer JM, Rodriguez-Sallaberry CJ, Yelich JV, Drost M. 2007. Insulin-like 
growth factor (IGF) family genes are aberrantly expressed in bovine conceptuses 
produced in vitro or by nuclear transfer. Theriogenology 68(5):717-727. 
Moreno JF, Turczynski CJ, Flores-Foxworth G, Kraemer DC. 1992. Influence of parity 
of donor and presence of a CL on quantitiy and quality of bovine oocytes from 
ovarian follicles aspirated post-mortem. Biol Reprod 46(Supplement #1):65. 
Morgan HD, Santos F, Green K, Dean W, Reik W. 2005. Epigenetic reprogramming in 
mammals. Hum Mol Genet 14 Spec No 1:R47-58. 
Nakao M. 2001. Epigenetics: interaction of DNA methylation and chromatin. Gene 
278(1-2):25-31. 
Notarianni E, Galli C, Laurie S, Moor RM, Evans MJ. 1991. Derivation of pluripotent, 
embryonic cell lines from the pig and sheep. J Reprod Fertil Suppl 43:255-260. 
Notarianni E, Laurie S, Moor RM, Evans MJ. 1990. Maintenance and differentiation in 
culture of pluripotential embryonic cell lines from pig blastocysts. J Reprod Fertil 
Suppl 41:51-56. 
Oback B, Wells D. 2002. Donor cells for nuclear cloning: many are called, but few are 
chosen. Cloning Stem Cells 4(2):147-168. 
Oback B, Wells DN. 2007. Cloning cattle: the methods in the madness. Adv Exp Med 
Biol 591:30-57. 
  45 
Oback B, Wiersema AT, Gaynor P, Laible G, Tucker FC, Oliver JE, Miller AL, 
Troskie HE, Wilson KL, Forsyth JT, Berg MC, Cockrem K, McMillan V, Tervit 
HR, Wells DN. 2003. Cloned cattle derived from a novel zona-free embryo 
reconstruction system. Cloning Stem Cells 5(1):3-12. 
Obata Y, Kaneko-Ishino T, Koide T, Takai Y, Ueda T, Domeki I, Shiroishi T, Ishino F, 
Kono T. 1998. Disruption of primary imprinting during oocyte growth leads to the 
modified expression of imprinted genes during embryogenesis. Development 
125(8):1553-1560. 
Oishi M, Gohma H, Hashizume K, Taniguchi Y, Yasue H, Takahashi S, Yamada T, 
Sasaki Y. 2006. Early embryonic death-associated changes in genome-wide gene 
expression profiles in the fetal placenta of the cow carrying somatic nuclear-
derived cloned embryo. Mol Reprod Dev 73(4):404-409. 
Okano M, Bell DW, Haber DA, Li E. 1999. DNA methyltransferases Dnmt3a and 
Dnmt3b are essential for de novo methylation and mammalian development. Cell 
99(3):247-257. 
Okano M, Xie S, Li E. 1998. Dnmt2 is not required for de novo and maintenance 
methylation of viral DNA in embryonic stem cells. Nucleic Acids Res 
26(11):2536-2540. 
Ono Y, Shimozawa N, Muguruma K, Kimoto S, Hioki K, Tachibana M, Shinkai Y, Ito 
M, Kono T. 2001. Production of cloned mice from embryonic stem cells arrested 
at metaphase. Reproduction 122(5):731-736. 
Park Y, Kuroda MI. 2001. Epigenetic aspects of X-chromosome dosage compensation. 
Science 293(5532):1083-1085. 
  46 
Patel OV, Yamada O, Kizaki K, Takahashi T, Imai K, Takahashi S, Izaike Y, Schuler 
LA, Takezawa T, Hashizume K. 2004. Expression of trophoblast cell-specific 
pregnancy-related genes in somatic cell-cloned bovine pregnancies. Biol Reprod 
70(4):1114-1120. 
Peter M, Nakagawa J, Doree M, Labbe JC, Nigg EA. 1990. In vitro disassembly of the 
nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinase. 
Cell 61(4):591-602. 
Peura TT. 2003. Improved in vitro development rates of sheep somatic nuclear transfer 
embryos by using a reverse-order zona-free cloning method. Cloning Stem Cells 
5(1):13-24. 
Piedrahita JA, Anderson GB, Bondurant RH. 1990. On the isolation of embryonic stem 
cells: Comparative behavior of murine, porcine and ovine embryos. 
Theriogenology 34(5):879-901. 
Polejaeva IA, Chen SH, Vaught TD, Page RL, Mullins J, Ball S, Dai Y, Boone J, Walker 
S, Ayares DL, Colman A, Campbell KH. 2000. Cloned pigs produced by nuclear 
transfer from adult somatic cells. Nature 407(6800):86-90. 
Powell AM, Talbot NC, Wells KD, Kerr DE, Pursel VG, Wall RJ. 2004. Cell donor 
influences success of producing cattle by somatic cell nuclear transfer. Biol 
Reprod 71(1):210-216. 
Prather RS, Barnes FL, Sims MM, Robl JM, Eyestone WH, First NL. 1987. Nuclear 
transplantation in the bovine embryo: assessment of donor nuclei and recipient 
oocyte. Biol Reprod 37(4):859-866. 
  47 
Presicce GA, Yang X. 1994. Parthenogenetic development of bovine oocytes matured 
in vitro for 24 hr and activated by ethanol and cycloheximide. Mol Reprod Dev 
38(4):380-385. 
Pujol M, Lopez-Bejar M, Paramio MT. 2004. Developmental competence of heifer 
oocytes selected using the brilliant cresyl blue (BCB) test. Theriogenology 
61(4):735-744. 
Reik W, Dean W. 2001. DNA methylation and mammalian epigenetics. Electrophoresis 
22(14):2838-2843. 
Reik W, Dean W, Walter J. 2001. Epigenetic reprogramming in mammalian 
development. Science 293(5532):1089-1093. 
Revel F, Mermillod P, Peynot N, Renard JP, Heyman Y. 1995. Low developmental 
capacity of in vitro matured and fertilized oocytes from calves compared with that 
of cows. J Reprod Fertil 103(1):115-120. 
Rizos D, Burke L, Duffy P, Wade M, Mee JF, O'Farrell K J, Macsiurtain M, Boland MP, 
Lonergan P. 2005. Comparisons between nulliparous heifers and cows as oocyte 
donors for embryo production in vitro. Theriogenology 63(3):939-949. 
Rosenkrans CF, Jr., First NL. 1994. Effect of free amino acids and vitamins on cleavage 
and developmental rate of bovine zygotes in vitro. J Anim Sci 72(2):434-437. 
Salamone DF, Damiani P, Fissore RA, Robl JM, Duby RT. 2001. Biochemical and 
developmental evidence that ooplasmic maturation of prepubertal bovine oocytes 
is compromised. Biol Reprod 64(6):1761-1768. 
Santos F, Dean W. 2004. Epigenetic reprogramming during early development in 
mammals. Reproduction 127(6):643-651. 
  48 
Santos F, Zakhartchenko V, Stojkovic M, Peters A, Jenuwein T, Wolf E, Reik W, 
Dean W. 2003. Epigenetic marking correlates with developmental potential in 
cloned bovine preimplantation embryos. Curr Biol 13(13):1116-1121. 
Schrader AD, Iqbal MJ, Jones KL. 2003. Gene expression in cloned bovine fetal liver. 
Cloning Stem Cells 5(1):63-69. 
Schwartz AG, Cook PR, Harris H. 1971. Correction of a genetic defect in a mammalian 
cell. Nat New Biol 230(1):5-8. 
Shi W, Dirim F, Wolf E, Zakhartchenko V, Haaf T. 2004. Methylation reprogramming 
and chromosomal aneuploidy in in vivo fertilized and cloned rabbit 
preimplantation embryos. Biol Reprod 71(1):340-347. 
Shi W, Haaf T. 2002. Aberrant methylation patterns at the two-cell stage as an indicator 
of early developmental failure. Mol Reprod Dev 63(3):329-334. 
Shi W, Zakhartchenko V, Wolf E. 2003. Epigenetic reprogramming in mammalian 
nuclear transfer. Differentiation 71(2):91-113. 
Shin MR, Park SW, Shim H, Kim NH. 2002a. Nuclear and microtubule reorganization in 
nuclear-transferred bovine embryos. Mol Reprod Dev 62(1):74-82. 
Shin T, Kraemer D, Pryor J, Liu L, Rugila J, Howe L, Buck S, Murphy K, Lyons L, 
Westhusin M. 2002b. A cat cloned by nuclear transplantation. Nature 
415(6874):859. 
Sims M, First NL. 1994. Production of calves by transfer of nuclei from cultured inner 
cell mass cells. Proc Natl Acad Sci USA 91(13):6143-6147. 
Siracusa G, Whittingham DG, Molinaro M, Vivarelli E. 1978. Parthenogenetic activation 
of mouse oocytes induced by inhibitors of protein synthesis. J Embryol Exp 
Morphol 43:157-166. 
  49 
Smith SL, Everts RE, Tian XC, Du F, Sung LY, Rodriguez-Zas SL, Jeong BS, Renard 
JP, Lewin HA, Yang X. 2005. Global gene expression profiles reveal significant 
nuclear reprogramming by the blastocyst stage after cloning. Proc Natl Acad Sci 
USA 102(49):17582-17587. 
Spemann H. 1938. Embryonic Development and Induction. New Haven: Yale University 
Press. 
Steinhardt RA, Epel D, Carroll EJ, Jr., Yanagimachi R. 1974. Is calcium ionophore a 
universal activator for unfertilised eggs? Nature 252(5478):41-43. 
Stice SL, Keefer CL. 1993. Multiple generational bovine embryo cloning. Biol Reprod 
48(4):715-719. 
Stice SL, Strelchenko NS, Keefer CL, Matthews L. 1996. Pluripotent bovine embryonic 
cell lines direct embryonic development following nuclear transfer. Biol Reprod 
54(1):100-110. 
Strahl BD, Allis CD. 2000. The language of covalent histone modifications. Nature 
403(6765):41-45. 
Strathdee G, Brown R. 2002. Epigenetic cancer therapies: DNA methyltransferase 
inhibitors. Expert Opin Investig Drugs 11(6):747-754. 
Sung LY, Gao S, Shen H, Yu H, Song Y, Smith SL, Chang CC, Inoue K, Kuo L, Lian J, 
Li A, Tian XC, Tuck DP, Weissman SM, Yang X, Cheng T. 2006. Differentiated 
cells are more efficient than adult stem cells for cloning by somatic cell nuclear 
transfer. Nat Genet 38(11):1323-1328. 
Tanaka H, Kanagawa H. 1997. Influence of combined activation treatments on the 
success of bovine nuclear transfer using young or aged oocytes. Anim Reprod Sci 
49(2-3):113-123. 
  50 
Tani T, Kato Y, Tsunoda Y. 2001. Direct exposure of chromosomes to nonactivated 
ovum cytoplasm is effective for bovine somatic cell nucleus reprogramming. Biol 
Reprod 64(1):324-330. 
Telford NA, Watson AJ, Schultz GA. 1990. Transition from maternal to embryonic 
control in early mammalian development: a comparison of several species. Mol 
Reprod Dev 26(1):90-100. 
Tsunoda Y, Kato Y. 1993. Nuclear transplantation of embryonic stem cells in mice. J 
Reprod Fertil 98(2):537-540. 
Urnov FD, Wolffe AP. 2001. Above and within the genome: epigenetics past and present. 
J Mammary Gland Biol Neoplasia 6(2):153-167. 
Vajta G, Kragh PM, Mtango NR, Callesen H. 2005. Hand-made cloning approach: 
potentials and limitations. Reprod Fertil Dev 17(1-2):97-112. 
Vajta G, Lewis IM, Hyttel P, Thouas GA, Trounson AO. 2001. Somatic cell cloning 
without micromanipulators. Cloning 3(2):89-95. 
Vassena R, Han Z, Gao S, Baldwin DA, Schultz RM, Latham KE. 2007a. Tough 
beginnings: alterations in the transcriptome of cloned embryos during the first two 
cell cycles. Dev Biol 304(1):75-89. 
Vassena R, Han Z, Gao S, Latham KE. 2007b. Deficiency in recapitulation of stage-
specific embryonic gene transcription in two-cell stage cloned mouse embryos. 
Mol Reprod Dev. 
Viuff D, Hyttel P, Avery B, Vajta G, Greve T, Callesen H, Thomsen PD. 1998. 
Ribosomal ribonucleic acid is transcribed at the 4-cell stage in in vitro-produced 
bovine embryos. Biol Reprod 59(3):626-631. 
  51 
Wabl MR, Brun RB, Du Pasquier L. 1975. Lymphocytes of the toad Xenopus laevis 
have the gene set for promoting tadpole development. Science 190(4221):1310-
1312. 
Wakayama S, Cibelli JB, Wakayama T. 2003. Effect of timing of the removal of oocyte 
chromosomes before or after injection of somatic nucleus on development of NT 
embryos. Cloning Stem Cells 5(3):181-189. 
Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R. 1998. Full-term 
development of mice from enucleated oocytes injected with cumulus cell nuclei. 
Nature 394(6691):369-374. 
Weiss A, Keshet I, Razin A, Cedar H. 1996. DNA demethylation in vitro: involvement of 
RNA. Cell 86(5):709-718. 
Wells DN, Misica PM, Day TA, Tervit HR. 1997. Production of cloned lambs from an 
established embryonic cell line: a comparison between in vivo- and in vitro-
matured cytoplasts. Biol Reprod 57(2):385-393. 
Wells DN, Misica PM, Tervit HR. 1999. Production of cloned calves following nuclear 
transfer with cultured adult mural granulosa cells. Biol Reprod 60(4):996-1005. 
Wells DN, Misica PM, Tervit HR, Vivanco WH. 1998. Adult somatic cell nuclear 
transfer is used to preserve the last surviving cow of the Enderby Island cattle 
breed. Reprod Fertil Dev 10(4):369-378. 
Westhusin ME, Pryor JH, Bondioli KR. 1991. Nuclear transfer in the bovine embryo: a 
comparison of 5-day, 6-day, frozen-thawed, and nuclear transfer donor embryos. 
Mol Reprod Dev 28(2):119-123. 
Willadsen SM. 1986. Nuclear transplantation in sheep embryos. Nature 320(6057):63-65. 
Willadsen SM. 1989. Cloning of sheep and cow embryos. Genome 31(2):956-962. 
  52 
Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. 1997. Viable offspring 
derived from fetal and adult mammalian cells. Nature 385(6619):810-813. 
Wolffe AP, Matzke MA. 1999. Epigenetics: regulation through repression. Science 
286(5439):481-486. 
Woods GL, White KL, Vanderwall DK, Li GP, Aston KI, Bunch TD, Meerdo LN, Pate 
BJ. 2003. A mule cloned from fetal cells by nuclear transfer. Science 
301(5636):1063. 
Xue F, Tian XC, Du F, Kubota C, Taneja M, Dinnyes A, Dai Y, Levine H, Pereira LV, 
Yang X. 2002. Aberrant patterns of X chromosome inactivation in bovine clones. 
Nat Genet 31(2):216-220. 
Yamazaki W, Ferreira CR, Meo SC, Leal CL, Meirelles FV, Garcia JM. 2005. Use of 
strontium in the activation of bovine oocytes reconstructed by somatic cell 
nuclear transfer. Zygote 13(4):295-302. 
Young LE, Beaujean N. 2004. DNA methylation in the preimplantation embryo: the 
differing stories of the mouse and sheep. Anim Reprod Sci 82-83:61-78. 
Young LE, Sinclair KD, Wilmut I. 1998. Large offspring syndrome in cattle and sheep. 
Rev Reprod 3(3):155-163. 
Zakhartchenko V, Mueller S, Alberio R, Schernthaner W, Stojkovic M, Wenigerkind H, 
Wanke R, Lassnig C, Mueller M, Wolf E, Brem G. 2001. Nuclear transfer in 
cattle with non-transfected and transfected fetal or cloned transgenic fetal and 
postnatal fibroblasts. Mol Reprod Dev 60(3):362-369. 
Zhang L, Denniston RS, Bunch TD, Godke RA. 1991. Cows vs. heifers for the 
production of in vitro matured, in vitro fertilized (IVF) embryos. J Anim Sci 
69(8):49. 
  53 
Zhou Q, Renard JP, Le Friec G, Brochard V, Beaujean N, Cherifi Y, Fraichard A, 
Cozzi J. 2003. Generation of fertile cloned rats by regulating oocyte activation. 
Science 302(5648):1179. 
Zimmermann U, Vienken J. 1982. Electric field-induced cell-to-cell fusion. J Membr 
Biol 67(3):165-182. 
  54 
CHAPTER 2  
THE DEVELOPMENTAL COMPETENCE OF BOVINE NUCLEAR  
TRANSFER EMBRYOS DERIVED FROM COW 




Due to its economic importance, the production of cattle by nuclear transfer has 
been a primary research focus for many researchers during the past few years. While 
many groups have successfully produced cattle by nuclear transfer, and progress in this 
area continues, nuclear transfer remains a very inefficient technology. This study 
evaluates the effect of the oocyte source (cow and heifer) on the developmental 
competence of nuclear transfer embryos. In order for nuclear transfer to be successful, a 
differentiated donor cell must be reprogrammed and restored to a totipotent state. This 
reprogramming is probably accomplished by factors within the oocyte cytoplasm. This 
study indicates that oocytes derived from cows have a greater capacity to reprogram 
donor cell DNA following nuclear transfer as compared to heifer oocytes based on in 
vitro development to the 2-cell stage and to the compacted morula/blastocyst stages. 
Nuclear transfer embryos derived from cow oocytes resulted in significantly higher rates 
of pregnancy establishment than embryos derived from heifer oocytes and resulted in 
higher pregnancy retention at 90 and 180 days and a greater number of term deliveries. 
Following delivery more calves derived from cow oocytes tended to be healthy and 
normal than those derived from heifer oocytes. The differences in developmental 
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efficiency between nuclear transfer embryos derived from cow and heifer cytoplasts 
demonstrate that subtle differences in oocyte biology can have significant effects on 
subsequent development of nuclear transfer embryos. 
Introduction 
Successful somatic cell nuclear transfer (NT) has been achieved in domestic 
animals and rodents as reported by the birth of offspring. The overall efficiency
 
of this 
technique, however, remains low, generally less than 2% (Hill 2002). A high frequency
 
of 
early post-implantation developmental arrest and abortion occurs, especially in cattle. 
The exact mechanism(s)
 
contributing to losses are still unclear. Epigenetic alterations 
(Cezar et al. 2003; Wrenzycki et al. 2001), and chromosomal abnormalities (Burgoyne et 
al. 1991; Li et al. 2004a; Li et al. 2004b) likely contribute to developmental failure.  
Following the transfer of a differentiated nucleus into an enucleated MII oocyte 
the nucleus is disassembled, an event involved in reprogramming the differentiated donor 
nucleus to a totipotent embryonic state. This disassembly involves nuclear envelope 
breakdown (NEBD) and premature chromosome condensation (PCC), mediated by high 
levels of mitosis/meiosis/maturation-promoting factor (MPF) in the oocyte cytoplasm 
(Barnes et al. 1993; Campbell et al. 1996; Czolowska et al. 1984). These events are 
followed by erasure of epigenetic modification of DNA including changes in histone 
acetylation (Nakao 2001) and DNA methylation (Kang et al. 2003; Shi et al. 2003a). 
Since maternal transcripts are responsible for the events of early embryonic development 
(Telford et al. 1990), nuclear reprogramming is presumably mediated by factors in the 
oocyte cytoplasm.  
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A number of studies have been undertaken to evaluate reprogramming 
dynamics in vitro following NT. Evaluation of DNA methylation patterns in developing 
NT embryos indicates demethylation and remethylation events are not always faithfully 
recapitulated in the mouse (Chung et al. 2003; Mann et al. 2003; Shi and Haaf 2002) and 
the cow (Bordignon et al. 2001; Dean et al. 2001; Kang et al. 2002). It is also clear that 
histone acetylation is sometimes aberrant in bovine NT embryos (Enright et al. 2003). 
This incomplete epigenetic reprogramming is the predominant explanation for the 
frequent aberrant gene expression in NT embryos and the subsequent failures in 
development (Santos et al. 2003).  
Improvements in NT efficiency will require an understanding of the factors that 
result in improved reprogramming. Two elements of the NT process likely have an effect 
on reprogramming efficiency: the state of the donor cell/nucleus and a suitable recipient 
cytoplast.  
Attempts have been made to improve the efficiency of NT by manipulation of the 
donor cell prior to NT. One approach is treatment of donor cells to change DNA 
methylation or histone acetylation levels to more closely approximate levels found in IVF 
embryos. The DNA methyl-transferase inhibitor 5-aza-2'-deoxycytidine (Aza-C) has been 
utilized to reduce DNA methylation levels in the transferred nucleus, and Trichostatin A 
(TSA), a histone deacetylase inhibitor has been used to increase histone acetylation 
(Enright et al. 2003; Enright et al. 2005; Shi et al. 2003b). These approaches have 
demonstrated reduced DNA methylation and increased histone acetylation in 
preimplantation NT embryos, but no report addressing the viability of transferred 
embryos exists.  
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The recipient cytoplast likely has a more profound impact on the success of NT 
than the donor cell simply because it makes a more significant contribution to the 
reprogramming process. In the early bovine embryo rRNA is not transcribed until the 4-
cell stage (Viuff et al. 1998), and high transcriptional activity is not observed until the 8-
16-cell stage (Bilodeau-Goeseels and Panich 2002; Memili et al. 1998), so events of early 
embryogenesis are almost completely dependent on maternal transcripts and oocyte 
proteins. Differences in developmental capacity of fetal, calf, and adult oocytes in IVF 
experiments have been noted by several groups (Pujol et al. 2004; Rizos et al. 2005) 
demonstrating important differences in developmental capacity depending on the source 
of oocytes. The present study was designed to examine the differences in developmental 
capacity in vitro and in vivo of NT embryos derived from cow versus heifer cytoplasts.  
Materials and Methods 
Unless otherwise noted, all reagents used were obtained from MP Biomedicals 
(Irvine, CA). 
Donor Cell Culture 
Donor cell lines were established from nine separate animals. Five cell lines were 
derived from lung tissue collected from slaughtered steers at approximately 18 months of 
age. The other four cell lines were derived from ear biopsy of dairy cows greater than 
three years of age. Tissues were washed thoroughly in Flush Medium; Hank’s Balanced 
Salt Solution supplemented with 2% Fetal Bovine Serum (FBS) and antibiotics. 
Following the wash, tissue was minced, suspended in DMEM/Ham's F12 (1:1) 
supplemented with 15% FBS and antibiotics, seeded in 25 cm
2
 tissue culture flasks, and 
cultured at 39˚C in a humidified atmosphere of 5% CO
2
 in air for several days. Upon 
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establishment of primary tissue outgrowths, cells were harvested and used to seed 
additional flasks. Primary cell lines were expanded then harvested in tissue culture 
medium containing 10% DMSO and stored in liquid N
2
 until use in NT.  Frozen/thawed 
cells were grown to 80-100% confluence then passaged for use as nuclear donors. Cells 
from passages 1-10 were used for NT. Donor cell type (lung and ear), cell line, and 
passage number were distributed evenly across oocyte groups such that an equivalent 
proportion of embryos from each cell line and passage was produced using heifer and 
cow oocytes and subsequently transferred. This was done in order to avoid confounding 
effects brought about by donor cell variation between groups. 
Oocyte Collection and Maturation 
Heifer and cow ovaries were collected from the abattoir and oocytes were 
aspirated into 50-mL centrifuge tubes from 3-8 mm follicles using an 18-gauge needle 
connected to a vacuum pump. Oocytes with evenly shaded cytoplasm and intact layers of 
cumulus cells were selected and washed in PB1 supplemented with 3 mg/mL BSA. 
Washed oocytes were then transferred into maturation medium; M199 containing 10% 
fetal bovine serum (FBS; HyClone Laboratories, Logan, UT), 0.5 µg/mL FSH (Sioux 
Biochemicals, Sioux City, IA), 5 µg/mL LH (Sioux Biochemicals), and 100 U/mL 
penicillin/ 100 µg/mL streptomycin (HyClone Laboratories, Logan, UT) and cultured for 
18-21 h prior to NT.  
Nuclear Transfer 
Nuclear transfer was performed according to established protocols common to 
this laboratory (Li et al. 2004b; Wells et al. 1999) with the following modifications. 
Briefly, enucleations were performed on matured MII bovine oocytes 18-21 h after the 
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initiation of maturation. Manipulations were performed in calcium- and magnesium-
free PB1 supplemented with 3mg/ml fatty acid-free BSA and 7.5µg/ml cytochalasin B. 
Fusions of NT couples were performed in mannitol fusion medium by two electric DC 
pulses of 2.2 kV/cm for 30 microseconds. Fused embryos were activated at 24 h after the 
onset of maturation by exposure to 5 µM ionomycin for 5 min followed by five h 
incubation in cycloheximide at a concentration of 10 µg/ml.   
Embryo Culture 
After activation, embryos were cultured on a monolayer of bovine cumulus cells 
in 50 µL drops of CR2 containing 3% FBS overlaid with mineral oil. The embryos were 
cultured at 39˚ C in a humidified atmosphere of 5% CO
2
 in air for 7-8 days, and media 
was changed and development evaluated approximately every 48 h. 
Embryo Transfer 
On Day 6 or 7, compacted morulae and blastocysts were shipped overnight in 
equilibrated CR2 at 38.5 ˚ C to the site of transfer. One to four embryos (average 1.9) 
were transferred nonsurgically to cows synchronized + 1 day to the stage of the embryos. 
Equal numbers of embryos per recipient were transferred from both cow and heifer 
groups.  
Pregnancy Evaluation 
Pregnancy was detected by trans-rectal ultrasound between days 25 and 30, and 
pregnant recipients were checked by ultrasound or palpation at approximately 30-day 
intervals to confirm ongoing pregnancies. 
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Statistical Analysis 
Data were pooled from at least 15 replicates per group for the in vitro 
development studies. Chi-square analysis was used to determine differences in cleavage, 
development to the compacted morula/blastocyst stages, and pregnancy establishment 
and maintenance. Unless otherwise noted, a probability of P<0.05 was considered 
statistically significant. 
Results 
NT embryos derived from cow oocytes developed to the 2-cell and compacted 
morula/blasocyst stages (79.5% and 26.5%, respectively) at a higher rate than those from 
heifer oocytes (59.8% and 14.8%, respectively, P<0.001; Table 2-1). Further, transferred 
morulae/blastocysts produced from cow oocytes established pregnancy at a higher rate 
than heifer oocyte-derived embryos, and pregnancies were retained at a higher rate at 90 
and 180 days and to term (P<0.025; Table 2-2 and FIG. 2-1). The difference in pregnancy 
rates at 60 days approaches significance (P<0.1) Pregnancy rates for cow oocyte-derived 
embryos at were 51.3% at 25 days, 38.5% at 60 days, 28.2% at 90 days, 28.2 at 180 days, 
and 25.6% at term. In contrast, pregnancy rates from heifer oocyte-derived NT embryos 
were 29.2% at 25 days, 23.1% at 60 days, 7.7% at 90 days, 3.1% at 180 days, and 3.1% at 
term.  It is also interesting to note that the differences in pregnancy retention are not 
simply the result of a higher proportion of embryos establishing pregnancy. When 
pregnancy retention is evaluated based on the number of initial pregnancies established, 
the difference in pregnancy retention approaches significance at 90 days when 26.3% of 
initial pregnancies are ongoing in the heifer group and 55.0% of pregnancies from the 
cow group were ongoing (P<0.1) The difference is significant (P<0.01) at 180 days 
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(10.5% for heifer and 55.0% for cow) and at term (10.5% for heifer and 50.0% for 
cow). At birth nine of the ten calves derived from cow oocytes were apparently normal 
and healthy while in the heifer group only one of the two calves that reached term was 
healthy. This difference approaches significance at P<0.20. 
Table 2-1. In vitro development of NT embryos derived from cow and heifer 
cytoplasts.  
Oocyte source No. Fused No. Cleaved (%)a No. Compacted Morulae/Blastocysts (%)a 
Heifer 1746 1044 (59.8)a 259 (14.8)a 
Cow 479 381 (79.5)b 127 (26.5)b 
Values with different superscripts within each column are different (P<0.001). 
a Percentage of fused embryos. 
Table 2-2. Rates of pregnancy establishment and retention throughout gestation of 
NT embryos derived from cow and heifer cytoplasts. 





25 days (%)a 
 
60 days (%)a 
 
90 days (%)a 
 






Heifer 65 19 (29.2)a 15 (23.1)     5 (7.7)a     2 (3.1)a     2 (3.1)a 1 (50.0) 
Cow 39 20 (51.3)b 15 (38.5) 11 (28.2)b 11 (28.2)b 10 (25.6)b 9 (90.0) 
Values with different superscripts within each column are different (P<0.025) 
a Percentage of total transfers. 
b Percentage of term calves. 




























Figure 2-1. Pregnancy rates throughout gestation following transfer of NT embryos 
derived from cow and heifer cytoplasts. 
a, b Values with different superscripts within each column are different (P<0.025). 
Discussion 
 These data indicate that there are important differences between cow and heifer 
oocytes which make cow oocytes more suitable for use in bovine NT. Understanding the 
differences between cow and heifer oocytes and how those differences affect the 
efficiency of development following NT is an important step in improving the reliability 
of the process. Little research has been done to evaluate these differences, however it has 
been well established that calf oocytes differ from cow oocytes, and embryos derived 
from calf oocytes following IVF are less developmentally competent than IVF embryos 
derived from cow oocytes (Damiani et al. 1996; de Paz et al. 2001; Gandolfi et al. 1998; 
Khatir et al. 1998; Levesque and Sirard 1994; Majerus et al. 2000; Revel et al. 1995; 
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Salamone et al. 2001). These studies may offer insights into potential differences 
between cow and heifer oocytes.  
Studies of pre-pubertal calf oocytes have indicated they differ from cow oocytes 
in several important ways. It has been demonstrated that IVF embryos derived from calf 
oocytes develop slower in vitro, arrest more frequently at the 9-cell stage, and exhibit a 
longer lag phase before maternal to zygotic transition (Majerus et al. 2000). Calf oocytes 
also undergo nuclear maturation at a slower rate than cow oocytes (Khatir et al. 1998). 
Gandolfi et al. reported that calf oocytes are smaller in diameter, metabolize glutamine 
and pyruvate at a lower rate during the first three h of IVM, and exhibit a decline in 
protein synthesis earlier as compared with cow oocytes (Gandolfi et al. 1998). Other 
groups have also reported different patterns of protein synthesis between cow and calf 
oocytes (Gandolfi et al. 1998; Levesque and Sirard 1994; Salamone et al. 2001). Calf 
oocytes contain more microvilli on their cell surface and more endocytic vesicles than 
cow oocytes, while cow oocytes contain a larger superior mitochondrial population than 
calf oocytes (de Paz et al. 2001). Numerous reports have indicated that fewer calf oocytes 
develop to blastocyst as compared with cow oocytes in IVF, parthenogenetic, and NT 
experiments (Damiani et al. 1996; Levesque and Sirard 1994; Majerus et al. 2000; Revel 
et al. 1995; Salamone et al. 2001). Additional work by Revel et al. indicated that a much 
lower pregnancy rate results from the transfer of blastocysts derived from calf oocytes (1 
of 23 recipients; 4%) compared with cow-oocyte-derived blastocysts (10 of 26 recipients; 
38%). The single pregnancy established from calf embryos resulted in a full-term live 
calf (Revel et al. 1995). This indicates that although the overall developmental 
competence of calf oocytes is much lower, some oocytes derived from pre-pubertal 
animals do have the capacity to direct development to term.     
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 While many studies have evaluated the differences in developmental 
competence between cow and pre-pubertal calf oocytes fertilized in vitro, less attention 
has been given to potential differences between cow and heifer oocytes. There are several 
reports of differences between cow and heifer oocytes in terms of numbers of oocytes per 
ovary and in vitro developmental efficiency. Researchers have reported fewer oocytes 
collected from cows than from heifers following slaughter (Moreno et al. 1992) and also 
in conjunction with ovum pick up (Rizos et al. 2005). Rizos et al. also compared the 
number and quality of oocytes from slaughtered crossbred beef heifers under thirty 
months and cows over four years old (Rizos et al. 2005). They found no differences in the 
number of oocytes collected per ovary, however following IVF significantly more cow 
oocytes developed to blastocyst on day 8 as compared to heifer oocytes (46.5% and 
33.4% respectively). In their experiment heifer oocytes were further divided into groups 
based on the age of the donor (12-18 months, 19-24 months, and 25-30 months). There 
was no difference in blastocyst development between the three age groups (35.0%, 
35.2%, and 36.5%, respectively) The superiority of cow oocytes over heifer oocytes in 
terms of development to blastocyst (27.5% and 16.4%, respectively) was also reported by 
Zhang et al. (Zhang et al. 1991). Mermillod et al. evaluated the developmental potential 
of oocytes collected from cows of different ages and found no significant difference in 
blastocyst yield between oocytes from 1-3 year old cows compared with oocytes from 
cows older than three years old (Mermillod et al. 1992). A study involving the collection 
of oocytes from a slaughtered, Bovine Spongiform Encephalopathy (BSE)-infected herd 
also compared rates of development to blastocyst of oocytes collected from heifers and 
cows. Cow oocytes developed to grade-one blastocysts at a slightly higher rate than 
heifer oocytes (14.6% and 10.2%, respectively) however the difference was not 
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significant (Galli et al. 2003). We are not aware of any study evaluating the quality of 
NT embryos derived from cow and heifer oocytes following transfer.   
 In addition to the scarcity of research evaluating the developmental competence 
of heifer oocytes, very little research has been done to evaluate the effect of oocyte 
source on bovine NT.  Two studies have evaluated the developmental competence of calf 
oocytes used in NT. Both reported lower rates of development to the 2-cell stage and to 
blastocyst compared with development using cow oocytes. In one study, cleavage of NT 
embryos was 75% with cow oocytes and 69% with calf oocytes, and blastocyst 
development was 21% and 9%, respectively (Mermillod et al. 1998). A second study 
reported cleavage rates of 67% and 22% and blastocyst rates of 20% and 5% using cow 
and calf oocytes, respectively (Salamone et al. 2001). 
 Similar to the data from NT studies using calf oocytes, the present study indicates 
that cow oocytes are superior to heifer oocytes in directing development of NT couplets 
in vitro. In vitro development to transferable compacted morula/blastocyst stage between 
the two groups differs significantly [Table 1 (14.8% for heifer and 26.5% for cow)], and 
the differences are further amplified following transfer to recipients (Table 2-2 and FIG. 
2-1). The development of heifer oocyte-derived NT embryos to blastocyst offers evidence 
that in vitro development alone is not a reliable indicator of overall embryo quality. 
While it is clear that in vitro development is not the best indicator, often it is not feasible 
to transfer embryos to evaluate quality. More reliable and efficient measures of embryo 
quality must be developed to assist in pre-transfer selection of NT embryos with high 
developmental competence.  
 In the environment of the recipient cytoplast following NT, the donor nucleus 
undergoes dramatic changes that result in the restoration of totipotency to a differentiated 
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nucleus in a process referred to as nuclear reprogramming. Events similar to those that 
occur during reprogramming of the donor cell can be observed in sperm and oocyte DNA 
following fertilization. Prior to fertilization, sperm and oocyte genomes are much more 
highly methylated than somatic cells (Obata et al. 1998). At fertilization, sperm 
chromatin is actively demethylated, possibly by direct removal of the methyl group from 
the cytosine (Bhattacharya et al. 1999) or by exchange of the 5-methylcytosine with 
unmethylated cytosine via base excision (Weiss et al. 1996). The maternal genome is also 
demethylated during early development, but in a passive, replication-dependent manner. 
This global demethylation is subsequently followed by de novo methylation of the 
genome starting at the 8-cell stage in bovine embryos and the blastocyst stage in mice 
resulting in differentiation of cell lineages during development (Reik et al. 2001).  
The same machinery that is involved in chromatin modifications following 
fertilization is likely recruited for reprogramming of the donor nucleus following NT. 
Nuclear reprogramming of the donor cell following NT involves nuclear envelope 
breakdown (NEBD) and premature chromosome condensation (PCC; Barnes et al. 1993; 
Campbell et al. 1996; Czolowska et al. 1984), followed by erasure of epigenetic 
modifications to DNA including changes in histone acetylation (Nakao 2001) and DNA 
methylation (Kang et al. 2003; Shi et al. 2003b). Since maternal transcripts are 
responsible for the events of early embryonic development (Telford et al. 1990), and 
given the events that occur naturally following fertilization, nuclear reprogramming is 
likely mediated by factors in the oocyte cytoplasm. The results of this study demonstrate 
the profound impact differences in the source of the oocyte can have on development of 
bovine NT embryos in vitro and in vivo.  
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 The improved efficiency in NT using cow oocytes reflects more efficient 
reprogramming of the donor nucleus, which leads to slightly improved development in 
vitro and higher rates of pregnancy establishment and retention throughout gestation. 
Determining the inherent differences between cow and heifer oocytes will offer insights 
into transcripts or proteins that are potentially important in the process of nuclear 
reprogramming. 
Conclusion 
These data demonstrate that when possible cow oocytes should be utilized for 
bovine NT experiments over heifer oocytes. The present study also indicates that heifer 
oocytes are capable of reprogramming donor nuclei and producing live NT offspring, 
albeit at a much lower rate. Understanding the molecular and physiological differences 
between cow and heifer oocytes will provide valuable insights into factors that are 
important in nuclear reprogramming. This could open doors to improvements in oocyte 
selection or maturation parameters and ultimately result in improved efficiency in the 
currently very inefficient process of bovine NT.   
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CHAPTER 3  
EFFECT OF THE TIME INTERVAL BETWEEN FUSION AND ACTIVATION 
ON NUCLEAR STATE AND DEVELOPMENT IN VITRO AND IN VIVO OF 
BOVINE SOMATIC CELL NUCLEAR TRANSFER EMBRYOS 
Abstract 
This study indicated that prolonged exposure of donor cell nuclei to oocyte 
cytoplasm prior to activation resulted in abnormal chromatin morphology, and reduced 
development to compacted morula/blastocyst stages in vitro, however following transfer 
of embryos to recipients there was no difference in pregnancy rates throughout gestation. 
Chromatin morphology was evaluated for embryos held 2.0, 3.0, 4.0, and 5.0 h between 
fusion and activation. In embryos held 2.0 h, 15/17 (88.2%) embryos contained 
condensed chromosomes, while only 12/24 (50.0%) embryos held 3.0 h exhibited this 
characteristic. The proportion of embryos with elongated or fragmented chromosomes 
tended to increase with increased hold time. While 15/19 (78.9%) of embryos held 2.0 h 
developed a single pronucleus 6 h after activation, only 8/22 (36.4%) had 1 pronucleus 
after a 4.0 h hold. Embryos held 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 h cleaved at rates of 
207/281 (73.7%), 142/166 (85.5%), 655/912 (71.8%), 212/368 (57.6%), 406/667 
(60.9%), 362/644 (56.2%), and 120/228 (52.6%) respectively. Further development to 
compacted morula/blastocyst stage occurred at rates of 78/281 (27.8%), 42/166 (25.3%), 
264/912 (28.9%), 79/368 (21.5%), 99/667 (14.8%), 94/644 (14.6%), and 27/228 (11.8%) 
respectively. Embryos held <2.5 h between fusion and activation established pregnancies 
in 18/66 (27.3%) of recipients, while embryos held >2.5 h established pregnancies at a 
rate of 17/57 (29.8%). This study indicates holding bovine nuclear transfer embryos <2.5 
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h between fusion and activation results in improved nuclear morphology and increased 
development to compacted morula/blastocyst, and results in pregnancy rates equivalent to 
embryos held >2.5 h. 
Introduction 
Successful somatic cell nuclear transfer (NT) has been achieved in domestic 
animals and rodents as reported by the birth of offspring. The overall efficiency
 
of this 
technique, however, remains low, generally less than 2% (Hill 2002). A high frequency
 
of 
early post-implantation developmental arrest and abortion occurs, especially in cattle. 
The exact mechanism(s)
 
contributing to losses are still unclear. Epigenetic alterations 
(Cezar et al. 2003; Wrenzycki et al. 2001), and chromosomal abnormalities (Burgoyne et 
al. 1991; Li et al. 2004a; Li et al. 2004b) likely contribute to developmental failure.  
Following the transfer of a differentiated nucleus into an enucleated MII oocyte, 
the nucleus is disassembled, an event involved in reprogramming the differentiated donor 
nucleus to a totipotent embryonic state. This disassembly involves nuclear envelope 
breakdown (NEBD) and premature chromosome condensation (PCC), mediated by high 
levels of mitosis/meiosis/maturation-promoting factor (MPF) in the oocyte cytoplasm 
(Barnes et al. 1993; Campbell et al. 1996; Czolowska et al. 1984). These events are 
followed by erasure of epigenetic modification of DNA including changes in histone 
acetylation (Nakao 2001) and DNA methylation (Kang et al. 2003; Shi et al. 2003). Since 
maternal transcripts are responsible for the events of early embryonic development 
(Telford et al. 1990), nuclear reprogramming is presumably mediated by factors in the 
oocyte cytoplasm.  
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Several groups have shown that the duration of exposure of the donor nucleus 
to oocyte cytoplasm following NT affects in vitro development, however the conclusions 
are mixed. Some reports have indicated a prolonged exposure to the oocyte cytoplasm 
prior to activation may be beneficial in promoting embryo development for bovine (Wells 
et al. 1999; Wells et al. 1998) and murine NT (Wakayama et al. 1998). Another study 
reported the exposure of transferred nuclei to cytoplasm for less than 30 min prior to 
activation yielded significantly lower blastocyst development than a 2-h exposure (Liu et 
al. 2001). Conversely, other research indicates excessive exposure of the donor DNA to 
oocyte cytoplasm results in lower rates of in vitro development in cloned embryos (Akagi 
et al. 2001). Most recently, Choi et al. demonstrated that in vitro development of bovine 
NT embryos to blastocyst decreased as time in hold was increased from 1 to 5 h (Choi et 
al. 2004).  
Given the conflicting data on the subject we have evaluated the effect of timing 
between fusion and activation on NT development. The present study was designed to 
examine the effect of different time intervals between fusion and activation on structure 
of the transferred nucleus and embryonic development in vitro and in vivo.      
Materials and Methods 
Unless otherwise noted, all reagents used were obtained from ICN Biochemicals. 
Donor cell culture 
Primary bovine fibroblast cultures were established from either lung tissue or ear 
biopsy. Previous data have demonstrated no difference in in vitro development between 
lung- and ear-derived donor cells (Kato et al. 2000). Tissues were washed thoroughly and 
minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone Laboratories, Logan, UT) 
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supplemented with 15% fetal bovine serum (FBS; HyClone Laboratories, Logan, UT) 
and 100 U/mL penicillin/ 100 µg/mL streptomycin (HyClone Laboratories), seeded in 25 
cm
2
 tissue culture flasks, and cultured at 39˚C in a humidified atmosphere of 5% CO
2
 in 
air for several days. Cells were then harvested in tissue culture medium containing 10% 
DMSO and stored in liquid N
2 
until use in NT.  Frozen/thawed cells were grown to 80-
100% confluence and passages 2-16 were used as nuclear donors.  
Oocyte Maturation 
Maturation of bovine oocytes was performed as described previously (Li et al. 
2004a; Li et al. 2004b). Briefly, cumulus oocyte complexes (COC) were aspirated from 
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.  
Only those with uniform cytoplasm and intact layers of cumulus cells were selected and 
matured in TCM 199 containing 10% FBS, 0.5 µg/mL FSH (Sioux Biochemicals, Sioux 
City, IA), 5 µg/mL LH (Sioux Biochemicals), and 100 U/mL penicillin/ 100 µg/mL 
streptomycin for 18-22 h.  
Nuclear Transfer 
Following maturation, cumulus cells were removed by vortexing COC in PB1 
(calcium and magnesium containing phosphate buffered saline [HyClone Laboratories, 
Logan, UT], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/mL BSA) medium 
containing 10 mg/mL hyaluronidase. Oocytes with a first polar body were used as 
recipient cytoplasts. Enucleation was employed to remove the first polar body and 
metaphase plate, and single cells were subsequently transferred to the perivitelline
 
space 
of recipient cytoplasts.  Fusions of NT couplets were performed in mannitol fusion 
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medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 
microseconds. Following fusion, embryos were held in CR2 medium supplemented with 
3% FBS for 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 h prior to activation. Fused embryos were 
activated between 23 and 25 h after the onset of maturation by exposure to 5 µM 
ionomycin for 5 min followed by five h incubation in 10µg/ml cycloheximide.  
Nuclear and Microtubule Assessment 
by Immunofluorescent Staining 
 
Reconstructed embryos were fixed 2.0, 3.0, 4.0, and 5.0 h after fusion. Some 
embryos activated 2.0 and 4.0 h after fusion were fixed 6.0 h after initial activation to 
evaluate pronuclear morphology. Immunofluorescent staining was performed as reported 
(Zhu et al. 2003) with some modifications. Briefly, embryos were fixed with 3.7% (w/v) 
paraformaldehyde
 
in PBS overnight at 4°C. Fixed embryos were extracted in PBS 
containing 1% (w/v) Triton X-100 and 0.3% BSA for 1.0 h at 37°C. After two washes 
with PBS containing 0.01% Triton X-100, embryos were blocked
 
in PBS containing 150 
mM glycine and 1% Triton X-100 for 1.0 h at 37°C. The embryos were then incubated 
for 1.0 h at 37°C in a mouse monoclonal
 
antibody against α-tubulin (Sigma, T-5168) 
diluted 1:100 in PBS. They were then washed with PBS and incubated in fluorescein 
isothiocyanate-labeled goat-anti-mouse IgG (Southern Biotechnology Associate, Inc. 
Birmingham, AL 35226. Cat No. 1030-02) diluted 1:100 in PBS for 1.0 h at 37°C. 
Chromatin
 
was stained with 10 µg/ml of propidium iodide.
 
Finally, embryos were 
mounted on slides with a solution of glycerol and PBS (1:1). The samples were examined 
under a Zeiss epifluorescent microscope (Carl Zeiss Optical, Inc., Chester, Virginia, 
USA). Images were captured by digital camera with the PIXERA Viewfinder Program 
(Pixera Corporation, Los Gatos, California, USA).
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Embryo Culture 
After activation, embryos were cultured under mineral oil in 50 µL droplets of 
CR2 with 3% FBS on a monolayer of bovine cumulus cells at 39°C in an atmosphere of 
5% CO
2
 in air for 6-7 days. Medium was changed every 48 h. Cleavage and compacted 
morula/blastocyst rates were recorded 48 h and 6-7 days post-activation, respectively. 
Embryo Transfer 
On Day 6 or 7, compacted morulae and blastocysts were shipped overnight in 
equilibrated CR2 at 38.5 ˚ C to the site of transfer. One to two embryos were transferred 
nonsurgically to cows synchronized + 1 day to the stage of embryonic development. 
Pregnancy was detected by trans-rectal ultrasound at embryonic d 25-30. 
Statistical Analyses 
Data were pooled from at least four replicates per group for the in vitro 
development studies. Chi-square analysis was used to determine differences in cleavage 
and development to the compacted morula stage between hold times. Differences in 
remodeling and nuclear morphology between groups were analyzed using Student's t-test. 
Unless otherwise noted, a probability of P<0.05 was considered statistically significant. 
Results 
Nuclear Morphology 
When the pre-activation reconstructed embryos were examined 2.0 h after fusion 
the majority of the embryos (88%, 15/17) possessed condensed chromosomes (Fig. 3-1a) 
or a chromosome array resembling the maternal metaphase plate (metaphase-like 
chromosomes, Fig. 3-1b), which was significantly higher (P<0.05) than embryos 
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examined 3 h after fusion (50%, 12/24). The proportion of the embryos possessing 
elongated or scattered chromosomes tended to increase with increasing time between 
fusion and activation (Table 3-1). Eighty-two percent of the embryos held 4.0 to 5.0 h 
between fusion and activation possessed elongated (Fig. 3-1c, d) or scattered (Fig. 3-1e) 
chromosomes.  
Table 3-1. Remodeling of transferred bovine somatic cells at various times after 
fusion.  
Time after fusion (h) No. embryos 
examined 
Nuclear remodeling types (%) 















    9 (52.9)
a 
               6 (35.3)
b
             2 (11.8)
c
                                                                
 
     2 (8.3)
c
               10 (41.7)
a
            9 (37.5)
b




                                   2 (8)
c
                12 (48)
a
               9 (36)
a
                  2 (8) 
  
                                   2 (8)
c
                 9 (36)
b
               11(44)
a 
                3 (12) 
a,b,c
 Values with different superscripts in the same column differ from each other at 
P<0.05. 
 
Of embryos observed 6.0 h after activation, 78.9% of the embryos activated 2.0 h 
after fusion developed a single pronuclear structure (PN), which was significantly higher 
than those activated 4.0 h after fusion (36.4%; Table 3-2). Of the embryos activated 4.0 h 
after fusion 63.6% possessed 2 or more PN (Fig. 3-1f-i). 
Table 3-2. Nuclear morphology of bovine NT embryos 6 h after activation. 
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Activation time post-fusion (h) No. embryos 
examined 
Pronucleus (PN) status (%) 







    15 (78.9)
a
           3 (15.8)          1 (5.3)             0                       0 
 
     8 (36.4)
b
            4 (18.2)          2 (9.0)        6 (27.3)            2 (9.0) 
a, b
 Values with different superscripts in the same column differ from each other at P<0.05. 
 
 
Figure 3-1. Nuclear remodeling and morphology of bovine nuclear transferred 
embryos. A-E, remodeling of nuclei after fusion. A. Condensed chromosomes, small 
microtubule aster existed among chromatin; B, metaphase-like chromosomes with 
strongly stained microtubules; C and D, elongated chromosomes and microtubules 
connecting the chromosomes; E, scattered chromosomes. From F to I, the representatives 
of 1 PN, 2 PN, 3 PN, 7 PN, respectively, after activation of fused nuclear transferred 
embryos. Bars represent 10µm. 
 
Embryo Development In Vitro and In Vivo  
Cleavage of embryos derived from groups activated 1.0-2.0 h after fusion (71.8%-
85.5%) was significantly higher (P<0.01) than embryos held 2.5-4.0 h between fusion 
and activation (52.6%-60.9%; Fig. 3-2 & Table 3-3). The compacted morula/blastocyst 
development of embryos activated 1.0-2.5 h post fusion (21.5%-28.9%) was higher 
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(P<0.01) than embryos activated after 3.0-4.0 h post fusion (11.8%-14.8%; Fig. 3-2 & 
Table 3-3).  Following transfer of the cloned compacted morulae/blastocysts to recipients 
no differences were observed in d 30 pregnancy rates between embryos held <2.5 h (18 
pregnancies/66 transfers (27.3%)) and embryos held >2.5 h (17 pregnancies/57 transfers 
(29.8%)).  Pregnancy retention was evaluated around days 60, 90, 180, and term, and no 
differences in pregnancy retention were observed at any stage of gestation with 3 calves 


















1 0 .0 %
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4 .0  h
  
Figure 3-2. In vitro development of bovine NT embryos based on time between 
fusion and activation. 
a, b, c
 Values with different superscripts in the same group differ from each other at P<0.01. 
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Table 3-3. In vitro development of bovine NT embryos with different hold times. 
Time in hold (h) No. cultured No. cleaved (%) No. compacted morulae/blastocysts (%) 




































 Values with different superscripts in the same column differ from each other at 
P<0.01. 
Discussion 
In order for NT to be successful the donor nucleus must be properly 
reprogrammed. During nuclear reprogramming epigenetic marks are erased from the 
donor nucleus genome, resulting in an erasure of tissue-specific gene expression patterns 
and effectively resetting the cell to a totipotent state (Santos and Dean 2004). Our studies 
indicate that timing between fusion and activation probably has a critical impact on 
reprogramming.  
Studies evaluating DNA methylation patterns in developing NT embryos indicate 
demethylation and re-methylation events are not always faithfully recapitulated in the 
mouse (Chung et al. 2003; Mann et al. 2003; Shi and Haaf 2002) and the cow (Bourc'his 
et al. 2001; Dean et al. 2001; Kang et al. 2002). It is also clear that histone acetylation is 
sometimes aberrant in bovine NT embryos (Santos et al. 2003). This incomplete 
epigenetic reprogramming is the predominant explanation for the frequent aberrant gene 
expression in NT embryos and the subsequent failures in development (Santos et al. 
2003).  
The mechanisms responsible for DNA demethylation may follow a pattern of 
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activity similar to MPF with high activity prior to activation and a diminishing of 
activity following activation. Further research will be required to determine those 
dynamics, but based on the study by Dean et al. there appears to be a critical window of 
time in which active demethylation can occur following fusion (Dean et al. 2001). The 
idea of this critical window between fusion and activation is supported by the work of 
Bourc'his et al. in which active demethylation was not observed when activation was 
performed at the time of fusion (Bourc'his et al. 2001). 
Nuclear remodeling is an important element in the process of reprogramming that 
must occur in NT embryos. Our research as well as the research of others has 
demonstrated that chromatin remodeling and blastomere ploidy frequently deviates from 
normal following NT in various species including cattle (Booth et al. 2003; Bureau et al. 
2003; Li et al. 2004a; Li et al. 2004b) rabbits (Shi et al. 2004), and pigs (Kim et al. 2005). 
Several significant morphological changes occur in the donor nucleus following NT into 
cytoplasts with high MPF activity. These changes include nuclear envelope breakdown 
(NEBD) and premature chromosome condensation (PCC) (Campbell et al. 1996; 
Czolowska et al. 1984). Following these two events, the nuclear envelope is re-formed, 
and DNA synthesis commences (Campbell et al. 1993). Aberrations or deficiencies in 
these events might result in some of the problems associated with early development in 
NT embryos.  
Figures 3-1-C and 3-1-D show elongated chromosome sets. It is clear how these 
cells might end up with 2-3 PN (as in Figures 3-1-G and 3-1-H) following activation as 
areas where microtubules are thinner are likely more prone to depolymerization and 
fragmentation. This is supported by the fact that more elongated chromosome sets were 
observed with increased time after fusion and more embryos displayed multiple PN when 
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held four h between fusion and activation as compared with embryos activated two h 
after fusion. Likewise, a scattered chromosome arrangement as observed in Figure 3-1-E 
would result in multiple PN following activation. It is also probable that those embryos 
with more than one PN following activation will result in nuclear fragmentation and 
unbalanced chromosome constitutions. 
The amount of time the donor nucleus is exposed to oocyte cytoplasm prior to 
activation is critical in subsequent development of NT embryos. Based on our data, it 
appears that prolonged exposure to arrested MII oocyte cytoplasm results in more 
frequent structural abnormalities in nuclear material, manifesting itself as elongated 
chromatin prior to activation and the development of multiple pronuclei following 
activation.     
While it is important to note that the number of morphologically “normal” 
embryos prior to activation (embryos with compacted or metaphase-like chromosomes) 
and following activation (single PN) declines when embryos are held longer than 3.0 h 
prior to activation, it is also noteworthy that some embryos held longer do appear normal 
and develop to compacted morula/blastocyt. Our data also indicate that those embryos 
that develop to compacted morula have an equal probability of establishing and 
maintaining pregnancy regardless of hold time, indicating that most embryos negatively 
affected by a prolonged hold time will stop developing prior to reaching compacted 
morula stage.   
This study evaluated the effect of the duration of exposure of the donor nucleus to 
MII oocyte cytoplasm prior to activation on nuclear structure, in vitro development, and 
pregnancy rates post-transfer. The data indicate that prolonged exposure to oocyte 
cytoplasm results in more embryos with elongated or scattered chromosomes prior to 
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activation as well as fewer embryos developing a single PN 6.0 h after activation. We 
found that a hold between 1.0 and 2.0 h results in higher in vitro development and lower 
rates of nuclear fragmentation. While in vitro development declines and fragmentation 
increases with increased hold time, those embryos that develop to compacted morula or 
blastocyst are equally likely to establish pregnancy following transfer. Based on this data, 
embryos that are chromosomally compromised probably cease development prior to 
reaching compacted morula stage. The data further indicates that 1 h between fusion and 
activation provides the donor nucleus with sufficient exposure to MII cytoplasm to 
initiate critical reprogramming events and that longer than 2 h results in reduced viability 
of embryos in vitro.  
 The process of nuclear reprogramming during NT is extremely complex and, as 
yet, not well understood. There are undoubtedly numerous proteins involved in the 
process of de-differentiation that occurs in NT. Even under conditions where proper 
chromosomal composition is maintained NT efficiency is still quite low. This indicates 
that while compromised chromosomal composition is a factor that reduces NT efficiency, 
improper epigenetic reprogramming of the donor nucleus probably has a greater impact 
on NT efficiency. Further research evaluating the molecular machinery involved in 
nuclear reprogramming prior to and following activation will pave the way to a better 
understanding of the mechanisms of nuclear reprogramming and the development of new 
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CHAPTER 4 
GLOBAL GENE EXPRESSION ANALYSIS OF BOVINE SOMATIC  
CELL NUCLEAR TRANSFER BLASTOCYSTS  
AND COTYLEDONS 
Abstract 
Low developmental competence of bovine somatic cell nuclear transfer (SCNT) 
embryos is a universal problem. Abnormal placentation has been commonly reported in 
SCNT pregnancies from a number of species. The present study employed Affymetrix 
bovine expression microarrays to examine global gene expression patterns of SCNT and 
in vivo produced (AI) blastocysts as well as cotyledons from day-70 SCNT and AI 
pregnancies. SCNT and AI embryos and cotyledons were analyzed for differential 
expression. Also in an attempt to establish a link between abnormal gene expression 
patterns in early embryos and cotyledons, differentially expressed genes were compared 
between the two studies. Microarray analysis yielded a list of 28 genes differentially 
expressed between SCNT and AI blastocysts and 19 differentially expressed cotyledon 
genes. None of the differentially expressed genes were common to both groups, although 
major histocompatibility complex I (MHCI) was significant in the embryo data and 
approached significance in the cotyledon data. This is the first study to report global gene 
expression patterns in bovine AI and SCNT cotyledons. The embryonic gene expression 
data reported here adds to a growing body of data that indicates the common occurrence 
of aberrant gene expression in early SCNT embryos. 
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Introduction 
The inefficiency associated with bovine SCNT has greatly limited its utility in a 
number of applications including production agriculture, conservation biology, and bio-
pharmaceutical research. While it is difficult to ascertain the overall efficiencies due to 
differences in protocols, embryo transfer criteria, and data presentation the overall 
efficiency of SCNT across species based on the number of embryos produced is less than 
5% (Campbell et al. 2005). In cattle, approximately 10-15% of SCNT embryos 
transferred develop to term (Oback and Wells 2007). 
A growing amount of data indicates the inefficiencies associated with SCNT 
largely result from deficiencies in nuclear reprogramming of the somatic nucleus 
following NT. Following the transfer of a differentiated cell or nucleus into an enucleated 
oocyte, the DNA must be reprogrammed from a cell-type-specific gene expression 
pattern to a totipotent embryonic-cell state. Modifications to the epigenetic order of the 
DNA are required in order for this to occur.  
The oocyte is well equipped to direct the nuclear reprogramming following 
normal fertilization, but less efficient at reprogramming somatic cells following SCNT. 
At fertilization, sperm chromatin is actively demethylated, and the maternal genome is 
demethylated in a passive, replication-dependent manner. This global demethylation is 
subsequently followed by de novo methylation of the genome starting at the 8- to 16-cell 
stage in bovine embryos and the blastocyst stage in the murine resulting in differentiation 
of cell lineages during development (Reik et al. 2001). Histone modifications are altered 
in a similar fashion following fertilization (Dean et al. 2003). A recent study analyzed the 
involvement of twenty-four chromatin factors (CFs) including transcription factors and 
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nuclear binding proteins in reprogramming following fertilization in the mouse. 
Shortly after fertilization nearly all CFs were removed from chromatin, and shortly after 
pronuclear formation CFs are re-established on the chromatin in what is described as an 
“erase-and-rebuild strategy” (Sun et al. 2007). 
A growing body of evidence supports the idea that SCNT inefficiency is a result 
of incomplete nuclear reprogramming. Differences in gene expression of embryos 
(Daniels et al. 2000; Han et al. 2003; Li et al. 2006; Santos et al. 2003) and fetuses (Hill 
et al. 2002; Schrader et al. 2003), as well as aberrant DNA methylation (Kang et al. 2001; 
Kang et al. 2002; Kang et al. 2003; Mann et al. 2003; Shi and Haaf 2002; Young and 
Beaujean 2004) and histone acetylation (Enright et al. 2003; Enright et al. 2005; Santos et 
al. 2003) in embryos and fetuses have all been reported previously. A follow-up study on 
the involvement of CFs on nuclear reprogramming evaluated the dynamics of the same 
CFs following SCNT and found similar patterns of CF removal and re-establishment in 
the somatic nucleus, but with some differences associated with timing and efficiency. In 
the case of control embryos, early development was characterized by a nearly complete 
removal of CFs from the DNA and export from the nucleus followed by sequential re-
establishment of the CFs. In SCNT embryos, even after removal of the majority of CFs, 
some remained associated with DNA throughout early development, an indication of 
incomplete reprogramming (Gao et al. 2007). Epigenetic changes associated with 
differentiation of somatic cells likely make them more difficult to reprogram following 
SCNT. 
A common phenotypic problem with bovine SCNT pregnancies is abnormal 
placentation. SCNT pregnancies are often noted to have larger and fewer placentomes 
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than controls (Constant et al. 2006; Heyman et al. 2002; Hill et al. 1999; Hoffert et al. 
2005; Oishi et al. 2006). Deficiencies in fetal-maternal nutrient and waste exchange 
contribute to the high rates of pregnancy failure and post-partum loss (Constant et al. 
2006; Heyman et al. 2002; Hill et al. 2000; Hill et al. 1999). 
Based on the growing amount of data implicating deficient nuclear 
reprogramming in many of the problems associated with SCNT, along with the apparent 
involvement of abnormal placentation in SCNT pregnancy loss, we conducted a series of 
experiments to evaluate global gene expression patterns in SCNT and AI blastocysts and 
cotyledons, the fetal contribution to the placentome. 
Materials and Methods 
Donor Cell Culture 
Primary bovine fibroblast cultures were established from lung tissue. Tissues 
were washed thoroughly and minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone 
Laboratories, Logan, UT 84321) supplemented with 15% fetal bovine serum (FBS; 
HyClone Laboratories) and 100 U/ml penicillin/ 100 µg/ml streptomycin (HyClone 
Laboratories), seeded in 25 cm2 tissue culture flasks, and cultured at 39˚C in a humidified 
atmosphere of 5% CO2 in air for several days. Cells between passages one and four were 
then harvested and re-suspended in tissue culture medium containing 10% DMSO, 
frozen, and stored in liquid N2 until use in SCNT.  Prior to SCNT, cells were thawed and 
grown to 80-100% confluence. Cells were treated with trypsin (.25%) and resuspended in 
manipulation medium for use in SCNT. 
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Oocyte Maturation 
Maturation of bovine oocytes was performed as described previously (Li et al. 
2004a; Li et al. 2004b). Briefly, cumulus oocyte complexes (COC) were aspirated from 
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.  
Only those oocytes with uniform cytoplasm and intact layers of cumulus cells were 
selected and matured in TCM 199 containing 10% FBS, 0.5 µg/ml FSH (Sioux 
Biochemicals, Sioux City, IA 51250), 5 µg/ml LH (Sioux Biochemicals), and 100 U/ml 
penicillin/ 100 µg/ml streptomycin for 18-22 h.  
SCNT Embryo Production 
Following maturation, cumulus cells were removed from oocytes by vortexing 
COC in PB1 (calcium and magnesium containing phosphate buffered saline [HyClone 
Laboratories], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/ml BSA) medium 
containing 10 mg/ml hyaluronidase. Oocytes with a first polar body were used as 
recipient cytoplasts. Enucleation was employed to remove the first polar body and 
metaphase plate, and single cells were subsequently transferred to the perivitelline space 
of recipient cytoplasts.  Fusions of NT couplets were performed in mannitol fusion 
medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 microseconds. 
Following fusion, embryos were held in CR2 medium supplemented with 3% FBS for 1-
2 h prior to activation (Rosenkrans and First 1994). Fused embryos were activated 
between 23 and 25 h after the onset of maturation by exposure to 5 µM ionomycin for 5 
min followed by five h incubation in 10µg/ml cycloheximide. For the purposes of the 
microarray experiments we produced three groups of ten grade 1-2 blastocysts from a 
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single cell line. For real-time PCR (Q-PCR) validation, an additional three groups of 
five embryos were produced. Embryos were placed in RNAlater RNA stabilization 
reagent (Ambion Inc., Austin, TX 78744) and stored at -20° C until RNA extraction.   
AI Embryo Production 
Control embryos for microarray studies were collected from super-ovulated cows 
using established protocols. Donor cows were synchronized using the EAZI-BREED™ 
CIDR® vaginal progesterone implant. The CIDR was used for 10 days followed by an 
I.M. injection of 50 mg Lutalyse (5ml at 10 mg/ml). Animals were bred by artificial 
insemination (AI) the morning following standing heat and again 12 and 24 h after 
standing heat. Seven days after the initial breeding, embryos were collected from donor 
animals by intra-uterine flush using embryo filters. Following collection, embryos were 
rinsed in flush medium, placed in RNAlater (Ambion Inc.) and stored at -20° C until 
RNA extraction. Three groups of ten grade 1 and 2 blastocysts were collected for the 
microarray studies, and an additional three groups of five embryos were collected for Q-
PCR validation. 
Cotyledon Collection 
 Control pregnancies were established by artificial insemination of CIDR-
synchronized cows, and SCNT pregnancies were established by non-surgical embryo 
transfer of day 7-8 SCNT blastocysts. Pregnancies were verified by ultrasound at 
approximately embryonic day-30 and again at day-60. On day 69-70 post-insemination 
/activation, recipient animals were slaughtered at a local abattoir. Cotyledonary tissue 
was collected within thirty min of slaughter, snap frozen and stored in cryovials in liquid 
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N2 until RNA extraction. Cotyledons were collected from three AI pregnancies and 
four SCNT pregnancies.   
RNA Extraction 
RNA extraction from embryos. Total RNA was extracted and DNA was digested 
with DNase I from AI and NT embryos using the RNAqueous micro kit (Ambion Inc.) 
according to manufacturer’s recommendations with modifications. Prior to RNA 
extraction each sample was spiked with 50 µg yeast tRNA as a carrier. The RNA was 
eluted from the RNAqueous column using two 20-µl volumes of pre-warmed (75° C) 
elution solution. Following RNA purification microarray samples were reduced to 3-5 µl 
using speed vacuum centrifugation in order to yield a sufficient RNA concentration for 
amplification using the Affymetrix 2-round labeling kit. All of the RNA extracted from 
the first three groups of ten AI and SCNT embryos was utilized for the microarray 
experiments, and a second group of embryos was collected and RNA-extracted for Q-
PCR validation. In order to obtain sufficient RNA for Q-PCR reactions, the RNA was 
amplified using the TargetAmp 2-Round Amplification Kit 2.0 (Epicentre, Madison, WI 
53713). Amplified RNA was reverse-transcribed and stored at -20ºC until Q-PCR 
analysis. 
RNA extraction from cotyledons. Cotyledons were removed from liquid N2, and 
approximately 30 mg of tissue was placed in RLT Buffer (Qiagen Inc., Valencia, CA 
91355) containing beta-mercapto ethanol (βME) and subsequently homogenized using a 
rotor stator homogenizer. The RNA extraction was performed using the RNeasy Mini 
RNA Extraction Kit (Qiagen) according to manufacturer’s recommendations.   
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Microarray Expression Studies 
 For the embryo microarray studies, previous experience as well as personal 
communications with other researchers indicated RNA concentration- and quality-
determination using the nanodrop and bioanalyzer are ineffective with RNA extracted 
from embryos, so preliminary checks of RNA were not performed on embryonic RNA. 
Blastocyst stage bovine embryos contain approximately 2 ng total RNA, in order to attain 
sufficient quantities of RNA for hybridization on Affymetrix GeneChips a two-round 
labeling protocol was used. Following the two-round labeling procedure RNA quantity 
and integrity were assessed using an Agilent 2100 Bioanalyzer.  Following quality 
assessment, labeled RNA was hybridized to the Affymetrix bovine microarray chip and 
subsequently scanned according to manufacturer’s protocols. Microarray analysis of 
cotyledons was also performed according to manufacturer’s protocols. Since sufficient 
RNA could be obtained from cotyledons, single-round labeling was used rather than the 
two-round labeling. Following microarray analysis, Q-PCR of cotyledon RNA and 
amplified blastocyst RNA was used to validate microarray data. 
Reverse Transcription and SYBR Green Q-PCR 
Reverse transcription was performed using Superscript III Reverse Transcriptase 
(Invitrogen, Carlsbad, CA 92008) with random primers. The cDNA was stored at -20°C 
until use. SYBR Green real-time PCR (Abgene, Rochester, NY 14610) was used to 
validate differential expression of genes in cotyledons and blastocysts that was 
determined, by microarray analysis, to be differentially expressed. Each real-time PCR 
reaction was performed in duplicate. Q-PCR was performed in white thin-walled 96-well 
plates. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the internal 
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control housekeeping gene as it has been determined to be the most reliable 
housekeeping gene in bovine pre-implantation embryos (Robert et al. 2002). Primers for 
Q-PCR analysis (Table 4-1) were designed using Primer3 primer-design software (Rozen 
and Skaletsky 2000). A standard PCR protocol with a 15µL reaction volume was used. 
The reactions consisted of Absolute™ QPCR SYBR® Green PCR Master Mix (Abgene) 
containing fluorescein reference dye, forward and reverse primers at 200-300 nM final 
concentration and 1 µL diluted template cDNA. The same PCR protocol was used for all 
primers: 15 min at 95°C for activation of the hot start Thermo-Start® DNA Polymerase; 
40 cycles of 95°C for 15 sec, 58°C for 30 sec, and 72°C for 15 sec (data collection step), 
then 95°C for 30 sec followed by an 80-cycle melt curve initiated by 30 sec at 55°C with 
a temperature increase of 0.5°C each cycle. 
Statistical analysis 
 Analysis of cotyledon microarray data. After RMA (Irizarry et al. 2003) 
preprocessing the limma/eBayes model (Smyth 2004) was applied to the data to test for 
differential expression between controls and clones. As all of the clones were bulls, and 
two of the controls were heifers, a gender covariate was added to the model. The results 
of this preliminary probeset-level analysis did not yield any significant genes when 
controlling the false discovery rate at 0.05.  
The inability of more traditional probeset-level models to detect significance in 
these data motivated a consideration of various probe-level models, which have 
performed favorably in previous applications (Bolstad 2004). RMA background 
correction and quantile normalization was performed, and again the limma/eBayes model 
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with the gender covariate was applied to the data. By analyzing the data in this 
manner, a number of genes were determined to be differentially expressed after 
controlling the false discovery rate (FDR) at 0.05 (adjusted p-value [q]<0.05). 
Analysis of embryo microarray data. Similar to the cotyledon data, after RMA 
(Irizarry et al. 2003) preprocessing the limma/eBayes model (Smyth 2004) was fit to the 
data to test for differential expression between controls and clones.  Unlike the cotyledon 
data, after controlling the FDR at 0.05 differentially expressed genes were found using 
the probeset-level data (q<0.05). 
Q-PCR analysis. The delta-delta Ct method (∆∆Ct) was used for real-time PCR 
data evaluation (Livak and Schmittgen 2001). Data was normalized for differing amounts 
of input cDNA using ∆Ct (Ct for the GAPDH housekeeping gene minus Ct for the gene 
of interest). Next, ∆∆Ct was calculated by subtracting the ∆Ct of each sample from the 
∆Ct of a reference cDNA sample. The n-fold increase or decrease in expression levels of 
each gene at each embryonic stage was calculated using the formula 2-∆∆Ct. Pair-wise 
comparisons between SCNT- and AI-∆∆Ct values were performed for each gene using 
the Student’s t-test. A probability of P<0.05 was considered significant. 
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Table 4-1 Details for primer sequences used in SYBR Green Q-PCR analyses. 
Primer name Sequence forward, reverse (5'-3') 
Size 
(bp)  Primer name Sequence forward, reverse (5'-3') 
Size 
(bp)  
Primers used in both experiments Embryo primers 
GAPDH  GATTGTCAGCAATGCCTCCT 240 LOC511508  TGGCACACGTTGTTGATTTT 171 
 TTGAGCTCAGGGATGACCTT   GATGAAGCAAAGGGACCAAA  
MHCI JSP.1  TCCTTGTCACTGGAGCTGTG 240 LOC510084  TTCTTGGGGTGTTCTGCTTT 237 
 ACAGACGCATTCAGATGCAG   CGGAGGACACTGGTTTTGTT  
LOC540552  TGTTGGAGTTGTTCCTTGCT 115 LOC614726  TGGACCGTGTAGGAAAAAGG 169 
 ACAGCCACAAAAATGTCCTG   AGCACTCAGCCCACAAACTT  
LOC533044  TTACGTTTTCAACGGCTGTG 235 S-N33  TCGTGGCAGAGTCACACATT 192 
 TCACTGGCCAAACACCATAA   GGTAGCCGTGGTACTTGGAA  
Cotyledon primers LOC616217  CAGTTTTTAATGCGCAAGCA 209 
LOC782061  CAAGCAGCTGGAGAAGATCC 201  AAGCTGTCTTTCTGGGCAAA  
 TCCAAGAGAAAGGGGAGGTT  IER3  GCAAGCACCCAGAACTAAGC 154 
MGC142541 TGTGGAAGTTTCTGCACTGG 199  TTCCCCGAATCTTCACAGAC  
 CATGTTTGGCAGCTTAGCAA  TL21877  GGCATTGCTTCCATTTGATT 247 
LOC613334 GCAGTGAAAATGCTGATGGA 216  CAATGAGAAACAGAGGAAAATCG  
 CTCTCAGAGGGGCAAAACAG  DR1  TGCTTAGGTTGCATTGGTTG 207 
RBP1  CGACTTTACCGGGTACTGGA 207  TGCCATTTCAAAGGAAGCAT  
 TCAAACTCCTTCCCAACCTG  TL24300  TCCCTGGAAGTGTTTCCAAC 202 
MGC139085 CTCCCTGAACTGGCATTCTC 207  TCCTACCCATCAAGAAGCTCA  
 GTTCTGAGGCCCTCTCTCCT  LOC513234  GCGACAGTGGAGACAACAGA 206 
LOC540923 TGCCTGGAGCCAGTCTACTT 244  GAACCTGCACAGGCTTCTTC  
 AGAGGGGCTTCCTAAAGCTG  LOC514267  TGCCTTCATGTTATGCGGTA 201 
MGC142636 GACGCTCACAGAGGAAGACC 175  GCCTTGTGAAAGCACCTCTC  
 GTCGGCTTTCCTCTTCTCCT  MGC152029  TGCCTTTAGCTCATGTCGTG 250 
LOC528380 CCACTTTGCTGCTGACTTGA 210  GGTTCTTTGGTGCGAATTGT  
 GCTGCATTTGACTCAGAAAGG  LOC539967  CAAGGAAGTCCTGCCTTCAG 215 
IL6  TGCAGTCTTCAAACGAGTGG 182  AAGGCTGGCTCCTGTGAATA  
 TAAGTTGTGTGCCCAGTGGA  LOC539627  ACATGGACAAGGCACATTGA 215 
PAG10  GAATGGGACAGTGGTTGCTT 177  ACTGTACCCCAAATCCCACA  
 AAGACAGCAGGAGGCAGTGT  LOC785489  AAGGGGTCTGTGTCTGTTGG 236 
B4GALT1  CAGTGATAGGCCCTCTCTGC 185  TGGGACACACAGCGTACATT  
 GCTTTGATTCTTTGGGGTGA  LOC785058  AGTTGCCCGAAGGTACTGTG 160 
LOC515356 TGTGAGCAGAGACTGGATCG 211  TTCAGTCCAGCTTTCCCAAG  
 AGCTTAGAGGGGGACAGAGC  MGC29463  CAGTGAGGAGGGTGGGATAA 231 
KRT10  CAAAGCTGCCTCCATAGCTC 200  GGGGTTTGGAGTTCAGCATA  
 ATCCCTCAGAATTTCGAGCA  S-Laminin  TCGGGAATCTCTTTGAGGAA 184 
TKDP5  ACGGTGGCTGTAATGGAAAG 230  GAACTTGTGGTGGAGGCATT  
 GGAAAGGAAAAGGCAGGTTC  S-NID-2  CCCTTCTCCAAACTGCTCTG 161 
TKDP3  TATCATCCGTGGTGTGGCTA 246  TCCCTTCTCCAGTCGGTATG  
 GTGCCGTGACCTACCACTTT  LOC786956  CAGAAGAGGTGCTCCCTCAC 178 
TSPAN1  ACCACTGCTGCTGTCGTATG 195  TGAACAGAATGCCAAGGACA  
 GGGCTCTGGAATAGGAGGAC  MGC143403  GGAGAAAGCACACGAAGGAG 167 
LOC514936 AAGCCACTTCAGCCACAGTT 219  CCCCATTGCTAGTGTCCATT  
 AGGAAGGACAAAGGGGAAGA  TL12963  ATGCCACATTGCAAAAGATG 258 
MGC139339 TCCTACGACATCCACTGCAC 192  TGCCCAAACATAGTCTCACA  
 CCCCTACCCTCTCTTGATCC  ANXA1  AAGGCTTTGCTTTCTCTTGC 346 
MGC139527 GCCTTTTTGTTTTCTGTTTGG 209  GACGAGTTCCAATACCCTTCA  
 ATATTGCCAAGGAGCTGGTG  PAH  TGCTTGCTATGAGCACAACC 193 
    GCAGTGGAAGACTCGGAAAG  
   ANXA4  AAATCCATGAAGGGCTTGG 221 
    GGGAATCTTCCTGGGCTTT  
   LOC507982  CAAGCACCCTGACCAACATT 151 
    CCTCCGTGCCCTTAGAGTTT  
 
Results 
By using an array-level model to fit the embryo microarray data, 28 probes 
representing 28 different genes were identified as being differentially expressed (q<0.05) 
with the FDR controlled at 0.05 (Table 4-2). By applying the probe-level model to the 
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cotyledon data only 93 probes had a q-value of less than 1. Of those 93, 22 probes 
representing 19 different genes were identified as significantly differentially expressed 
(q<0.05), controlling the FDR at 0.05 (Table 4-3).  
Table 4-2 Microarray data for blastocyst experiments. 
Gene Symbol Gene Name Fold change Q-value NCBI ID 
Over-expressed in SCNT blastocysts     
LOC540552 hypothetical LOC540552 19.16 0.018 CB534828 
*S-NID-2 similar to NID-2 12.04 0.018 CK770586 
PAH phenylalanine hydroxylase 8.77 0.028 CK849069 
LOC533044 similar to Phosphoserine aminotransferase 1 7.59 0.049 CB166901 
TL21877 Transcribed locus 5.54 0.035 BF707348 
MHCI JSP.1 MHC Class I JSP.1 5.12 0.122 M21044.1 
LOC614726 Similar to adaptor protein Lnk 4.85 0.037 AW670030 
LOC785058 hypothetical protein LOC785058 4.84 0.037 BM433653 
LOC507982 similar to WDSUB1 protein 4.63 0.018 AW307635 
ANXA4 annexin A4 4.19 0.018 M22248.1 
ANXA1 annexin A1 3.74 0.037 NM_175784.2 
*S-N33 strong similarity to protein sp:Q13454 (H.sapiens) N33_HUMAN N33 protein 3.65 0.037 CB534173 
MGC152029 similar to source of immunodominant MHC-associated peptides 3.51 0.037 CK849836 
*S-Laminin similar to Laminin beta-1 chain precursor 3.39 0.037 CK849175 
DR1 down-regulator of transcription 1, TBP-binding (negative cofactor 2) 3.36 0.049 AW356106 
LOC511508 similar to KIAA0438 3.30 0.045 BI536262 
TL12963 transcribed locus 3.24 0.037 CF930841 
LOC785489 similar to O-acyltransferase (membrane bound) domain containing 2 3.04 0.037 AW658325 
MGC143403 similar to coronin, actin binding protein, 1C 3.03 0.037 CB428145 
LOC539967 hypothetical LOC539967 2.88 0.037 BM480824 
MGC29463 hyp protein 2.88 0.028 AU276541 
LOC539627 similar to KIAA0551 protein 2.41 0.037 CB221260 
LOC514267 hypothetical LOC514267 2.23 0.039 CK780156 
LOC786956 hypothetical protein LOC786956 2.20 0.038 CK947614 
LOC510084 similar to ankyrin repeat domain 10 2.05 0.049 CK770463 
TL24300 Transcribed locus 2.01 0.038 BP100594 
Reduced expression in SCNT blastocysts     
LOC513234 similar to ovary-specific acidic protein 3.24 0.038 CK778634 
LOC616217 hypothetical LOC616217 4.38 0.037 BF045590 
IER3 immediate early response 3 4.26 0.037 CK775895 
Table 4-3 Microarray data for cotyledon experiments. 
Gene Symbol Gene Name Fold change Q-value NCBI ID 
Over-expressed in SCNT cotyledons     
PAG10 pregnancy-associated glycoprotein 10 3.90 0.001 NM_176621.2 
TKDP3 trophoblast Kunitz domain protein 3 3.45 0.023 BE682514 
TKDP5 trophoblast Kunitz domain protein 5 3.03 0.002 BP108664 
MGC139527 similar to Sorting nexin-10 2.68 <0.001 CK847894 
IL6 interleukin 6  2.32 0.007 NM_173923.2 
MGC139339 similar to Cell death-inducing DFFA-like effector a 2.24 0.004 CK849502 
B4GALT1 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 2.13 0.001 NM_177512.2 
MHCI JSP.1 MHC Class I JSP.1 1.93 0.253 M21044.1 
LOC540923 similar to plasma glutamate carboxypeptidase 1.89 0.046 BF652540 
TSPAN1 tetraspanin 1 1.86 0.004 CK847262 
LOC540552 hypothetical LOC540552 1.57 0.219 CB534828 
Reduced expression in SCNT cotyledons     
LOC782061 similar to AKR1C1 protein 4.77 0.001 AY135401.1 
LOC613334 similar to Fragile X mental retardation 1 neighbor 2.68 0.001 CK847504 
RBP1 retinol binding protein 1, cellular 2.20 0.012 CK957614 
LOC528380 Hypothetical LOC528380 2.15 0.001 CK771895 
MGC142541 similar to membrane-associated RING-CH protein III 1.99 0.015 BI849604 
LOC515356 similar to Cytochrome b5 domain containing 2 1.82 0.019 CK770131 
MGC142636 similar to carbonyl reductase 3 1.75 0.021 CK778163 
MGC139085 similar to paraoxonase 3 1.74 0.009 CK959273 
KRT10 keratin 10  1.69 0.050 NM_174377.1 
LOC514936 hypothetical LOC514936 1.66 0.006 BM088453 
LOC533044 similar to Phosphoserine aminotransferase 1 1.52 0.434 CB166901 
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Comparison of the lists of differentially expressed genes showed no genes that 
were common to both data sets, however two of the genes that were differentially 
expressed in embryos were among the list of 93 genes whose differential expression 
approached significance in the cotyledon data. In addition MHCI approached significance 
in both data sets. Expression of MHCI was analyzed in embryos and cotyledons because 
it approached significance in both groups and based on previous reports of its over-
expression in cloned bovine placenta (Davies et al. 2004; Hill et al. 2002). In all, 22 
genes were analyzed by Q-PCR in cotyledons, and 29 genes were analyzed in embryos. 
Variability of gene expression levels between biological replicates was considerably 
higher among cotyledons (Figure 4-1). 
Following Q-PCR analysis of embryo cDNA, expression levels were found to 
follow the same trends as microarray data for 25 of the 28 genes, and 9 were significantly 
different based on Q-PCR results (Figure 4-2). In the case of the cotyledons, 19 of the 22 
cotyledon genes followed the same trends as microarray data, however only two were 
significantly different (Figure 4-3). By Q-PCR analysis expression of MHCI was 
determined to be higher in SCNT blastocysts and cotyledons, but the difference was only 
significant in the blastocysts. While microarray-based expression studies are a powerful 
means of generating lists of differentially expressed candidate genes, Q-PCR is widely 
accepted as a more robust test of differential expression. For this reason Q-PCR 
validation is requisite for validation of microarray results. 
 
 





























































































Figure 4-1 Heatmaps for embryo and cotyledon data. (A) 28 significant probe-sets 
from embryo array data plus MHCI probe-set and (B) 22 significant probe-sets from 
cotyledon array data (representing 19 different genes) plus MHCI and two probe-sets 
that approached significance and were common to embryo data set. Control embryos 
and cotyledons are labeled C, and SCNT embryos and cotyledons are labeled NT. 
Dark red represents low expression, and dark blue represents high expression. 
 
Discussion 
For the embryo experiments, 28 genes were determined to be differentially 
expressed between SCNT and AI blastocysts. Q-PCR analysis of those 28 genes verified 
25 followed the same trend as predicted in the microarray data, however the differences 
between SCNT and AI blastocysts were significant for only nine of those genes plus 
MHCI (P<0.05). This disparity could be because only 6 chips were run in the experiment, 
a marginal experiment size for even the best data. A relatively high degree of variability 
between groups was observed in the Q-PCR results. The other factor that might account 
for the validation rate of about 30% is that the RNA for the microarray and Q-PCR 
experiments was derived from two separate embryo collections. This design lends 
additional credibility to the study in that ten of the same genes were found to be 
differentially expressed in both embryo collections. Interestingly, of the genes identified  
























































































































































































































































Figure 4-2 Relative gene expression in blastocysts based on Q-PCR analysis. The 
yellow bars represent predicted SCNT expression relative to AI expression based on 
microarray data, blue and maroon bars represent actual expression in SCNT and AI 
blastocysts respectively as determined by Q-PCR. Genes are ordered by significance 
based on microarray data from most-to-least. The y-axis represents scaled expression 
values for purposes of comparison of SCNT, AI, and microarray-predicted SCNT 
expression levels. Error bars represent SEM.                                                              
Note: for scaling purposes, some bars are truncated. Actual values are noted above 
truncated bars.                                                                                                                   
* AI and SCNT gene expression differs significantly based on Q-PCR (P<0.05).              
** Q-PCR results are opposite microarray predictions. 
























































































































































































Figure 4-3 Relative gene expression in cotyledons based on Q-PCR analysis. The 
yellow bars represent predicted SCNT expression relative to AI expression based on 
microarray data, blue and maroon bars represent actual expression in SCNT and AI 
cotyledons respectively as determined by Q-PCR. Genes are ordered by significance 
based on microarray data from most-to-least.  The y-axis represents scaled expression 
values for purposes of comparison of SCNT, AI, and microarray-predicted SCNT 
expression levels.Error bars represent SEM.                                                                     
* AI and SCNT gene expression differs significantly based on Q-PCR (P<0.05).                
** Q-PCR results are opposite microarray predictions. 
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to be differentially expressed by microarray analysis, all but three were over-
expressed in SNCT blastocysts. 
At least two previous studies have evaluated global gene expression differences 
between SNCT and control blastocysts (Smith et al. 2005; Somers et al. 2006). These 
reports as well as the study reported here are similar in that they all report a relatively 
small subset of genes that are differentially expressed between SCNT and control 
blastocysts, indicating the majority of genes are reprogrammed to express the appropriate 
genes at the appropriate levels by the blastocyst stage. One study evaluated global gene 
expression patterns in bovine SCNT, IVF and AI blastocysts as well as expression 
patterns in the donor cells. As expected, the donor cell gene expression patterns were far 
divergent from the expression patterns in any of the blastocysts. Surprisingly SCNT 
embryo expression profiles were more similar to AI embryos than IVF compared to AI. 
Comparing SCNT and AI embryo expression patterns, fifty genes were found to be 
differentially expressed while 198 genes were differentially expressed between AI and 
IVF embryos (Smith et al. 2005). A similar study evaluating global gene expression 
differences between bovine SCNT and IVF embryos reported 164 differentially 
expressed genes (Somers et al. 2006). In the present study twenty eight genes were found 
to be differentially expressed between SCNT and AI blastocysts. Q-PCR validation 
seemed to follow similar patterns as well. The first study selected six genes for validation 
by Q-PCR, and five were reported to validate microarray results, however statistical 
treatment is not discussed (Smith et al. 2005). In the other study seven genes were 
evaluated by Q-PCR, and of the seven only two were found to be significantly different 
(Somers et al. 2006). The disparity between microarray and Q-PCR results reported in 
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these two papers illustrate the importance of comprehensive Q-PCR validation of 
microarray experiments. Accordingly, we applied Q-PCR analysis to every gene 
determined by microarray analysis to be differentially expressed.  
Interestingly, there do not appear to be any differentially expressed genes 
common between these three studies. Likewise, there does not seem to be much 
consensus between other gene expression studies evaluating expression differences 
between SCNT and control bovine blastocysts (Daniels et al. 2000; Li et al. 2006; 
Niemann et al. 2002; Oishi et al. 2006; Wrenzycki et al. 2004). The lack of concensus 
between studies does not indicate any study is flawed; rather it emphasizes the need for 
continued research to better understand the factors that affect gene expression following 
SCNT. The impact of differences in nuclear transfer protocols and culture conditions on 
gene expression likely explains the lack of consensus between experiments (Wrenzycki et 
al. 2001).  
Ten genes were verified by Q-PCR to be significantly different in SCNT 
blastocysts. The majority of those genes are not well-annotated, but several were 
identified as being similar to genes in other species. Genes similar to osteonidogen (Nid-
2), Laminin beta-1 (Lamb1), adaptor protein Lnk, tumor suppressor candidate 3 (N33), 
and O-acyltransferase domain containing 2 (Oact2) were all identified as differentially 
expressed as well as three hypothetical proteins- LOC540552, LOC786956, and 
LOC785058. In addition, down-regulator of transcription 1 (Dr1) and MHCI were 
identified by Q-PCR as significantly different. In every case, these genes were over-
expressed in SCNT embryos.  
NID-2 and LAMB1 have been shown to be important in development of the 
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basement membranes (Kohfeldt et al. 1998). Adaptor protein Lnk is a broad inhibitor 
of a number of growth factor and cytokine signaling pathways (Buza-Vidas et al. 2006). 
N33 is a putative tumor suppressor involved in regulation of cell proliferation (Sun et al. 
2004). The functions of Oact2, LOC540552, LOC786956, and LOC785058 are unknown. 
DR1 binds to the TATA binding protein (TBP) and blocks the binding of RNA 
polymerases II and III. In this way, DR1 can act as a potent transcriptional regulator 
(White et al. 1994). If Dr1 is commonly over-expressed in SCNT embryos it could have a 
profound impact on transcriptional regulation in early embryos. MHCI molecules are 
important for antigen presentation associated with cell mediated immunity. The over-
expression of MHCI in the bovine SCNT placenta has been reported previously and is 
proposed as a factor in the frequent losses in bovine SCNT pregnancies (Hill et al. 2002). 
MHCI expression has not been previously reported in bovine embryos. Evaluation of 
MHCI expression in cotyledons found expression to be higher in SCNT cotyledons 
compared with AI but not significantly.  
Of the 19 genes predicted to be different between SCNT and AI cotyledons, only 
two were verified to be significantly different by Q-PCR. This again reflects a large 
degree of variability between samples. In fact, greater variability was observed between 
cotyledon expression patterns than between embryo expression patterns. This is likely 
due to the fact that multiple embryos were pooled to reduce variability in the microarray 
and Q-PCR experiments, and cotyledons were analyzed individually. In addition, the 
blastocysts were all subjected to essentially the same environment- in vitro culture 
conditions for SCNT embryos and pre-implantation uterine environment for AI embryos. 
Cotyledons were collected from different dams, and factors such as condition of the dam 
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or nutrient demands of the fetus could easily impact gene expression in cotyledons. 
The probe-level model did not prove to be a highly effective means of detecting 
differentially expressed genes in the cotyledon experiments. Nevertheless, two genes 
were validated by Q-PCR to be significantly different, and these genes might be of 
physiological importance. A gene similar to carbonyl reductase 3 (Cbr3) was found to be 
under-expressed, and retinol binding protein 1 (Rbp1) was over-expressed in day-70 
SCNT cotyledons. CBR3 is a cytosolic enzyme that catalyzes the reduction of 
prostaglandins, steroids and other carbonyls (Forrest and Gonzalez 2000). The function 
of CBR3 has not yet been characterized in the placenta. RBP1 serves as the carrier 
protein for retinol (vitamin A), a vitamin critical for normal embryonic development. 
Either an excess or a deficiency in vitamin A can result in embryonic defects (Cohlan 
1953; Ross et al. 2000). 
The physiological relevance of the genes determined by microarray analysis and 
Q-PCR to be differentially expressed in SCNT blastocysts and cotyledons has not yet 
been elucidated. Continued research evaluating the role of these genes in development is 
required, however several of the genes merit further research based on function; in 
particular Dr1, MHCI, and Rbp1.  
The data presented here as well as in a number of other studies evaluating gene 
expression differences between clones and controls all lend support to the idea that 
incomplete epigenetic reprogramming lies at the heart of poor SCNT efficiency. 
Unfortunately a large degree of variability is observed in every aspect of SCNT, from 
rates of in vitro development to differences in pregnancy establishment and maintenance 
rates. The variability even extends to phenotypes of genetically identical cloned offspring 
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(Lee et al. 2004). It can arise from differences in manipulation or culture conditions 
(Wrenzycki et al. 2001), donor cell type (Batchelder et al. 2005; Powell et al. 2004), 
oocyte source (Chapter 2; Miyoshi et al. 2003), and a host of other factors. Continued 
global gene expression studies under a variety of conditions will shed light on some of 
the factors most important in the nuclear reprogramming process as well as offer insights 
into the complex and poorly characterized field of epigenetic reprogramming. Until the 
factors affecting reprogramming efficiency are better characterized or methods for 
augmentation of epigenetic reprogramming are developed, it is unlikely SCNT efficiency 
will improve to any great degree.  
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CHAPTER 5 
ABERRANT EXPRESSION OF TRANSCRIPTION FACTORS AND OTHER 
GENES IN VARIOUS STAGES OF PREIMPLANTATION BOVINE 
 SOMATIC CELL NUCLEAR TRANSFER EMBRYOS 
Abstract 
Based on microarray data comparing gene expression of fibroblast donor cells and 
bovine somatic cell nuclear transfer (SCNT) and in vivo produced (AI) blastocysts, a 
group of genes including several transcription factors was selected for expression studies. 
Using SYBR green-based real-time PCR (Q-PCR) the expression levels of POU domain 
class 5 transcription factor (Oct4), snail homolog 2 (Snai2), annexin A1 (Anxa1), 
thrombospondin (Thbs), tumor-associated calcium signal transducer 1 (Tacstd1), and 
transcription factor AP2 gamma (Tfap2c) were evaluated in bovine fibroblasts, oocytes, 
embryos 30 min post-fusion (SCNT), 12 h post-fertilization/activation, as well as 2-cell, 
4-cell, 8-cell, morula, and blastocyst-stage in vitro fertilized (IVF) and SCNT embryos. 
For every gene except Oct4, levels of expression were indistinguishable between IVF and 
SCNT embryos at the blastocyst stage, however in many cases expression of these genes 
during stages prior to blastocyst differed significantly. Altered levels of gene expression 
early in development likely have developmental consequences downstream. These results 
indicate that experiments evaluating gene expression differences between control and 
SCNT blastocysts may underestimate the degree of difference between clones and 
controls and further offer insights into the dynamics of gene reprogramming following 
SCNT. 
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Introduction 
 While SCNT has been successfully applied to a large and growing number of 
species since Dolly, the success rate of the technology in producing live, healthy 
offspring is quite low. In cattle approximately 10-15% of transferred SCNT embryos 
result in live births (Oback and Wells 2007). Following transfer of a donor cell or nucleus 
into an enucleated oocyte, cell-type-specific epigenetic marks must be removed from 
chromatin as the DNA is transformed from a differentiated state to the totipotent state 
required for proper embryo development in the process of nuclear reprogramming. The 
oocyte is well-equipped to perform this process on maternal and paternal DNA following 
fertilization; however, it often seems to be insufficient for reprogramming a differentiated 
donor cell following SCNT. Inefficient or incomplete nuclear reprogramming of the 
donor nucleus is generally recognized as a major cause for the low success rates observed 
with SCNT (Beyhan et al. 2007; Bourc'his et al. 2001; Dean et al. 2003). This hypothesis 
is supported by a number of publications that report a variety of deficiencies in nuclear 
reprogramming of SCNT embryos including differences in global DNA methylation 
(Bourc'his et al. 2001; Dean et al. 2001; Kang et al. 2002; Shi and Haaf 2002) and histone 
modifications (Enright et al. 2003; Enright et al. 2005) as well as many reports of 
aberrant gene expression in cloned embryos (Chapter 4; Beyhan et al. 2007; Bortvin et al. 
2003; Li et al. 2006; Niemann et al. 2002; Smith et al. 2005; Somers et al. 2006).  
Incomplete nuclear reprogramming following SCNT is manifest in a variety of 
ways. Low rates of development and pregnancy establishment (Hill et al. 2000; Powell et 
al. 2004) as well as high rates of pregnancy failure throughout gestation (Heyman et al. 
2002) and frequent postnatal loss are obvious indicators of deficiency in the SCNT 
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process. Additionally, a variety of abnormalities can be observed in SCNT embryos, 
fetuses, placentas, and neonates. Differences in cell number and cell allocations have 
been observed in SCNT embryos as well as increased incidence of aneuploidy and 
fragmented nuclei (Booth et al. 2003; Li et al. 2004a; Li et al. 2005a). Following embryo 
transfer and pregnancy establishment a number of factors likely contribute to the high 
rates of pregnancy failure. Abnormal placentation has been reported in a number of 
species following SCNT (Constant et al. 2006; Fletcher et al. 2007; Hashizume et al. 
2002; Ogura et al. 2002). In addition, fetal overgrowth (Constant et al. 2006), 
hydroallantois (Lawrence et al. 2005), stillbirth, respiratory and circulatory problems 
(Hill et al. 1999), and liver malformations have all been observed in clones (Li et al. 
2005b).  Most of these problems may directly result from the primary problem of 
improper placentation. 
A number of studies have undertaken to characterize abnormal gene expression 
patterns following SCNT; however the majority of the studies have evaluated gene 
expression in blastocysts, fetal tissues or placental tissues. Many studies have evaluated 
the expression levels of specific genes important in early development in SCNT 
blastocysts by Q-PCR. The list of genes reported to be differentially expressed in SCNT 
blastocysts includes Mash2, DNMT1, Hsp 70.1, IFNτ, Cx43 (Niemann et al. 2002), Oct4 
(Boiani et al. 2002), G6PD, Xist, Pgk (Wrenzycki et al. 2002),several imprinted genes 
including IGF2 (Han et al. 2003), H19 and Snrpn (Mann et al. 2003), and many others. It 
is important to note that factors such as activation protocol, stage of donor cells, and 
culture conditions all impact gene expression in SCNT blastocysts (Wrenzycki et al. 
2001).    
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Evaluation of global gene expression patterns in bovine SCNT blastocysts 
(Beyhan et al. 2007; Smith et al. 2005), placental tissue (Oishi et al. 2006) and liver 
(Herath et al. 2006; Schrader et al. 2003) have also reported a number of differentially 
expressed genes. Surprisingly these studies generally find fewer than 100 differentially 
expressed genes when compared with controls. In global gene expression studies little-to-
no consensus exists in the lists of differentially expressed genes, likely a consequence of 
different SCNT protocols utilized by different researchers.  
A recent report evaluating global gene expression of mouse SCNT embryos 
during the first two cell cycles illustrates the importance of evaluating gene expression 
differences in early preimplantation embryos prior to the blastocyst stage in order to 
appreciate the scope of the problems in gene expression following SCNT. It was found 
that during the second cell cycle over 1000 genes were differentially expressed between 
SCNT and control embryos indicating the reprogramming process occurs over several 
cell cycles, and the divergence in gene expression patterns narrows greatly by the 
blastocyst stage (Vassena et al. 2007).  
While various studies report differential gene expression between SCNT and 
control tissues, they do not attempt to determine the point in development when 
expression levels in the SCNT tissues diverged from controls, nor do they address the 
question of timing of reprogramming events. These questions are important in elucidating 
mechanisms involved in epigenetic reprogramming following SCNT with the ultimate 
goal of improving the efficiency of SCNT. Two recent studies evaluated the mechanisms 
and timing of nuclear reprogramming globally following normal fertilization (Sun et al. 
2007) and SCNT (Gao et al. 2007). Localization and activity of 20 different chromatin 
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factors including transcription factors and transcriptional regulators was evaluated 
through early preimplantation development, and it was determined that in the case of 
normal fertilization and SCNT an “erase-and-rebuild” strategy for epigenetic 
modifications was employed. This strategy involves the global removal of chromatin 
factors prior to pronuclear formation followed by re-association of the factors after 
pronuclear formation. While the mechanisms of epigenetic reprogramming were found to 
be similar for IVF and SCNT embryos, the erasure of epigenetic marks as well as the re-
establishment of new modifications was found to be both incomplete and delayed in 
SCNT embryos (Gao et al. 2007).    
The inefficiencies associated with SCNT, numerous reports of abnormal 
epigenetic reprogramming manifest by gene specific and global gene expression 
differences in SCNT embryos and fetal tissues, as well as the extremely limited 
understanding of epigenetic reprogramming mechanisms following SCNT all provided 
impetus for the present study. The aim of this study was to evaluate the dynamics of 
nuclear reprogramming by measuring the relative levels of transcript abundance through 
various stages of preimplantation development of several developmentally important 
genes known to undergo a high degree of change in expression following SCNT. This 
work was undertaken in an effort to gain insight into the timing of gene expression 
regulation following SCNT with the ultimate goal of elucidating reprogramming 
mechanisms. This is the first study to report detailed stage-by-stage gene expression 
levels in preimplantation bovine SCNT embryos.  
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Materials and Methods 
Donor Cell Culture 
Primary bovine fibroblast cultures were established from either lung tissue or ear 
biopsy. Previous data have demonstrated no difference in in vitro development between 
lung- and ear-derived donor cells (Kato et al. 2000). Tissues were washed thoroughly and 
minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone Laboratories, Logan, UT 
84321) supplemented with 15% fetal bovine serum (FBS; HyClone Laboratories) and 
100 U/ml penicillin/ 100 µg/ml streptomycin (HyClone Laboratories), seeded in 25 cm2 
tissue culture flasks, and cultured at 39˚C in a humidified atmosphere of 5% CO2 in air 
for several days. Cells between passages one and four were then harvested and re-
suspended in tissue culture medium containing 10% DMSO, frozen, and stored in liquid 
N2 until use in microarray experiments or SCNT.  Prior to gene expression studies cells 
were thawed and expanded from about three million cells to approximately twenty seven 
million cells through two passages.  Cells utilized for SCNT were treated with trypsin 
(.25%) and resuspended in manipulation medium prior to use. 
Oocyte Maturation 
Maturation of bovine oocytes was performed as described previously (Li et al. 
2004a; Li et al. 2004b). Briefly, cumulus-oocyte-complexes (COCs) were aspirated from 
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.  
Only those oocytes with uniform cytoplasm and intact layers of cumulus cells were 
selected and matured in TCM 199 containing 10% FBS, 0.5 µg/ml FSH (Sioux 
Biochemicals, Sioux City, IA 51250), 5 µg/ml LH (Sioux Biochemicals), and 100 U/ml 
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penicillin/ 100 µg/ml streptomycin for 18-22 h.  
SCNT Embryo Production 
Following maturation, cumulus cells were removed from oocytes by vortexing 
COCs in PB1 (calcium- and magnesium-containing phosphate buffered saline [HyClone 
Laboratories], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/ml BSA) medium 
containing 10 mg/ml hyaluronidase. Oocytes with a first polar body were used as 
recipient cytoplasts. Enucleation was employed to remove the first polar body and 
metaphase plate, and single cells were subsequently transferred to the perivitelline space 
of recipient cytoplasts.  Fusions of NT couplets were performed in mannitol fusion 
medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 microseconds. 
Following fusion, embryos were held in CR2 medium supplemented with 3% FBS for 1-
2 h prior to activation (Rosenkrans and First 1994). Fused embryos were activated 
between 23 and 25 h after the onset of maturation by exposure to 5 µM ionomycin for 5 
min followed by five h incubation in 10µg/ml cycloheximide. For the purposes of the 
microarray experiments we produced three groups of ten grade 1-2 blastocysts from a 
single cell line. For the Q-PCR studies, three groups of five embryos each were collected 
at each embryonic stage to be analyzed. Embryos were placed in RNAlater RNA 
stabilization reagent (Ambion Inc., Austin, TX 78744) and stored at -20° C until RNA 
extraction.   
AI Embryo Production 
Control embryos for microarray studies were collected from super-ovulated cows 
using established protocols. Donor cows were synchronized using the EAZI-BREED™ 
  127 
CIDR® vaginal progesterone implant. The CIDR was used for ten days followed by 
an I.M. injection of 50 mg Lutalyse (PGF2α) (5 ml at 10 mg/ml). Animals were bred by 
artificial insemination (AI) the morning following standing heat and again twelve and 
twenty-four h after standing heat. Seven days after the initial breeding, embryos were 
collected from donor animals by intra-uterine flush using embryo filters. Following 
collection embryos were rinsed in flush medium, placed in RNAlater (Ambion Inc.) and 
stored at -20° C until RNA extraction. Three groups of ten grade 1 and 2 blastocysts were 
collected for the microarray studies. 
IVF Embryo Production 
IVF embryos were collected for the Q-PCR component of the study. 
Cyropreserved bovine semen (Hoffman AI, Logan, UT) was thawed and live sperm were 
separated by centrifugation on a 45%/95% layered Percoll gradient. Motile spermatozoa 
obtained by this method were diluted in fert-TALP to a final concentration of 1.0 X 106 
per ml (Reed et al. 1996). Capacitation occurred in fert-TALP containing heparin at a 
concentration of 10 µg/ml. In vitro matured oocytes were fertilized in vitro for 18-20 h at 
39°C in 5% CO2 and air.  After the fertilization period, oocytes were vortexed in a 15-ml 
conical centrifuge tube containing 1 ml of PB1 2 min 40 sec to completely remove 
cumulus cells.  Embryos were co-cultured with cumulus cells in CR2 medium 
supplemented with 3% FBS (Rosenkrans and First 1994) at 39°C in 5% CO2 in air. Three 
groups of five embryos each were collected at each embryonic stage to be analyzed. 
Embryos were rinsed through several drops of PB1 and through a single drop of 
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RNAlater then placed in RNAlater (Ambion Inc.) and stored at -20° C until RNA 
extraction.   
RNA Extraction 
 RNA extraction from donor cells. Cells were harvested by trypsinization, washed 
with cell culture medium (DME/F12 1:1 supplemented with 15% Defined FBS [Hyclone 
Laboratories] and Penicillin/Streptomycin) followed by a second wash with PBS. 
Washed cells were pelleted and resuspended in RLT Buffer (Qiagen Inc., Valencia, CA 
91355) containing beta-mercapto ethanol (βME) and subsequently homogenized using a 
syringe with a 21-gauge needle. RNA extraction was performed using the RNeasy Mini 
RNA Extraction Kit (Qiagen) according to manufacturer’s recommendations.   
RNA extraction from embryos. Total RNA was extracted and DNA was digested 
with DNase I from AI, IVF, and NT embryos using the RNAqueous micro kit (Ambion 
Inc.) according to manufacturer’s recommendations with modifications. Prior to RNA 
extraction each sample was spiked with 50 µg yeast tRNA as a carrier. The RNA was 
eluted from the RNAqueous column using two 20 µl volumes of pre-warmed (75° C) 
elution solution. Following RNA purification, microarray samples were reduced to 3-5 µl 
using speed vacuum centrifugation in order to yield sufficient RNA concentration for 
amplification using the Affymetrix 2-round labeling kit, and Q-PCR samples were 
immediately reverse-transcribed and stored at -20ºC until Q-PCR analysis. 
Microarray Expression Studies 
For the embryo microarray studies previous experience as well as personal 
communications with other researchers indicated RNA concentration- and quality-
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determination using the nanodrop and bioanalyzer are ineffective with RNA extracted 
from embryos, so preliminary checks of RNA were not performed on embryonic RNA. 
Blastocyst stage bovine embryos contain approximately 2 ng total RNA so in order to 
attain sufficient quantities of RNA for hybridization on Affymetrix GeneChips a two-
round labeling protocol was used. After the two-round labeling procedure RNA quantity 
and integrity were assessed using an Agilent 2100 Bioanalyzer.  Following quality 
assessment labeled RNA was hybridized to the Affymetrix bovine microarray chip and 
subsequently scanned according to manufacturer’s protocols. Microarray analysis of 
donor cells was also performed according to manufacturer’s protocols. Since sufficient 
RNA could be obtained from donor cells, single-round labeling was used instead of the 
two-round labeling. Following microarray analysis, Q-PCR of un-amplified SCNT and 
IVF blastocyst cDNA was used to verify the differential expression of the six genes of 
interest was real and not simply an artifact of the differences in labeling protocols. 
Selection of Target Genes 
Initially bovine SCNT and in vivo produced (AI) embryos (three groups of ten 
embryos each SCNT and AI) along with several fibroblast donor cell lines were subjected 
to microarray analysis to measure the degree of reprogramming that occurs between the 
time of nuclear transfer and the blastocyst stage. Following microarray analysis (see 
Chapter 4), several genes were selected for further analysis based on degree of change as 
well as physiological importance. Thbs and Snai2 underwent dramatic down-regulation 
following SCNT and Anxa1 underwent moderate down-regulation. Tacstd1 and Oct4 
were of interest because they were highly expressed in blastocysts and expressed at low 
levels or not at all in fibroblast donor cells. While Tfap2c was not represented on the 
  130 
microarray, this gene was known based on previous work in our laboratory to be 
unexpressed in fibroblasts and strongly expressed in blastocysts.  
Reverse Transcription and  
SYBR Green Q-PCR 
Reverse transcription was performed using Superscript III Reverse Transcriptase 
(Invitrogen, Carlsbad, CA 92008) with random primers.  Optizyme Recombinant RNase 
Inhibitor (Fisher Scientific, Fair Lawn, NJ 07410) was utilized at a concentration of 1 
unit per µl during the reverse transcription of embryonic RNA. The cDNA was stored at  
-20°C until use. 
SYBR Green real-time PCR (Abgene, Rochester, NY 14610) was used to 
characterize relative expression levels of Thbs, Snai2, Anxa1, Tacstd1, Oct4, and Tfap2c 
in fibroblast cells and IVF and SCNT embryos. Expression levels were analyzed by at 
various stages following fertilization or activation. Following SCNT, embryos 30 min 
and 12 h post-activation and at the 2-cell, 4-cell, 8-cell, morula, and blastocyst stages 
were analyzed. The thirty min-post-activation group was analyzed to establish a base-line 
level of transcript abundance for each gene against which other stages could be 
compared. An IVF thirty min-post-fertilization group was not collected because 
fertilization times can vary following insemination, so the embryos collected would 
exhibit unacceptable variability in terms of fertilization status and timing (Kim et al. 
2002). IVF embryos were analyzed 16 h post-insemination (approximately 12 h post-
fertilization), and at the 2-cell, 4-cell, 8-cell, morula, and blastocyst stages. Embryos were 
pooled in groups of five to provide sufficient RNA for reverse transcription and Q-PCR 
analysis without the need for linear amplification, and the pooling of embryos served to 
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minimize variability between replicates. Q-PCR was performed in white thin-walled 
96-well plates, and each Q-PCR reaction was performed in triplicate. Glyceraldehyde-3-
phosphate dehydrogenase (Gapdh) was used as the internal control housekeeping gene as 
it has been determined to be the most reliable housekeeping gene in bovine pre-
implantation embryos (Robert et al. 2002). Primers for Gapdh, Thbs, Snai2, Anxa1, 
Tacstd1, Oct4, and Tfap2c (Table 5-1) were designed using Primer3 primer-design 
software (Rozen and Skaletsky 2000). A standard PCR protocol with a 15µL reaction 
volume was used. The reactions consisted of Absolute™ QPCR SYBR® Green PCR 
Master Mix (Abgene) containing fluorescein reference dye, forward and reverse primers 
at 200-300 nM final concentration and 1 µL diluted template cDNA. The same PCR 
protocol was used for all primers: 15 min at 95°C for activation of the hot start Thermo-
Start® DNA Polymerase; 40 cycles of 95°C for 15 sec, 58°C for 30 sec, and 72°C for 15 
sec (data collection step), then 95°C for 30 sec followed by an 80-cycle melt curve 
initiated by 30 sec at 55°C with a temperature increase of 0.5°C each cycle. 
Table 5-1 Details for genes analyzed and sequences of primers used in Q-PCR analyses. 
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Statistical analysis 
 Microarray. The raw intensity data from the twelve microarray chips were 
preprocessed together using the RMA algorithm (Irizarry et al. 2003).  The limma/eBayes 
test (Smyth 2004) was used to test for differential expression between the six donor cell 
samples and the six embryo samples.  The Benjamini-Hochberg adjustment (Benjamini 
and Hochberg 1995) was applied to the resulting P-values, and the false discovery rate 
(FDR) was controlled at 0.01. 
 Q-PCR. The delta-delta Ct method (∆∆Ct) was used for real-time PCR data 
evaluation (Livak and Schmittgen 2001). Data was normalized for differing amounts of 
input cDNA using ∆Ct (Ct for the Gapdh housekeeping gene minus Ct for the gene of 
interest). Next, ∆∆Ct was calculated by subtracting the ∆Ct of each sample from the ∆Ct 
of a reference liver cDNA sample run in each plate. The n-fold increase or decrease in 
expression levels of each gene at each embryonic stage was calculated using the formula 
2-∆∆Ct. Pair-wise comparisons were performed using the Student’s t-test. A probability of 
P<0.05 was considered significant. 
Results 
Microarray Analysis 
After applying the Benjamini-Hochberg adjustment (Benjamini and Hochberg 
1995) to the p-values resulting from the comparison of chips from six donor cell lines 
with six embryo chips (three SCNT and three AI) using the limma/eBayes test (Smyth 
2004) for differential expression and controlling the FDR at 0.01, there were 10,942 
probe sets (out of 24,128) called significantly differentially expressed between fibroblast 
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donor cells and all embryos. Figure 5-1 is a volcano plot of the fibroblast/embryo 
comparison. Figure 5-2 is a heatmap of five of the genes selected for further analysis. 






Figure 5-1 Volcano plot summarizing 
results, with points colored by density. 
Points above the reference line 
correspond to probe sets called 
significant when controlling the FDR at 
0.01.  Five of the genes selected for 
further evaluation are highlighted. The 
highlighted points are, left to right:  
Thbs, Snai2, Anxa1, Oct4, Tacstd1 
Figure 5-2 Heatmap of five genes of 
interest. The color scale is from dark red 
for low expression values to dark blue for 
high expression values. The columns are 




 The expression levels of Thbs, Snai2, Anxa1, Tacstd1, Oct4, and Tfap2c were 
analyzed by Q-PCR in various stages of SCNT and IVF embryos as well as donor cells. 
For every gene except Tacstd1 there were differences in expression levels between SCNT 
and IVF embryos in multiple embryonic stages. Interestingly, these differences were 
generally rectified by the blastocyst stage so SCNT and IVF embryos were 
indistinguishable at the blastocyst stage for every gene except Oct4 which was expressed 
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at a lower level in SCNT embryos at every stage of development. The results of the 
Q-PCR experiments are represented graphically in figure 5-3. 
Thbs, Anxa1, and Snai2 exhibit similar patterns of gene regulation following 
SCNT although the timing differs for each gene. In each case expression remains higher 
in SCNT embryos than IVF embryos through several cell cycles- through the 4-cell stage 
for Thbs1, through the 8-cell stage for Anxa1 and through the morula stage for Snai2. In 
the case of Thbs1, expression is the same between SCNT and IVF embryos at the 8-cell, 
morula, and blastocyst stages, Anxa1 expression is equivalent at morula and blastocyst, 
and Snai2 expression remains higher in SCNT embryos until the blastocyst stage when it 
is abruptly shut off. Tacstd1, Tfap2c, and Oct4 all require transcriptional induction as 
embryos develop to blastocyst. In general patterns of expression in SCNT embryos 
closely resemble those of IVF controls with some important differences. Expression 
levels of Tacstd1 do not differ between SCNT and IVF embryos at any stage, however 
Tfap2c and Oct4 both exhibit differential expression patterns. Tfap2c is detectable at the 
8-cell stage in SCNT embryos but not until morula in IVF embryos, and while expression 
is induced earlier in SCNT embryos it is under-expressed in SCNT morulae. Tfap2c 
expression declines significantly between morula and blastocyst stages in IVF embryos 
and declines to a lesser degree in SCNT morulae so that expression levels are equivalent 
at the blastocyst stage. Of the six genes analyzed, Oct4 is the only one differentially 
expressed at the blastocyst stage. In fact, Oct4 expression is significantly higher in IVF 
embryos at every stage analyzed except in 4-cell embryos where the difference 
approaches significance (P=0.082).    
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Figure 5-3 Relative expression of genes based on Q-PCR. Yellow and blue bars 
represent SCNT and IVF embryos respectively. Green bars represent donor cells and 
oocytes. Lowercase superscripts compare SCNT embryos, and uppercase superscripts 
compare IVF embryos between stages. Stages with unlike superscripts are different 
(P<0.05). Asterisk indicates expression levels between SCNT and IVF embryos of the 
same stage differ (P<0.05). The stage with highest expression for each gene is scaled to 
1.0 on the y-axis, and other stages are scaled accordingly. Abbreviations are: Fibroblast 
(Fib), Oocyte (Oo), 30 min post-fusion (30m), 12 h post-fusion/fertilization (12h), 2-cell 
(2c), 4-cell (4c), 8-cell (8c), Morula (Mor), Blastocyst (Bl). 
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Discussion 
 The microarray studies indicate that a substantial amount of reprogramming of the 
donor cell genome has occurred by the blastocyst stage. Microarray analysis of donor cell 
expression patterns compared with SCNT and AI blastocysts combined found differential 
expression of 10,942 probe sets. Remarkably, by the blastocyst stage, a similar analysis 
comparing SCNT and AI blastocysts found only 28 probe sets differentially expressed 
(see Chapter 4). These results are quite similar to previously published results (Smith et 
al. 2005). Despite the apparent efficiency with which the somatic cell genome is 
reprogrammed by the blastocyst stage, of the six genes analyzed by Q-PCR, five were 
differentially expressed at two or more stages prior to blastocyst formation. These results 
indicate a substantial amount of time is required for the SCNT expression profile to 
“catch up” with the profile of control embryos. This is not surprising given the fact that 
the oocyte is designed to reprogram gamete nuclei, and the epigenetic modifications to 
somatic cells are much different than those of germ cells. The remarkable thing is the 
adaptability of the oocyte cytoplasm to successfully reprogram a variety of different 
somatic cell types- albeit inefficiently. A recent study evaluating the global transcriptome 
of murine SCNT embryos during the first two cell cycles also indicated a large degree of 
aberrant gene expression in early mouse SCNT embryos. It was also found that 
transcription of the donor cell genome continues during the first cell cycle when the 
embryonic genome is typically silenced (Vassena et al. 2007).  
  The genes analyzed by Q-PCR were selected because they exhibited dynamic 
changes in gene expression in SCNT embryos and because of their important biological 
functions in early development and differentiation. OCT4 is a homeodomain transcription 
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factor and a hallmark of undifferentiated stem cells. Reduced expression of Oct4 has 
been shown in mouse embryos (Niwa et al. 2000) and human embryonic stem cells 
(Matin et al. 2004) to result in trophoblast differentiation. Conversely, over-expression of 
the gene results in differentiation of primitive endoderm and mesoderm (Niwa et al. 
2000). Precise expression levels of Oct4 are clearly important in proper early embryonic 
development. SNAI2 is a member of the Snail family of transcription factors that also has 
important roles in early development (Cobaleda et al. 2007). It has been shown to be 
required for gastrulation, epithelial-mesenchymal transition, and cell survival in the 
mouse (Sefton et al. 1998). TACSTD1 is believed to be important in directing cell 
migration during early development in zebrafish (Villablanca et al. 2006). TFAP2C is a 
transcription factor that appears to be an important regulator of trophoblast development 
and differentiation (Li and Kellems 2003). Tfap2c-null mice die around embryonic day 
7.5 as a result of malformation of extra-embryonic membranes (Auman et al. 2002; 
Winger et al. 2006). THBS is a secreted glycoprotein involved in cell migration and 
proliferation and is apparently important in ossification, and neural and lung development 
(Iruela-Arispe et al. 1993). ANXA1 is a calcium and phospholipid binding protein which 
has been shown to be involved in membrane trafficking, cell division, and differentiation. 
Annexins are expressed in a broad range of tissue types, possibly indicating they play 
important roles in basic cell physiology (Gerke and Moss 2002). 
 Each of the genes analyzed is functionally important during early development, 
and even transient expression differences could potentially have negative consequences 
downstream. Complete nuclear reprogramming following SCNT would result in 
expression profiles in SCNT embryos that mirror IVF profiles. This is not the case for 
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any of the genes analyzed except for Tacstd1. Quantitative analysis of these genes 
only at the blastocyst stage would indicate, with the exception of Oct4, that proper 
reprogramming has occurred. Studies that evaluate gene expression only at the blastocyst 
stage might underestimate the scope of reprogramming deficiencies following SCNT. 
The importance of the early embryonic expression levels of the genes analyzed in this 
study remains to be seen, but it is probable that any divergence from normal expression 
levels at any stage of development and for any amount of time has a negative effect on 
the health of the embryo. The fact that Tacstd1 was expressed normally in SCNT 
embryos indicates that some genes may be more amenable to reprogramming following 
SCNT than others. Understanding the properties of genes that make them more 
reprogrammable might offer insights into nuclear reprogramming mechanisms. 
Thbs, Snai2, and Anxa1 were all highly abundant transcripts in fibroblast donor cells, and 
consequently expression continued at an above-normal level in early SCNT embryos. 
This observation is in agreement with previous reports of ectopic expression of 
fibroblast-specific genes following SCNT (Ng and Gurdon 2005). Following SCNT 80-
90% of non-histone proteins are removed from somatic nuclei effectually erasing the 
somatic cell transcription program (Gurdon et al. 1979). This is followed by re-
establishment of an embryonic transcription program by numerous chromatin factors 
(CFs) (Gao et al. 2007). Incomplete erasure of epigenetic modifications prior to CF re-
establishment is likely the cause of these patterns of over-expression. Likewise, the 
differential expression of Tfap2c and Oct4 might be caused by similar deficiencies in the 
process of epigenetic erasure or the subsequent process of epigenetic re-establishment 
(Gao et al. 2007).       
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The present study further characterizes the deficiencies associated with 
nuclear reprogramming following SCNT. In addition to aberrant gene expression 
(Chapter 4; Arnold et al. 2006; Herath et al. 2006; Hill et al. 2002; Humpherys et al. 
2002; Li et al. 2005b; Niemann et al. 2002)  and incomplete or inefficient epigenetic 
modification (Alberio and Campbell 2003; Cezar et al. 2003; Enright et al. 2003; Kang et 
al. 2001; Kremenskoy et al. 2006; Santos et al. 2003) following SCNT it is apparent from 
this study as well as the work by Vassena et al. (2007) that the earliest embryonic stages 
in SCNT embryos are highly divergent from control embryos in terms of transcriptional 
profiles. The fact that these highly aberrant transcriptional profiles can be almost 
completely rectified by the blastocyst stage following SCNT and a portion of these 
embryos have the capacity to develop normally to term reflects the incredible plasticity of 
the oocyte in its reprogramming activities. Great strides have been made in understanding 
the molecular mechanisms associated with nuclear reprogramming following SCNT, and 
continued progress will ultimately lead to improved SCNT efficiency as well as increased 
understanding of universal epigenetic mechanisms associated with cancer and stem cell 
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CHAPTER 6  
GENETIC REPROGRAMMING OF TRANSCRIPTION FACTOR AP-2γ  IN 
BOVINE SOMATIC CELL NUCLEAR TRANSFER  
PREIMPLANTATION EMBRYOS  
AND PLACENTOMES 
Abstract 
Bovine somatic cell nuclear transfer (SCNT) efficiency remains very low despite 
a tremendous amount of research devoted to its improvement over the past decade. 
Frequent early and mid-gestational losses are commonly accompanied by placental 
abnormalities. A transcription factor, activating protein AP-2γ , has been shown to be 
necessary for proper placental development in the mouse. We first evaluated the 
expression of the gene coding for AP-2 γ  (Tfap2c) in several bovine fibroblast donor cell 
lines and found it was not expressed. Subsequently we determined the expression profile 
of Tfap2c in oocytes and various stages of pre-implantation in vitro fertilized (IVF) 
embryos. Tfap2c was undetectable in oocytes and early embryos and was detectable at 
relatively high levels in morula and blastocyst IVF embryos. The lack of expression in 
oocytes and donor cells means Tfap2c must be induced in the zygote at the morula stage 
in properly reprogrammed embryos. SCNT embryos expressed Tfap2c at the 8-cell stage, 
two days earlier than control embryos. Control embryos first expressed Tfap2c at the 
morula stage, and at this stage Tfap2c was significantly lower in the SCNT embryos. No 
differences in expression were detected at the blastocyst stage.  To determine whether 
Tfap2c was properly reprogrammed in the placenta of SCNT pregnancies, we evaluated 
its expression in cotyledons and caruncles of SCNT and control pregnancies between 
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days 55 and 90 gestation. Expression of Tfap2c in caruncles significantly increased 
between days 55 and 90, while expression in cotyledons was relatively consistent over 
that same period. Expression levels in SCNT tissues were not different from controls. 
This data indicates Tfap2c expression is altered in early preimplantation SCNT embryos, 
which may have developmental consequences resulting from genes influenced by Tfap2c, 
but expression was not different at the blastocyst stage and in placentomes.    
Introduction 
Since the first report of successful SCNT in sheep over a decade ago (Campbell et 
al. 1996) a great deal of research has focused on SCNT in a variety of species. While new 
species are added to the list of those successfully produced by SCNT on a regular basis, 
very few advancements have been made to improve the efficiency of the process. The 
underlying mechanisms behind the low efficiencies associated with SCNT are widely 
believed to be incomplete nuclear reprogramming of the somatic cell following nuclear 
transfer. During nuclear reprogramming epigenetic marks are erased from the donor 
nucleus genome, resulting in an erasure of tissue-specific gene expression patterns 
effectively resetting the cell to a totipotent state (Santos and Dean 2004). Studies 
evaluating the epigenetic status of embryos following SCNT have demonstrated 
deficiencies in epigenetic reprogramming frequently occur as manifest by aberrant gene 
expression in preimplantation embryos (Arnold et al. 2006; Daniels et al. 2000; Han et al. 
2003; Li et al. 2006; Santos et al. 2003) and fetuses (Arnold et al. 2006; Hill et al. 2002; 
Schrader et al. 2003). 
The beginnings of differentiation in the preimplantation bovine embryo occur at 
the morula stage, and differentiation is visibly apparent by the blastocyst stage, 
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characterized by the inner cell mass (ICM) that will develop into the embryo proper 
and the surrounding trophoblast cells that give rise to extra-embryonic tissues. A number 
of studies have found aberrant gene expression in bovine SCNT embryos at the blastocyst 
stage (Daniels et al. 2000; Somers et al. 2006). Abnormal phenotypes associated with 
SCNT likely arise as a result of incomplete nuclear reprogramming giving rise to altered 
gene expression levels during early preimplantation development. 
A prominent abnormal phenotype observed in SCNT pregnancies from a variety 
of species is that of abnormal placentation. In cloned mice, abnormally large placentas 
resulting from placental hyperplasia of basal or spongiotrophoblast layers has been 
reported (Ogura et al. 2002; Ono et al. 2001). Reduced development of the 
spongiotrophoblast layer has also been observed in murine SCNT pregnancies 
(Wakisaka-Saito et al. 2006). Placental abnormalities associated with SCNT in ruminant 
species include reduced numbers and enlargement of placentomes, avascularization or 
hypovascularization, hydroallantois, and hyperplasia of fetal membranes (De Sousa et al. 
2001; Hashizume et al. 2002; Hill et al. 2000; Wells et al. 1999). Poor placental 
development has been reported to be a primary contributor to pregnancy failure following 
SCNT (De Sousa et al. 2001; Fletcher et al. 2007; Heyman et al. 2002; Hill et al. 2000; 
Loi et al. 2006). 
Several groups have evaluated differential gene expression as a causative 
mechanism for the frequently observed placental abnormalities. One group evaluated 
expression patterns in blastocysts of several genes important in early placental 
development. In this study ERR2, Cdx2, and Acrogranin were aberrantly expressed in 
some of the SCNT embryos, and methods employed in the nuclear transfer process 
altered expression patterns (Hall et al. 2005). Differences in mRNA expression levels for 
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prolactin-related protein-1 (Prp-1), placental lactogen (Pl), and pregnancy associated 
glycoproteins-1 (Pag-1) and -9 (Pag-9) were reported in placental tissues of SCNT 
pregnancies between 30 and 100 days of gestation compared with controls (Patel et al. 
2004). Another study evaluated expression levels of genes important in trophoblast 
proliferation (Mash2), differentiation (Hand1), and function (Ifn-τ  and Pag-9) in d-17 
preimplantation embryos and d-40 post-implantation cotyledons. They reported increased 
expression of Mash2 and reduced expression of Hand1 in SCNT embryos. In addition, 
Pag-9 mRNA was undetectable in SCNT embryos but expressed in IVF and AI control 
embryos. Evaluation of mRNA expression in cotyledonary tissue found both Mash2 and 
Hand1 to be over-expressed in SCNT pregnancies (Arnold et al. 2006). Other groups 
have evaluated binucleate cell (BNC) populations in SCNT-derived cotyledons with 
mixed results. In ruminant species BNCs present at the fetomaternal interface play 
critical roles in pregnancy maintenance by producing and secreting proteins necessary for 
pregnancy establishment and maintenance such as Pl, Prps, and Pags (Hashizume et al. 
2007). BNCs in ruminant species are analogous to trophoblast giant cells (TGCs) in mice 
and are believed to arise from endoreplication and acytokinesis of mononucleate cells 
(MNCs) (Nakano et al. 2002). Increased numbers (Ravelich et al. 2004), normal numbers 
(Hoffert et al. 2005), and reduced numbers (Arnold et al. 2006) of BNCs have all been 
reported in bovine SCNT placentomes, so the involvement of BNCs in abnormal 
placental development and function in bovine SCNT pregnancies is unclear. 
Another gene shown to be critical in differentiation of extra-embryonic tissues 
and expressed in TGCs in mice is Tfap2c which codes for the transcription factor AP-2γ  
(Auman et al. 2002). The AP-2 family of transcription factors includes AP-2 α , β , γ , and δ . β γ δγ δδ
AP-2 proteins have been shown to be involved in regulation of cell proliferation, 
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differentiation, and tumor progression (Auman et al. 2002). AP-2γ  in particular has 
been demonstrated to be intimately involved in proper placental development and 
function. In the mouse, AP-2γ  is expressed in the oocyte, and the maternally-derived 
transcript persists through the 2-cell stage. As maternal transcript declines rapidly zygotic 
transcription of the gene is initiated, so AP-2γ  is present at relatively high levels through 
the blastocyst stage (Winger et al. 2006). The transcription factor has been shown in mice 
to be required for normal development of extra-embryonic membranes, and Tfap2c
-/-
 mice 
fail to develop a functional placenta and generally do not survive beyond 7.5 days post-
coitus (d.p.c.) (Auman et al. 2002; Winger et al. 2006). Normal embryos at 7.5 d.p.c. 
contained 50-60 TGCs, while mutant embryos contained as few as two. In addition, 
disorganization of extra-embryonic ectoderm, lack of exocoelemic and ectoplacental 
cavity formation, and reduced or absent ectoplacental cones were reported (Auman et al. 
2002; Winger et al. 2006). In a recent study analyzing global gene expression patterns in 
bovine placenta throughout gestation Tfap2c was found to be expressed in MNCs but not 
in BNCs, an important difference between murine and bovine Tfap2c expression 
(Ushizawa et al. 2007). 
Given the importance of Tfap2c demonstrated in murine placental development 
along with the numerous reports of placental abnormalities in bovine SCNT pregnancies, 
we undertook to investigate the involvement of Tfap2c in early embryonic development 
and placental function in cattle. The goal of the present study was to evaluate expression 
patterns of Tfap2c in control preimplantation embryos and placental tissues as well as 
donor cells, SCNT embryos, and placental tissues collected from SCNT pregnancies in 
order to determine whether aberrant expression of the transcription factor might be 
implicated in the abnormal placental development observed in bovine SCNT pregnancies. 
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We characterized temporal expression patterns of Tfap2c in early stages of 
preimplantation bovine IVF and SCNT embryos and in cotyledonary and caruncular 
tissue derived from AI and SCNT pregnancies between days 55 and 90 of gestation.  
Tfap2c expression was analyzed in fibroblast donor cells, oocytes, and in IVF and 
SCNT embryos 12 h post-fertilization/activation and at the 2-cell, 4-cell, 8-cell, morula, 
and blastocyst stages. This work was undertaken in an effort to gain insight into the 
timing of gene expression regulation following SCNT with the ultimate goal of 
elucidating reprogramming mechanisms. Tfap2c expression was futher analyzed in 
SCNT and control cotyledons and caruncles between 55 and 90 days gestation. This is 
the first study to report detailed stage-by-stage gene expression levels in preimplantation 
bovine SCNT embryos as well as the first to evaluate Tfap2c expression in SCNT 
placental tissues.  
Materials and Methods 
Donor Cell Culture 
Primary bovine fibroblast cultures were established from lung tissue. Tissues 
were washed thoroughly and minced, suspended in DMEM/Ham's F12 (1:1) (Hyclone 
Laboratories, Logan, UT 84321) supplemented with 15% fetal bovine serum (FBS; 
HyClone Laboratories) and 100 U/mL penicillin/ 100 µg/mL streptomycin (HyClone 
Laboratories), seeded in 25 cm
2
 tissue culture flasks, and cultured at 39˚C in a humidified 
atmosphere of 5% CO
2
 in air for several days. Cells between passages one and four were 
then harvested and re-suspended in tissue culture medium containing 10% DMSO and 
stored in liquid N
2 
until use in SCNT.  Prior to SCNT cells were thawed and grown to 80-
100% confluence. Cells were subsequently harvested by trypsinization and re-suspended 
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in manipulation medium for use in SCNT. 
Oocyte Maturation 
Maturation of bovine oocytes was performed as described previously (Li et al. 
2004a; Li et al. 2004b). Briefly, cumulus oocyte complexes (COC) were aspirated from 
3-8 mm follicles using an 18-gauge needle from ovaries collected from a local abattoir.  
Only those oocytes with uniform cytoplasm and intact layers of cumulus cells were 
selected and matured in TCM 199 containing 10% FBS, 0.5 µg/mL FSH (Sioux 
Biochemicals, Sioux City, IA 51250), 5 µg/mL LH (Sioux Biochemicals), and 100 U/mL 
penicillin/ 100 µg/mL streptomycin for 18-22 h.  
SCNT Embryo Production 
Following maturation, cumulus cells were removed from oocytes by vortexing 
COC in PB1 (calcium and magnesium containing phosphate buffered saline [HyClone 
Laboratories], 0.32 mM sodium pyruvate, 5.55 mM glucose, 3 mg/mL BSA) medium 
containing 10 mg/mL hyaluronidase. Oocytes with a first polar body were used as 
recipient cytoplasts. Enucleation was employed to remove the first polar body and 
metaphase plate, and single cells were subsequently transferred to the perivitelline
 
space 
of recipient cytoplasts.  Fusions of NT couplets were performed in mannitol fusion 
medium (Wells et al. 1999) by two electric DC pulses of 2.2 kV/cm for 25 microseconds. 
Following fusion, embryos were held in CR2 medium supplemented with 3% FBS for 1-
2 h prior to activation. Fused embryos were activated between 23 and 25 h after the onset 
of maturation by exposure to 5 µM ionomycin for 5 min followed by 5 h incubation in 
10µg/ml cycloheximide. Three groups of five embryos each were collected at each 
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embryonic stage to be analyzed. Embryos were placed in RNAlater RNA stabilization 
reagent (Ambion Inc., Austin, TX 78744) and stored at -20° C until RNA extraction.   
IVF Embryo Production 
Cyropreserved bovine semen (Hoffman AI, Logan, UT) was thawed and live 
sperm were separated by centrifugation on a 45%/95% layered Percoll gradient. Motile 
spermatozoa obtained by this method were diluted in fert-TALP to a final concentration 
of 1.0 X 10
6
 per ml (Reed et al. 1996). Capacitation occurred in fert-TALP containing 
heparin at a concentration of 10 µg/ml. In-vitro matured oocytes were fertilized in vitro 
for 18-20 h at 39°C in 5% CO
2
 and air.  After the fertilization period, oocytes were 
vortexed in a 15-ml conical centrifuge tube containing 1 ml of PB1 2 min 40 sec to 
completely remove cumulus cells.  Embryos were co-cultured with cumulus cells in CR2 
medium supplemented with 3% FBS (Rosenkrans and First 1994) at 39°C in 5% CO
2
. 
Three groups of five embryos each were collected at each embryonic stage to be 
analyzed. Embryos were rinsed through several drops of PB1 and through a single drop 
of RNAlater then placed in RNAlater (Ambion Inc.) and stored at -20° C until RNA 
extraction.   
Cotyledon and Caruncle Collection 
 Control pregnancies were either established by artificial insemination of CIDR-
synchronized cows or collected from the abattoir and aged based on crown-rump 
measurements, and SCNT pregnancies were established by non-surgical embryo transfer 
of day 7-8 SCNT blastocysts. Pregnancies were monitored by ultrasound around 
embryonic day-30 and again around day-60 and day-90. Recipient animals were 
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slaughtered at a local abattoir. Cotyledon and caruncle tissues were collected within 
thirty min of slaughter, snap frozen and stored in cryovials in liquid N
2
 until RNA 
extraction. Cotyledons were collected from nine control pregnancies (days 54, 56, 60, 69, 
70, 75, 83, 90, and 91) and seven SCNT pregnancies (days 69, 70(3), 89(2), and 90).   
RNA Extraction 
RNA extraction from embryos. Total RNA was extracted and DNA was digested 
with DNase I IVF, and NT embryos using the RNAqueous micro kit (Ambion Inc.) 
according to manufacturer’s recommendations with modifications. Prior to RNA 
extraction each sample was spiked with 50 µg yeast tRNA as a carrier. RNA was eluted 
from the RNAqueous column using two 20-µl volumes of pre-warmed (75° C) elution 
solution. Following RNA purification samples were immediately reverse-transcribed and 
stored at -20ºC until Q-PCR analysis. 
RNA extraction from cotyledons and caruncles. Cotyledons were removed from 
liquid N
2
, and approximately thirty mg of tissue was placed in RLT Buffer (Qiagen Inc., 
Valencia, CA 91355) containing beta-mercapto ethanol (βME) and subsequently 
homogenized using a rotor stator homogenizer. RNA extraction was performed using the 
RNeasy Mini RNA Extraction Kit (Qiagen) according to manufacturer’s 
recommendations.   
Reverse Transcription and  
SYBR Green Q-PCR 
Reverse transcription was performed using Superscript III Reverse Transcriptase 
(Invitrogen, Carlsbad, CA 92008) with random primers. cDNA was stored at -20°C until 
use. SYBR Green real-time PCR (Abgene, Rochester, NY 14610) was used to evaluate 
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Tfap2c expression in cotyledons, caruncles and preimplantation embryos. Each real-
time PCR reaction was performed in duplicate. Q-PCR was performed in white thin-
walled 96-well plates. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was be 
used as the internal control housekeeping gene as it has been determined to be the most 
reliable housekeeping gene in bovine preimplantation embryos (Robert et al. 2002). 
Primers for Q-PCR analysis were designed using Primer3 primer-design software (Rozen 
and Skaletsky 2000). The primer sequences were as follows: GAPDH forward: GAT 
TGT CAG CAA TGC CTC CT, GAPDH reverse: TTG AGC TCA GGG ATG ACC TT, 
Tfap2c forward: CTG CTC AGT CCC TGG AAG AC, and Tfap2c reverse: AAG GTA 
CGG CCA CCA TTT TT. A standard PCR protocol with a 15µL reaction volume was 
used. The reactions consisted of Absolute™ QPCR SYBR® Green PCR Master Mix 
(Abgene) containing fluorescein reference dye, forward and reverse primers at 200 nM 
final concentration and 1 µL diluted template cDNA. The same PCR protocol was used 
for all primers: 15 min at 95°C for activation of the hot start Thermo-Start® DNA 
Polymerase; 40 cycles of 95°C for 15 sec, 58°C for 30 sec, and 72°C for 15 sec (data 
collection step), then 95°C for 30 sec followed by an 80-cycle melt curve initiated by 30 
sec at 55°C with a temperature increase of 0.5°C each cycle. 
Statistical Analysis 
The delta-delta Ct method (∆∆Ct) was used for real-time PCR data evaluation 
(Livak and Schmittgen 2001). Data was normalized for differing amounts of input cDNA 
using ∆Ct (Ct for the GAPDH housekeeping gene minus Ct for the gene of interest). 
Next, ∆∆Ct was calculated by subtracting the ∆Ct of each sample from the ∆Ct of a 
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reference cDNA sample. The n-fold increase or decrease in expression levels of each 
gene at each embryonic stage was calculated using the formula 2
-∆∆Ct. Pair-wise 
comparisons between SCNT- and AI-∆∆Ct values were performed for each gene using 
the Student’s t-test. A probability of P<0.05 was considered significant. 
Results 
Tfap2c Expression in Fibroblast  
Donor Cells 
Initially several fibroblast donor cell lines which have been used successfully in 
our laboratory were analyzed for Tfap2c expression. Tfap2c was not detected in any of 
the cell lines analyzed. Figure 6-1 indicates pregnancy rates and rates of development to 
term of SCNT embryos derived from the cell lines analyzed. Twenty or more embryo 
transfers were performed for each of the cell lines represented. Subsequent analysis of 
gene expression was performed on embryos and placental tissue derived from the cell 
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Figure 6-1 Pregnancy rates of four fibroblast cell lines analyzed for the expression of 
Tfap2c. White bars represent the proportion of pregnancies detected at embryonic day-
30, and black bars represent proportion of embryo transfers resulting in term deliveries.  
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Tfap2c Expression in Preimplantation IVF  
and SCNT Embryos 
Oocytes and embryos were pooled in groups of five to provide sufficient RNA for 
reverse transcription and Q-PCR analysis without the need for linear amplification, and 
the pooling of embryos served to minimize variability between replicates. Unlike Tfap2c 
expression in murine oocytes and preimplantation embryos, the transcript was not 
detectable by Q-PCR analysis in bovine oocytes or early preimplantation SCNT or 
control embryos. In control embryos the gene was first detectable in morulae at high 
levels. Transcript abundance declined quite dramatically between morula and blastocyst. 
In contrastTfap2c expression in SCNT embryos was detectable approximately 48 h 
earlier in 8-cell embryos. While expression increased between 8-cell and morula, Tfap2c 
expression was significantly lower in SCNT morulae compared with IVF. Expression 
declined in to a lesser degree in SCNT blastocysts, so at the blastocyst stage Tfap2c 















Figure 6-2 Relative expression of Tfap2c in early preimplantation embryos. White 
bars represent SCNT embryos, and black bars represent IVF embryos. 
*- Expression differs significantly within stages between IVF and SCNT embryos. 
(P<0.05) 
  161 
 
Tfap2c Expression in AI and SCNT Cotyledons and Caruncles 
 Between days 55 and 85 of gestation Tfap2c expression remained constant in 
cotyledons (Figure 6-3) whereas expression increased in caruncles over the same time 
period (Figure 6-4). Tfap2c expression was higher in cotyledons than caruncles at every 
stage analyzed however, the difference in expression between the two tissues decreased 
as pregnancy progressed. SCNT and AI caruncles and cotyledons did not differ 
significantly in Tfap2c expression levels based on Q-PCR analysis. 
Discussion 
 Thirty-day and term pregnancy rates of SCNT embryos derived from the four 
donor cell lines analyzed were similar to those reported by other laboratories (Oback and 
Wells 2007). Tfap2c transcript was not detectable by Q-PCR in any of the bovine 
fibroblast cell lines analyzed. Previously it was reported that Tfap2c is likewise not 
expressed in mouse embryo fibroblasts (Winger et al. 2006).  
  162 
 
Figure 6-3 Relative expression of Tfap2c 
in cotyledons. White bars represent 
SCNT, and black bars represent AI. 
SCNT placental tissues were not available 
for analysis at day 55. 
a-Bars with unlike subscripts are different 
(P<0.05) 
*-Ranges for the above time points are 54-
60, 69-75, and 83-91. 
Figure 6-4 Relative expression of Tfap2c 
in caruncles. White bars represent SCNT, 
and black bars represent AI. SCNT 
placental tissues were not available for 
analysis at day 55. 
b-Bars with unlike subscripts are different 
(P<0.05) 
*-Ranges for the above time points are 54-
60, 69-75, and 83-91. 
 
Subsequent analysis of Tfap2c expression in oocytes and control preimplantation 
revealed several important differences from previous reports in the mouse. Tfap2c was 
not detectable in bovine oocytes nor was it expressed in early preimplantation embryos. 
The first stage in which Tfap2c was detectable in bovine IVF embryos was morula, 
where it was highly expressed. It remained detectable in control bovine blastocysts but at 
a reduced level. In the mouse Tfap2c is expressed in oocytes and at relatively constant 
levels in oocytes, 2-cell and 4-cell embryos, morulae, and blastocysts (Winger et al. 
2006). 
 Following fertilization maternal proteins and mRNAs direct embryo development 
until zygotic genome activation (ZGA). Following ZGA many of the maternal RNAs are 
degraded, and gene expression and embryo development are primarily under the control 
of the zygotic genome (Schier 2007). ZGA occurs at the 2-cell stage in mice (Zeng and 
Schultz 2005) and at the 8-cell stage in cattle (Memili and First 2000), however a limited 
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expression in mouse preimplantation embryos has demonstrated that the transcript 
present prior to ZGA is maternally derived, and following ZGA, maternal Tfap2c 
declines rapidly, and zygotic Tfap2c is actively transcribed (Winger et al. 2006). The 
differences in Tfap2c expression in murine and bovine preimplantation embryos likely 
reflect the differences in timing of ZGA.  
During the earliest stages of cell division and differentiation the embryonic 
program utilizes unique mechanisms of gene regulation. Experiments utilizing luciferase 
reporter genes under the control of a thymidine kinase promoter with and without an 
enhancer site provided the first evidence for a transcriptionally repressive state 
characterized by an increased requirement for enhancers in preimplantation mouse 
embryos following ZGA (Wiekowski et al. 1991). Attenuated response to promoters and 
increased dependence on enhancers for transcriptional activation has also been reported 
in rabbit preimplantation embryos (Christians et al. 1994). Other studies have 
demonstrated a shift in TATA box requirements of some genes in preimplantation 
embryos. While differentiated cells generally utilize TATA-containing promoters to drive 
gene expression, TATA-less promoters seem to be more efficiently used following ZGA 
(Davis and Schultz 2000). Significantly, Tfap2c expression has been shown to be under 
the control of a TATA-less promoter (Li and Kellems 2003). The expression patterns 
observed in preimplantation bovine embryos suggest Tfap2c expression is tightly 
regulated in the early embryo. Its function as a transcription factor regulated by a TATA-
less promoter as well as its precise and rapid induction at the morula stage suggest its 
important involvement in early differentiation events. 
The unique expression profiles of Tfap2c in fibroblasts, oocytes, and 
preimplantation embryos as well as the functional importance of AP-2 γ  as a transcription 
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factor critical for placental development and function compelled us to evaluate its 
expression in preimplantation SCNT embryos. Since Tfap2c is not detectable in donor 
cells or oocytes, any subsequent expression in SCNT embryos must be a consequence of 
some reprogramming event following SCNT. The timing of the induction of the 
transcription factor in SCNT embryos is certainly important for proper embryo 
development and differentiation. 
We analyzed Tfap2c expression in preimplantation SCNT embryos and found the 
gene to be detectable in 8-cell embryos- about 48 h prior to the first detectable expression 
in IVF embryos. Expression increased between the 8-cell stage and morula, but transcript 
abundance in SCNT morulae was less than half that of IVF morulae. The decline in 
Tfap2c expression between morula and blastocyst SCNT embryos was less marked than 
in IVF embryos so that by the blastocyst stage Tfap2c expression was equivalent in IVF 
and SCNT embryos.  
The early induction of Tfap2c in SCNT embryos as well as lower expression in 
SCNT morulae is likely indicative of abnormal gene regulation during the critical period 
of ZGA. While the differences in Tfap2c expression observed between SCNT and IVF 
preimplantation embryos appear relatively minor, and no difference in expression of the 
gene is observed in IVF and SCNT embryos by the blastocyst stage, these transient 
differences could have a profound impact the expression of a host of other genes 
important in early development. Early studies involving the characterization of the 
transcriptional control following ZGA suggested broad and somewhat indiscriminate 
genome activation, however, more recent transcriptional profiling studies indicate ZGA is 
a tightly controlled event in which a very specific sub-set of genes important in early 
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development are activated, particularly genes involved in transcription and RNA 
processing (Ko et al. 2000; Wang et al. 2004; Zeng and Schultz 2005).    
Subtle differences in timing and levels of expression of transcription factors such 
as Tfap2c in early preimplantation embryos could affect the timing and level of 
expression of numerous other genes downstream. Analysis of Tfap2c transcript 
abundance at various stages of preimplantation development further demonstrates that 
while expression analysis in blastocysts may indicate proper reprogramming has occurred 
following SCNT, expression analysis in earlier embryonic stages might indicate the 
opposite to be true. Global expression analysis of cloned mouse embryos during the first 
two cell cycles indicated differential gene expression in early SCNT embryos might be 
the rule rather than the exception (Vassena et al. 2007).  Given the apparent precision by 
which gene expression is controlled following ZGA, it is clear that perturbations in 
timing of gene expression may be as important developmentally as aberrant expression in 
SCNT blastocyst-stage embryos. 
Numerous reports of abnormal placental development in SCNT pregnancies exist. 
In cattle, reduced numbers of abnormally large placentomes have been observed. In 
addition hypovascularization and hyperplasic fetal membranes as well as increased 
incidence of hydroallantois have been reported (Hashizume et al. 2002; Hill et al. 2000). 
Various studies have reported abnormal gene expression in SCNT-derived placentas 
(Arnold et al. 2006; Oishi et al. 2006; Patel et al. 2004). Other groups have evaluated 
binucleate cell (BNC) populations in SCNT-derived cotyledons with mixed results. 
Increased numbers (Ravelich et al. 2004) normal numbers (Hoffert et al. 2005) and 
reduced numbers (Arnold et al. 2006) of BNCs have all been reported in SCNT 
placentomes. As BNCs are derived from MNCs, evaluation of expression of a MNC-
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derived transcript in SCNT placental tissue might offer insight into the problems 
associated with SCNT placental function.  
The expression of Tfap2c was analyzed in control and SCNT cotyledons and 
caruncles to determine whether aberrant expression might account for some of the 
abnormalities commonly associated with SCNT placentomes. Our analysis of Tfap2c 
expression in control cotyledons and caruncles substantiated a recent report (Ushizawa et 
al. 2007). The transcript was detected in both cotyledons and caruncles collected from 
pregnancies between days 55 and 90. In agreement with the previous report, Tfap2c was 
expressed at constant levels in all cotyledons analyzed, while expression in caruncles 
increased steadily over the same period. These patterns of expression (constant in 
cotyledons and increasing in caruncles) have been shown to continue at least through day 
250 gestation (Ushizawa et al. 2007). By day-250, expression levels are equivalent 
between cotyledons and caruncles. Interestingly, Tfap2c expression in cotyledons and 
caruncles derived from SCNT pregnancies around day-70 and day-90 was very closely 
correlated with Tfap2c expression in controls, an indication that Tfap2c expression levels 
in placentomes are probably not a causative agent in abnormal SCNT placentation. As 
Tfap2c expression was found to be exclusive to MNCs (Ushizawa et al. 2007), similar 
levels of Tfap2c expression in SCNT and control placentomes likely indicates normal 
MNC number and function in SCNT placentomes, at least in the context of this study. 
The normal levels of Tfap2c expression in SCNT cotyledons and caruncles does 
not preclude its involvement in the placental abnormalities frequently observed in bovine 
SCNT pregnancies. As discussed previously, aberrant expression of transcription factors 
in early embryos could have numerous downstream consequences. It is likely the gene 
expression profiles during early differentiation have a greater impact on placental 
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morphology and function than expression in differentiated placental tissue. In order 
for proper placental development to occur the initial signals for placental differentiation 
must be present. Reduced placentome numbers and altered function are certainly 
consequences of inappropriate gene expression prior to implantation when differentiation 
of trophectodermal lineages along with embryo-uterine signaling results in the union of 
fetal and maternal tissues and the establishment of placentomes. In cattle, implantation is 
initiated around day-25 gestation (Hashizume 2007), so correct expression of genes 
involved in placental function and implantation prior to this time are of critical 
importance in proper placental function. Further research of gene expression in pre- and 
peri-implantation bovine SCNT-derived tissues will be important in elucidating genes 
expression patterns associated with abnormal placentation.      
The data presented here provides impetus for the continued evaluation of gene 
expression in early preimplantation SCNT embryos prior to the blastocyst stage, 
particularly genes associated with ZGA. Clearly there remains a great deal we do not 
understand in regards to mechanisms involved in nuclear reprogramming and the 
functional importance of timing of gene expression during early embryogenesis, and 
continued research in this area will help in answering these questions. In addition this 
data offers important insights into potential roles of Tfap2c in early embryonic 
development and placentome function. Functional studies in cattle will be important in 
elucidating the roles of Tfap2c in development and differentiation of extra-embryonic 
tissues in bovine pregnancies. 
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       CHAPTER 7 
SUMMARY 
A great deal of research over the past decade has been focused on improving the 
efficiency of bovine SCNT, characterizing deficiencies in the process that impact 
efficiency, and finally understanding the mechanisms by which the oocyte successfully 
reprograms somatic cell nuclei to give rise to a complete organism from what was once 
believed to be terminally differentiated cell types. To date, the efficiency of the process 
remains quite low, though limited advances have been made in that regard. Numerous 
studies have added to the growing body of information regarding differences between 
SCNT and control embryos and fetuses. These studies have reported differences in 
epigenetic status of SCNT embryos as well as altered patterns of gene expression and 
phenotypic differences in SCNT embryos and fetuses. Advances are being made to 
understand the mechanisms of epigenetic reprogramming employed by the oocyte 
following SCNT, but progress in this area is incremental. 
The experiments reported in this dissertation identify factors associated with 
oocyte source as well as timing of activation following nuclear transfer that result in 
improved efficiencies. In addition, several aberrantly expressed genes are identified in 
somatic cell nuclear transfer blastocysts and cotyledons that could have an impact on 
cloning efficiency. The expression levels of six developmentally important genes were 
analyzed in various stages of preimplantation nuclear transfer embryos using QPCR in 
order to determine the timing of nuclear reprogramming following nuclear transfer. These 
experiments report factors associated with improved bovine somatic cell nuclear transfer 
efficiency, provide insight into potential mechanisms for low developmental rates, 
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abnormal placentation and fetal loss of bovine clones, and characterize the timing of 
nuclear reprogramming in preimplantation embryos of several important genes following 
somatic cell nuclear transfer. 
 Evaluation of embryo development and pregnancy data representing several 
thousand SCNT embryos indicated the time interval between nuclear transfer and 
activation was critical for optimal in vitro embryo development. Further experimentation 
indicated the effect was due, at least in part, to altered chromatin morphology in an 
increasing proportion of embryos as the time interval between fusion and activation 
increased. Embryos activated between one and two h after fusion exhibited higher 
cleavage and compacted morula/blastocyst rates than embryos held three h or longer 
between fusion and activation. We evaluated chromatin structure and pronuclear 
formation in embryos held between two and five h between fusion and activation and 
found normal chromatin condensation occurred at a significantly lower rate in embryos 
held three h or longer prior to fusion. In addition fragmentation of nuclei tended to 
increase with prolonged fusion/activation intervals. Interestingly, embryos that developed 
to compacted morula/blastocyst established pregnancies at equivalent rates following 
embryo transfer. Based on this data we concluded that embryos that are chromosomally 
compromised probably cease development prior to reaching compacted morula stage. 
The data further indicated that 1 h between fusion and activation provides the donor 
nucleus with sufficient exposure to MII cytoplasm to initiate critical reprogramming 
events and that longer than two h results in reduced viability of embryos in vitro. 
Further evaluation of in vitro development and pregnancy data along with 
anecdotal reports from other researchers in the field of bovine SCNT indicated a 
significant affect of oocyte source on SCNT efficiency. We compared in vitro 
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development rates as well as pregnancy rates of SCNT embryos derived from heifer 
oocytes and cow oocytes and found significant improvements in development in vitro and 
in vivo in embryos derived from cow oocytes.  We found a significantly higher 
proportion of embryos derived from cow oocytes cleaved and further developed to 
compacted morula/blastocyst. In addition, following transfer of these embryos to 
recipient animals, a higher initial pregnancy rate and significantly increased pregnancy 
retention was observed. These data demonstrated that when possible cow oocytes should 
be utilized for bovine NT experiments over heifer oocytes. The study also indicated that 
heifer oocytes are capable of reprogramming donor nuclei and producing live SCNT 
offspring, albeit at a much lower rate.  
 A second facet of the research reported in this dissertation was the identification 
of factors associated with deficiencies in nuclear reprogramming that resulted in poor 
SCNT efficiency. As reduced rates of in vitro development and pregnancy establishment 
with SCNT embryos had been reported previously, we undertook to characterize global 
gene expression differences between SCNT and control blastocysts with the goal of 
identifying gene expression differences that might account for the phenotypic differences 
observed. In addition, the common observation in our own research group as well as in 
the literature of abnormal placentation associated with SCNT pregnancies lead us to 
perform similar global gene expression experiments on cotyledonary tissues collected 
from control and SCNT pregnancies. The results of these experiments revealed a 
relatively small number of aberrantly expressed genes in SCNT embryos and cotyledons. 
The most promising genes determined to be differentially expressed in SCNT blastocysts 
were Dr1 and MHCI. DR1 binds to the TATA binding protein (TBP) and blocks the 
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binding of RNA polymerases II and III. In this way, DR1 can act as a potent 
transcriptional regulator. If Dr1 is commonly over-expressed in SCNT embryos it could 
have a profound impact on transcriptional regulation in early embryos. MHCI molecules 
serve as important antigen presenting cells in the immune response. The over-expression 
of MHCI in the bovine SCNT placentas has been reported previously, and immune 
rejection of the pregnancy by the dam resulting in placental MHCI expression has been 
proposed as a factor in the frequent losses in bovine SCNT pregnancies. In the cotlyledon 
expression studies, Rbp1 was found to be over-expressed in SCNT cotyledons. RBP1 
serves as the carrier protein for retinol (vitamin A), a vitamin critical for normal 
embryonic development. Proper doses of vitamin A are critical for normal embryonic 
development, and either an excess or a deficiency has been shown to result in embryonic 
defects. Functional studies evaluating the involvement of these genes in SCNT 
embryonic and placental development and function will be insightful. 
In order to better understand the dynamics by which nuclear reprogramming 
occurs following SCNT, we used microarray analysis to identify a number of genes that 
underwent a high degree of change in expression by the blastocyst stage following 
SCNT. We selected six functionally important genes to further investigate, three of which 
underwent down-regulation following SCNT and three that were up-regulated. Using 
QPCR we followed the expression levels of these genes through early embryonic stages 
to identify temporal differences in expression in SCNT embryos compared with IVF 
embryos. We found that five of the six genes analyzed exhibited altered levels of 
expression at some stage of preimplantation development. Only one of the six genes was 
aberrantly expressed by the blastocyst stage. These results indicate that experiments 
evaluating gene expression differences between control and SCNT blastocysts may 
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underestimate the degree of difference between clones and controls and further offer 
insights into the dynamics of gene reprogramming following SCNT.  
One of the genes evaluated in the reprogramming study, Tfap2c was investigated 
further because of its importance as a transcription factor in development and 
differentiation of extra-embryonic tissues. We analyzed Tfap2c expression levels in 
control and SCNT cotyledons collected from day-55 to day-90 pregnancies. We found 
that expression was relatively high and maintained at constant levels in cotyledons and 
that it was lower and increased over the same period in caruncles. No difference in 
expression levels was observed in SCNT cotyledons and caruncles, evidence that Tfap2c 
expression levels do not account for the reduced placental function in bovine SCNT 
pregnancies. 
Further research will be required to determine factors that impact the efficiency 
with which DNA is reprogrammed following SCNT. The data presented here includes a 
group of differentially expressed genes whose aberrant expression likely impacts SCNT 
efficiency negatively. Whether these differentially expressed genes work in concert with 
one another or independently is unclear, but it is likely the affects of aberrant gene 
expression are cumulative. Several of the genes identified herein as differentially 
expressed in SCNT blastocysts or cotyledons are certainly of physiological importance, 
and further investigation into their involvement in SCNT inefficiency is warranted. 
Additionally, the data associated with reprogramming dynamics following SCNT 
provides several important insights into reprogramming mechanisms. The observation 
that the timing of gene activation or suppression varies between genes indicates the 
timing of reprogramming is gene-dependent. It is probable that the epigenetic architecture 
of specific genes in the donor cell dictates the efficiency with which each genes is 
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reprogrammed. This data also provides the first detailed analysis of gene expression 
in multiple pre-implantation stages of SCNT and IVF embryos and indicates the 
divergence in gene expression patterns is very high in early SCNT embryos and narrows 
greatly by the blastocyst stage. 
Together these data represent a significant contribution to the field of bovine 
SCNT. We have identified factors important in SCNT efficiency as well as several 
aberrantly expressed genes in SCNT embryos and cotyledons that might account for 
some of the inefficiencies associated with SCNT. In addition, high resolution analysis of 
expression patterns of developmentally important genes in preimplantation embryos 
provides significant insight into the poorly understood mechanisms of nuclear 
reprogramming following SCNT. Continued research is required, particularly in the area 
of nuclear reprogramming in order to better understand the mechanisms involved and 
ultimately make SCNT a more efficient process.
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